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ABSTRACT 
 
During fertilisation the egg undergoes a series of remarkable activation events 
including a prolonged series of intracellular Ca2+ oscillations. The Ca2+ oscillations 
are necessary and sufficient to trigger egg activation and support pre-implantation 
embryo development. The mechanism of the signal trigger is well established and 
involves a sperm factor released into the egg upon gamete fusion.   Phospholipase 
C zeta (PLCζ) appears to be the mammalian sperm factor responsible for triggering 
Ca2+ oscillations during fertilisation. Consistent with this idea it has been found that, 
some cases of male factor infertility have been attributed to either qualitative or 
quantitative deficiencies in PLCζ. Intra-cytoplasmic sperm injection (ICSI) has 
overcome many cases of male factor  infertility. However, some ICSI cases still see 
partial or total fertilisation failure. To overcome such failures, artificial egg activation 
using various protocols has been introduced.  Ionophores are the main agents used 
to trigger artificial egg activation in human eggs. The work in this thesis provides 
evidence that the human PLCζ protein is effective and more efficient in triggering 
egg activation and in supporting pre-implantation embryo development in mouse 
eggs than other activators. That was achieved via a direct comparison of various 
activation protocols in a mouse model of ICSI fertilization failure. Furthermore 
through the use of ICSI and Ca2+ measurements in mouse eggs my studies have 
provided further evidence that the number of Ca2+ transients during activation can 
influence development to the blastocyst stage. Moreover, my work also investigates 
what methods could be used for injecting PLCζ protein within a clinic setting.  . 
Other work has attempted to investigate how Ca2+ oscillations during fertilisation 
may influence later embryo development by testing the use of probe of hydrogen 
peroxide in mouse eggs.  Overall the studies provide an important step in the 
development of new therapies for treating patients having problems conceiving with 
ICSI treatment.   
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1 Introduction 
This introduction shall act as a general analysis of the areas that are directly related 
and relevant to the areas of my study. As the work that I have done was on mouse 
gametes, eggs and sperm I shall start with an overview of gametogenesis, in which 
an explanation of the creation of male and female gametes is given. Gametogenesis 
differs between male and female; oogenesis for females and spermatogenesis in 
males. The section to follow will be an overview of Ca2+ changes that occur during 
the process of fertilisation and how it affects embryo development, in addition to 
PLCζ effect. Mitochondrial production of reactive oxygen species in relation to Ca2+ 
changes during fertilisation and its effect on pre-implantation embryo development 
within an egg then shall be discussed. 
1.1 Oogenesis 
The primordial germ cells (PMGCs) start to develop in the genital ridge before birth 
in the female foetus, these PMGCs go through a series of mitotic divisions to give 
rise to what is known as oogonia (Monk and McLaren, 1981). At around mid-
gestation in mouse these oogonia enter the first meiotic division and will reach the 
prophase of meiosis1 by the 5th postnatal day. At this stage they will remain arrested 
in the ovarian cortex within the primordial follicle and from now on they will be 
referred to as primary oocytes. By the age of 3-5 weeks the mouse will only have 
around half of the original primary oocytes that it was born with as they will 
degenerate before reaching sexual maturation which is around 6 weeks of age (Sato 
et al., 2006, Mattson and Albertini, 1990). Although these primary oocytes are 
arrested they continue to grow in size from 12 and 30µm in mouse and human 
respectively to 15 and 85µm, and this growth is completed within 10-18 days (Breed 
and Moore, 1996). The growth in size is accompanied with other structural changes 
such as the gradual appearance of what is known as the zona pellucida (ZP). The 
zona pellucida is a 6.2µm layer containing around 3.5ng of protein surrounding all 
mammalian eggs. This coating of glycoproteins is synthesised and secreted by the 
growing primary oocyte (Bleil and Wassarman, 1980). It not only regulates the 
egg/sperm interaction but supports communication between the oocyte and the 
follicular cells during oogenesis (Wassarman, 1987). The ZP consists of 3 different 
of glycoproteins in mice while in humans and many other mammals it consists of 4 
types, their proposed function is to act as receptors for the sperm.  In mouse the 
ZP3 protein has been thought to be the 'primary receptor' for sperm binding and in 
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initiating the acrosome reaction which is essential if fertilisation is to take place 
(Nixon et al., 2007). This view has been recently challenged (Jin et al., 2011).  The 
evidence put forward was that the sperm starts the acrosome reaction before 
contact with the ZP (Jin et al., 2011). The appearance is not the only change that 
occurs to the primary oocyte during its growth. This stage is characterised by the 
appearance of a large centrally located nucleus called the germinal vesicle (GV) and 
accumulation of molecules which are essential for embryogenesis. Moreover, it 
further expands in diameter to 80 and 120 µm in mouse and humans respectively 
(Breed and Moore, 1996). Every single arrested primary oocyte is contained within a 
primary follicle of many layers of follicular cells known as granulosa cells. The first 
layer of granulosa cells forms gap junctions with each other as well as with the 
primary oocyte. These GAP junctions are essential for regulation of meiotic 
maturation late in oogenesis.  The observed growth rate of the oocyte is dependent 
upon the communication through the GAP junctions. It has been found that the 
absence of specific GAP junctions would lead to cessation of growth at the type 4 
pre-antral stage at a diameter of around 50 µm (Carabatsos et al., 2000). Therefore 
it comes with no surprise that the number of granulosa cells in contact with the 
oocyte is a rate limiting step in this process (Brower and Schultz, 1982). This growth 
is responsible for the ability of the oocyte to pass into the later stages of meiosis 
triggered either by a hormonal signal in-vivo or release from the follicle in vitro. 
Primary oocytes are arrested as diploid cells that need to undergo meiosis in order 
to get fertilised. 
Meiosis is a two stage process, including meiosis I and meiosis II, in order to 
produce a haploid gamete containing one set of chromosomes. GV breakdown is 
marked by the loss of its surrounding membrane it indicates the start of the first 
meiotic division. The chromosomes at this point will have arranged themselves on 
the spindle towards the periphery of the oocyte. The chromosomes equally 
segregate into each of the first two daughter cells, but the size of the daughter cells 
are dissimilar with one cell being about 30 times larger than its sister, this is due to 
unequal cytoplasmic distribution. Degeneration is the fate of the small cell which is 
called the first polar body and the larger cell is now known as the secondary oocyte 
that contains a full set of chromosomes. This again arrests at metaphase II of the 
second meiotic division (Figure 1.1).  
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1.2 Ovulation 
One of the markers of puberty is the onset of menstrual cycle in humans which is 
accompanied by physiological changes of the hormonal levels. These changes will 
allow the arrested oocyte to enter the final stages of meiosis. At around 6 weeks of 
age mice are reproductively mature and their reproductive cycle is known as the 
estrous cycle and occurs every 4 days in laboratory conditions (Mattson and 
Albertini, 1990), each ovary will contain about 104 oocytes. The length of the cycle 
could be influenced and varied by the use of hormones and the mouse strain is one 
of many factors that affect the length of the estrous cycle in mice (Caligioni, 2009). 
Follicular stimulating hormone (FSH) secreted from the anterior pituitary gland will 
stimulate follicles that have reached a specific size and this will promote a further 
increase in size and will induce fluid collection (Caligioni, 2009). At this stage the 
follicle will be known as the graafian follicle which will start to migrate towards the 
periphery of the ovarian cortex where it will reach final stages of maturation after it 
will be released (McLean et al., 2012). The final phase of the cycle is where 
luitenising hormone (LH) secreted from the anterior pituitary gland surges and 
causes nuclear maturation before the oocyte’s release. By the time that the follicle is 
ready for release the oocyte will have completed the first meiosis and contain a full 
set of chromosomes and will arrest at metaphase II of the second meiosis (Donahue 
and Stern, 1968). Certain canine species such as dog and fox are an exception 
where their oocytes are arrested as primary oocytes with intact GV’s (Farstad, 
2000). In mice about 8-12 eggs are released during ovulation and when ovulation is 
stimulated by injection of hormones this number doubles and a single mouse can 
give around 20-30 eggs in a single cycle. 
 
1.3 Spermatogenesis 
Spermatogenesis is a process of sperm formation and like oocytes they originate 
from the primordial germinal cells (PMGCs) (Donovan, 1998). Spermatozoa were 
identified as the primary component of the semen to cause fertilisation. In humans, 
during early development the PMGCs can be detected by the end of the 3rd week of 
gestation in the extra-embryonic mesoderm. Ameboid movement of the PMGCs 
allows their migration toward the genital ridge by the end of 6 weeks of gestation 
(Anderson et al., 2000).  
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Figure 1.1 A schematic illustrating oogenesis and fertilisation. 
The sperm diagram is not in scale as the egg diameter in reality is 20X greater than the 
diameter of the sperm head. 
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During their migration phase they undergo several rounds of multiplication and by 
this time the embryo is yet to gain sex differentiation (Stoop et al., 2005). A week 
later the embryo will have established its sex and formed its gonads. Normal 
spermatogenesis is maintained via the Y chromosome, yet a number of factors 
influence this process such as hormones, growth factors and vitamins (Skaletsky et 
al., 2003). Once the testis is formed the migrated PMGCs continue to proliferate into 
gonocytes until about 12 weeks of gestation where spermatogonia can be identified 
(Skaletsky et al., 2003). Spermatogonia are identified as the multi-potent stem cells 
of the germ line. The process of spermatogenesis is supported by two types of 
interstitial cells of the testis, sertoli and leydig cells. FSH and LH secreted from the 
pituitary gland regulate the function of both of these cells respectively.  
The process of spermatogenesis starts by formation of diploid primary 
spermatocytes (46XY) via the mitotic division of spermatogonia (Stoop et al., 2005). 
The first meiotic division yields haploid cells (23X or 23Y) while 20X or 20Y in mice 
and these are known as secondary spermatocytes, and subsequently a second 
meiotic division occurs and spermatids are the result. Significant morphological 
changes occur during this process and continue during the postmeiotic period (Fig. 
1.2). The rounded spermatid converts to a normal spermatozoon. At this stage the 
nucleus compacts, DNA condenses, mitochondria accumulates and form an 
axoneme, one of the cellular centrioles elongates to form the tail while the golgi 
apparatus form the acrosomal cap. These morphological changes take up to 6 
weeks to finalise in human spermatogenesis (Heller and Clermont, 1963). The cycle 
of maturation from spermatogonium to spermatids takes around 65 days to 
complete (Dym, 1994). Cells from successive stages of the process arrange within 
the seminiferous tubules depending on their stage of maturation with the spermatids 
progressing towards the lumen. The process in itself is insufficient to produce sperm 
capable of fertilisation and the spermatids spend about 2 weeks to reach the cauda 
epididymis via peristaltic movements of the tubules. Once they get to the epididymis 
they attain their ability to fertilise via gaining motility. In mice the duration to produce 
sperm capable of fertilising an egg is almost half of that required in humans (Reijo et 
al., 1995). In humans 100 million sperm are produced daily and each ejaculate 
releases about 200 million sperm (Reijo et al., 1996). The sperm head is species 
specific, however, in all mammals the head contains highly condensed chromatin 
which is the DNA mass (Fig. 1.3) (Ward and Coffey, 1991).  
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Figure 1.2 A schematic illustrating the maturation process during 
spermatogenesis. 
As the process goes the maturation process is accompanied by the movement of the germ 
cells toward the lumen of the seminiferous tubule as the population of the germinal cells are 
located at the base of the tubule. 
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Figure 1.3 An illustration showing the main parts of the sperm. 
A, a schematic representing the main parts of a sperm, the head containing the condensed 
haploid nucleus, mid-piece with mitochondria for energy production, the tail to propel the 
sperm through the aqueous medium in female genital tract. 
B, Head of a mouse sperm. C, Human sperm with a morphologically different head from that 
of mouse. 
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1.4 Sperm capacitation 
After ejaculation the sperm will have to acquire the ability to fertilise the egg 
although they are supposed to be mature and do appear to be normal, they are not 
able to do so until they undergo a process known as capacitation, this process 
occurs inside the female genital tract before it reaches the egg (Visconti et al., 
1995). Chang in 1984 defined capacitation as a process where the sperm requires a 
certain length of time which could be in vivo or in vitro to bring about its final 
functional maturation (Chang, 1984). Capacitation as mentioned could be achieved 
using cauda epididymal and/or ejaculated sperm under a variety of different 
incubation conditions.  In vitro capacitation refers to a method where the collected 
sperm is left in an optimal media within a humidified incubator set with an optimum 
temperature of 37oC and CO2 level of 5%. On the cellular level a number of changes 
do occur, levels of Ca2+ as well as cAMP are affected (Fraser, 1998), sperm 
swimming patterns change as does the membrane fluidity, protein phosphorylation 
activity and cholesterol efflux is seen as well (Breitbart, 2002). Phosphorylation of 
several proteins is an essential step in capacitation and in humans it has been 
shown that reactive oxygen species play a role in this process (Aitken et al., 1989, 
Aitken et al., 2012). 
1.5 Acrosome reaction 
Once the sperm completes the capacitation process it undergoes another unique 
process during its short life-span within the female genital tract. The changes that 
have occurred within the cell membrane of the spermatozoon during the 
capacitation process are decisive for the success of the acrosome reaction. This 
vital process is mainly characterised by exocytosis of the contents of the acrosome 
along with the release of vesicles formed by patches of the outer acrosomal plasma 
membrane. The process as a whole has been shown to have slow kinetics (t ½ 
=14minutes), the fastest step in this development is the cytosolic Ca2+ increase (t ½ 
=0.1 minutes). However, the acrosomal swelling seems to be the rate determining 
step as it consumes most of the time to be completed (t ½ =13 minutes). Basically 
the process involves rupture of the cell plasma membrane followed by the release of 
enzymes and the exposure of surface antigens (Fraser et al., 1995, Marín-Briggiler 
et al., 2003).  It has long been thought that the site of the actual occurrence of the 
acrosomal reaction was the zona pellucida, the ZP3 glycoprotein has both sperm 
binding and acrosomal reaction triggering capacity. Therefore, it is generally 
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conceived that the reaction occurs as a consequence of the binding (Florman and 
Storey, 1982, Storey et al., 1984). Recently, in mice, it has been suggested that the 
cumulus cells surrounding the egg are vital in triggering this reaction. It has been 
found that eggs stripped from their cumulus cells were fertilised as an exception 
whereas the cumulus enclosed ones were fertilised as a rule (Jin et al., 2011) 
1.6 Fertilisation and egg activation events 
Amongst different species fertilisation occurs at different points of the cell cycle. 
However, MII is the most common stage where the mammalian eggs arrest and 
await for fertilisation to commence. Notable exceptions for this rule is the canine 
eggs that arrest at the prophase of first meiosis (Farstad, 2000), sea urchin eggs 
arrest after completion of meiosis and star fish eggs once gone through the second 
meiosis they can be fertilised without arresting (Whitaker, 1996).  
1.6.1 Sperm-egg interaction 
The first encounter between the sperm and the egg starts when the sperm comes in 
contact with the zona pellucida; this is a species specific event (Swenson and 
Dunbar, 1982).  Once the sperm gets in contact with the surface of the ZP, 
receptors on the sperm head (Izumo 1) bind to the corresponding ligands found on 
the ZP. The identification of Izumo1 protein has been a breakthrough in the 
understanding of the fertilisation process as sperm lacking this receptor were unable 
to fertilise eggs (Inoue et al., 2005). It took about nine years for the egg receptor to 
be identified and was named “Juno”, again sperm failed to fuse to eggs lacking the 
receptor (Bianchi et al., 2014). 
1.6.2 How does sperm activate an egg? 
The mechanism by which a sperm activates an egg and fertilises it has gone 
through steps of evolution where theories have been proposed then refuted. Three 
models initially have been set as an explanation to how the sperm sets off egg   
activation. The conduit, contact and content models were the main proposed 
theories to explain the Ca2+ release mechanism and hence the start of fertilisation 
(Jaffe, 1991). I will provide some background of what is known about the Ca2+ 
increases before describing the sperm factor mechanism that currently has been 
widely accepted as the most likely mechanism for this process.  
The first model states that the sperm acts as a channel to allow access for 
extracellular Ca2+ ions to pass into the egg cytoplasm via pores located on the 
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sperm cytoplasmic membrane (Fig 1.4 1). The initial rise in egg cytosolic Ca2+ 
caused by direct Ca2+ influx from the sperm was thought to induce a process known 
as Ca2+induced Ca2+ release (CICR) (Jaffe, 1991). This particular model was 
supported by the findings of which showed that sperm egg fusion occurs prior to any 
start of Ca2+ increments (McCulloh and Chambers, 1992, Lawrence et al., 1997). 
However, further studies did not support this model as it was found that Ca2+ influx 
into the egg cytosol only had the ability to produce a single Ca2+ transient and did 
not lead to the signature Ca2+ changes in the form of oscillations recorded during 
fertilisation (Swann and Ozil, 1994).  
29 
 
1. Calcium influx theory
2. The receptor theory
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Figure 1.4 The 3 different theories explaining the calcium release in the egg 
during fertilisation. 
All theories have a consensus on Ca2+ being the main trigger of egg activation. 1, sperm 
operating as a channel to allow Ca2+ into the egg, while 2, the receptor ligand theory 
activates a cascade of events after sperm-egg fusion starting with Ca2+ mobilisation. 3, the 
sperm factor theory allows an introduction of a phospholipase into the egg which triggers  
Ca2+ release from the ER. 
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The next theory is based on contact between sperm and egg through a receptor-
ligand (Fig. 1.4 2). This theory is based on a signal transduction pathway where a 
sperm ligand interacts with a receptor on the cytoplasmic membrane of the egg 
(Foltz and Shilling, 1993). In spite of evidence supporting surface proteins facilitating 
sperm-egg binding there is no direct proof that this is linked to any intracellular 
signalling mechanism switching on (Runft and Jaffe, 2000) The receptor-ligand 
theory was suggested after studies revealed an increase in inositol 1,4,5-
triphosphate (InsP3)  turnover during fertilisation in sea-urchin eggs (Ciapa and 
Whitaker, 1986). The receptor in action was thought to activate an egg derived PLC 
which in turn initiates phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis 
causing the release of InsP3 acting as a Ca2+ releasing messenger. The proposed 
receptor on the egg was suggested to be coupled to a tyrosine kinase or a G protein 
signalling cascade that eventually will lead to Ca2+ increases within the egg cytosol. 
Again, this model was refuted on the basis that an antibodies developed to the Gq 
family of the G-proteins could not avert Ca2+ changes that occur during fertilisation in 
mouse eggs (Williams et al., 1998). However, there has been consensus upon the 
role of InsP3 in regulating the Ca2+ oscillations since a number of studies showed 
that direct injection of InsP3 into an egg caused a Ca2+ release in rabbits (Fissore 
and Robl, 1993), bovine (Fissore et al., 1995) and hamster eggs (Miyazaki, 1988). 
The main challenge to the receptor-ligand theory came in when a sperm was directly 
injected into the egg cytoplasm bypassing direct surface contact between both 
gametes, yet resulted in egg activation and embryo development with subsequent 
offspring delivery at term (Kimura and Yanagimachi, 1995).    
This brings us to the sperm factor theory (Fig. 1.4 3), this theory proposes that once 
sperm egg fusion occurs, a soluble sperm factor passes through the pore formed 
into the egg cytosol and induce egg activation. This theory was supported when 
hamster sperm extracts were injected into eggs resulted in Ca2+ oscillations 
mimicking those seen during fertilisation (Swann, 1990). The sperm factor 
hypothesis explained what the conduit and receptor model came short of. Most 
importantly it could explain the possibility of fertilisation taking place without any 
sperm-egg surface interaction. Further support to this theory came from the 
demonstration of passage of fluorescent dextrans (Lawrence et al., 1997) and large 
molecular weight proteins (Jones et al., 1998b) between gametes once fusion 
occurs and this occurs before any recorded Ca2+ changes within the egg cytosol. 
Moreover, the gamete fusion itself precedes the Ca2+ change seen in sea urchin 
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eggs (McCulloh and Chambers, 1992). All of this data supported the notion that a 
soluble sperm factor is introduced into the egg cytosol after fusion.  
Another interesting finding is that the proposed sperm factor functions across 
species resulting in Ca2+ changes and egg activation. For instance injecting porcine 
sperm extracts into cow, mouse (Wu et al., 1997) and hamster (Swann, 1990) eggs 
led to Ca2+ oscillations. Microinjection of sperm extracts from frogs, chickens (Dong 
et al., 2000) and fish (Coward et al., 2003) also has the ability to release Ca2+ in 
mouse eggs in a fashion similar to that seen during fertilisation. On the other hand 
when non-mammalian eggs such as nemertean eggs were injected with sperm 
extracts from mammals such as pigs, they responded with a pattern of Ca2+ of 
oscillations similar to those seen at fertilisation (Stricker et al., 2000). Collectively 
this data provided strong evidence that the sperm factor theory is highly conserved 
not only between mammalian species but across mammalian and non-mammalian 
species. Strikingly, this observation was established between the plant and animal 
kingdoms as well. That was when Li et al 2001 managed to show Ca2+ oscillations in 
mouse eggs resulting from injection of sperm extract of the plant Brassica 
campestris (Li et al., 2001).  
During the early days of the sperm factor theory criticism was based around the 
amount of sperm extract injected into the eggs to induce Ca2+ oscillations, as it was 
predicted that more than what was equivalent to single sperm content was injected 
to result in a satisfactory level of response (Swann, 1990). It is worthwhile noting 
that the proposed sperm factor was a proteinaceous molecule and its extraction has 
been proved to be difficult hence the possibility of a significant loss of activity during 
this process. However, ICSI as a successful assisting reproductive technology has 
proved that a single sperm was sufficient to cause a physiological set of Ca2+ 
oscillations, egg activation followed by embryo development to term (Palermo et al., 
1992, Tesarik and Sousa, 1994, Sato et al., 1999a). 
1.7 ICSI and fertilisation failure 
 The improvements that have been seen in fertilisation rates due to IVF techniques 
has been predominantly seen in cases that have been diagnosed with tubal causes 
of infertility (Thonneau et al., 1991). Male causes of infertility had poorer rates of 
success (Tournaye, 2012).  The introduction of the intracytoplasmic sperm injection 
(ICSI) technique has allowed cases with especially severe sperm factor infertility to 
32 
 
see high success rates in fertilisation and pregnancy (Van Steirteghem et al., 1993). 
In the early days of this technique the cause of activation was thought to be to the 
damaging of the membrane, as this was mimicking to some extent the sperm 
membrane changes that occur in the early egg sperm fusion (Sathananthan and 
Chen, 1986). It was even suggested that the low success rates when injecting a 
whole sperm was due to the active tail disrupting the egg membrane (Fishel et al., 
1995). The breaking off the sperm tail in advance of injecting the sperm into the egg 
appears to be a vital step in the process, to allow for adequate sperm head de-
condensation and subsequent pronuclear formation (Fishel et al., 1995). However, it 
was later suggested that a sperm cytosolic component was readily introduced into 
the egg cytoplasm by this method and many of the early biochemical changes that 
happen at fertilisation still do occur during ICSI as shown by Swann and Ozil 1994 
(Swann and Ozil, 1994). The interaction between sperm and egg cytoplasmic 
membrane is not a pre-requisite for Ca2+ oscillations as proved by Ca2+ recordings 
following ICSI procedure and that when sperm extract were injected directly into an 
egg it caused Ca2+ oscillations and egg activation (Tesarik and Sousa, 1994, Homa 
and Swann, 1994). 
ICSI has the ability to overcome many causes of fertilisation failure, however it could 
not totally eliminate it. The additional problems include an exhaustive list of 
complexities (Swain and Pool, 2008). The prominent cause of failure in such cases 
is considered to be sperm defects. The sperm factor being defective is the leading 
basis of these causes (Heytens et al., 2008). Previous studies have shown a 
specific localisation of PLCζ in the sperm head of fertile men is highly likely to be in 
the perinuclear theca, while in  cases of fertilisation failure following ICSI it has been  
shown to have an abnormal localisation pattern (Yoon et al., 2008, Kashir et al., 
2010). In another study that assessed the ability of human sperm to cause Ca2+ 
oscillations in mouse eggs in order to identify sperm that can cause egg activation 
versus those that fail to activate eggs, the variability resulting suggests that human 
sperm are highly variable (Vanden Meerschaut et al., 2013a). It is worth mentioning 
that in this  study only about  50% of the control sperm, that were considered to be 
from normal fertile male, that were injected into mouse eggs resulted into a 
frequency of Ca2+ oscillations that was considered to be of a normal pattern (Vanden 
Meerschaut et al., 2013a). Currently some fertility clinics are using artificial egg 
activators such as Ca2+ ionophores in attempting to overcome cases of activation 
failure and reasonably high success rates were reported (Taylor et al., 2010). 
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However, the current trend of using these chemicals could have potential risk on the 
developing embryo which could be mutagenic or even teratogenic (Nasr-Esfahani et 
al., 2010). In addition to the possible adverse effects, the Ca2+ changes using 
ionophores have no resemblance to the physiological pattern seen during 
fertilisation. The ionophores cause a single high rise of Ca2+ while the changes seen 
in fertilisation consist of a series of Ca2+ transients that last for a few hours (Swann 
and Lawrence, 1996). Therefore the pure PLCζ recombinant protein has the 
potential to stand as a viable alternative in treating these cases as it represents a 
physiological sperm factor that can induce egg activation (see later) (Nomikos et al., 
2013). 
1.8 Ca2+; effects on Fertilisation and development 
Ca2+ is considered as a universal intracellular messenger and acts as a stimulus for 
egg activation during fertilisation and is considered a vital component of initiating a 
fertilisation response in both animal and plant kingdoms (Whitaker, 2006, Li et al., 
2007).  
1.8.1 Ca2+ changes and fertilisation 
Once the sperm enters the egg it elicits a Ca2+ change that can take many form 
depending on the species. In the majority of the mammalian eggs the change 
commences at the point of sperm entry and disseminates throughout the cytoplasm 
as a wave (Stricker, 1999). In marine worms sperm entry does not cause waveform 
Ca2+ changes, the Ca2+ change typically starts around the egg cortex where it peaks 
after in the nucleoplasm (Stephano and Gould, 1997). On the other hand non-
mammalian eggs respond to sperm penetration by a single Ca2+ rise. Interestingly in 
some marine species the sperm is not responsible for the activation during 
fertilisation. In brine shrimp for instance, the ovulation process per se and the 
contact of eggs with water causes the Ca2+ change (Lindsay and Clark Jr, 1992).   
Evidence shows that the source of Ca2+ change seems to come from internal stores, 
Ca2+ waves could be detected in sea urchin eggs when fertilised in media devoid of 
Ca2+ (Schmidt et al., 1982, Crossley et al., 1988). Mouse eggs managed to produce 
an initial Ca2+ transient even when the surrounding media had almost no Ca2+ 
(Jones et al., 1998a).  Conceptually, the thought of Ca2+ being responsible for egg 
activation during fertilisation was postulated since the early 1930’s from observation 
made during artificial activation of eggs. Ca2+ changes during fertilisation were 
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shown at fertilisation by the use of aequorin which is a protein that luminesces when 
it binds to Ca2+ in a variety of eggs (Cuthbertson and Cobbold, 1985, Whitaker, 
2006). An alternative method also proved that egg activation is correlated with Ca2+ 
changes. In hamster eggs a series of hyperpolarisation was detected along with the 
series of Ca2+ changes during fertilisation. The explanation behind this association is 
that during a cytosolic Ca2+ rise activation of a potassium conductance  leads to a 
membrane hyperpolarisation (Miyazaki and Igusa, 1981). A distinctive feature of the 
Ca2+ changes that occur during egg activation is that they take the form of a 
repetitive pattern named oscillations and they continue till around the time of 
pronuclei formation (Kline and Kline, 1992, Miyazaki i, 1993). The series of Ca2+ 
transients are not all uniform, in mouse eggs, the first Ca2+ transient typically takes 
longer to finish, but has a higher amplitude and on top of this transient smaller 
changes at the peak of this transient can be detected. The rest of the Ca2+ transients 
occur at a rate of about once every 10-15 minutes, have lower amplitude and last for 
a shorter time (Swann and Ozil, 1994). 
1.8.2 Ca2+ changes and development 
Physiological embryo development is totally dependent on the occurrence of Ca2+ 
oscillations; their necessity and sufficiency for the process of egg activation and 
promotion of further development have been proved so far (Kline and Kline, 1992). 
Egg activation is a process encompassing a number of phases including cortical 
granule exocytosis which prevents polyspermy, changes in synthesis of different 
proteins and exiting meiotic arrest (Ozil et al., 2005). If BAPTA-AM, which chelates 
Ca2+, is added to the media, the total prevention of Ca2+ oscillations during 
fertilisation occurs and all events of egg activation are blocked (Kline and Kline, 
1992). Furthermore, if Ca2+ oscillations are prematurely terminated, pronuclear 
formation is affected and progression to blastocyst stages will be influenced as well 
(Lawrence et al., 1998). Ca2+ spike number seems to play an essential role in the 
ability of the embryo to further develop. A maintained series of Ca2+ oscillations is to 
allow a sustained degradation of the maturation promoting factor (MPF) to allow 
release of the egg from its meiotic arrest (Ducibella et al., 2002). Otherwise it will 
remain arrested after extrusion of the second polar body in metaphase II. The need 
for a definite number of Ca2+ spikes   is explained by the ability of the activated egg 
to form pronuclei after fertilisation via reducing the levels of mitogen activated 
protein kinase (MAPK) activity (Ducibella et al., 2002, Gonzalez-Garcia et al., 2014).  
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1.9 Post activation development 
In mammals, once the pronuclei have developed a series of cleavages are initiated, 
and these cleavages are mitotic in nature and they are considered to happen at the 
slowest rate in the animal kingdom, typically occurring every 12-14 hours. Rotational 
cleavage is the mechanism for their occurrence, where one of the blastomere cells 
starts off by a meridonally cleavage the other divides equatorially. The blastomeres 
divisions do not synchronise, therefore, it explains the presence of an odd number of 
cells within the embryo at any given time point.  About 17-20 hours post fertilisation 
the first cell division takes place yielding two identical daughter cells, about 24 hours 
later the second cleavage starts. By 60 hours post fertilisation the embryo reaches 
the 8 cell stage and blastocyst stage is formed by 84-96 hours (3.5-4 days) (Munne 
et al., 1995). A blastocyst develops due to the secretion of fluid into the morula, 
presence of Na+ and K+ ion pumps that cause a water flow by osmosis due to 
sodium movement into the extracellular space (Watson and Barcroft, 2001). 
Following the process of compaction the cells reorganise into two groups, the first is 
a layer towards the outside that forms gap junctions between themselves. This layer 
provides protection to the second group of cells that forms a mass in the inside. This 
specific arrangement influences cell differentiation as each group is exposed to 
different environmental factors. The early differentiation is then that the outer cells 
develop into the trophoectoderm (TE) giving rise to the placental structure and the 
inner cell mass (ICM) which will provide origin of fetal tissue. 
Along with the cleavage activity, compaction and blastocyst formation the embryo 
moves towards the uterine cavity. Usually travelling embryos do not implant within 
the oviduct due to the presence of the zona-pellucida. Occasionally ectopic 
implantation occurs leading to a potentially life threatening haemorrhage when the 
oviduct can no longer accommodate the growing embryo and eventually ruptures.  
Once the expanding blastocyst reaches the uterine cavity two factors allow 
emergence of the embryo from its protective shell; the zona-pellucida. The 
expanding growth of the blastocyst by increasing the inside pressure from the fluid 
secreted along with its contractile activity and the action of Strypsin which has a 
trypsin like activity that aids in lysing the fibrillase material of the zona-
pellucida(Watson and Barcroft, 2001). As soon as the embryo is released from its 
protective shell it will implant into the uterine epithelium which has transformed  by a 
decidual reaction under hormonal influence to accept the embryo (Sandra, 2016). 
36 
 
1.10 Ca2+ effects on pre-implantation development. 
Once the embryo has passed the first cell cycle, for the embryo to proceed with its 
development it requires Ca2+ oscillations at fertilisation to be with a specific pattern 
and intensity. Studies showed that when Ca2+ oscillations were manipulated in terms 
of frequency, amplitude and duration with the use of electrical field pulses (Ozil, 
1998) they influenced the quality and quantity of developing embryos. The 
percentage of compacted embryos and further blastocysts where highly effected by 
the structure of Ca2+ oscillations as shown in rabbits (Ozil, 1990), cow embryos 
(Collas et al., 1993) and mouse embryos (Bos-Mikich et al., 1997). The duration of 
exposure to parthenogenetic activators such as Sr2+ affected the number of cells 
within the inner cell mass, increasing the duration of exposure stepwise from 2 to 4 
to 6 caused a parallel increase in the cell number (Bos-Mikich et al., 1997).  The 
early reports of cRNA encoding PLCζ injection into mouse eggs also revealed that it 
could support development up to blastocyst stage (Cox et al., 2002, Rogers et al., 
2004). However, a study by Yu et al 2008 assessed the relationship between the 
level of protein expressed and the corresponding Ca2+ oscillations resulting along 
with developmental capacity. This study concluded that the higher the level of 
protein expression, the earlier the oscillation start with a higher frequency, an 
interesting finding was that the higher the frequency the earlier the oscillation would 
terminate (Yu et al., 2008). Another important finding was that there was a window 
of about 4 fold that PLCζ protein expression would translate into successful 
development to the blastocyst stage. The exact mechanism by which Ca2+ changes 
effect embryo development is yet to be known, but these data suggest that there 
may be a window of Ca2+ oscillations consistent with good development. This is 
consistent with observations in somatic cells where the frequency of repetitive Ca2+ 
transients influence gene expression more efficiently than the monophasic Ca2+ rise 
(Dolmetsch et al., 1998). 
 
1.11 The quest to find the Sperm factor 
Over the past years the search for the sperm factor was based on the evidence 
available that Ca2+ release within mammalian eggs is initiated following sperm egg 
fusion (Lawrence et al., 1997). The search needed to answer two important 
questions; 1 proposing and identification a potential molecule as a sperm factor and 
2_ showing the proposed factor is capable of activating an egg physiologically. 
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Several proteins have come up over the years as sperm factor candidates. In the 
early days of the search for the factor, Ca2+ itself was proposed as the factor that 
initiates the activation process. The explanation was that Ca2+ was entering the egg 
cytosol from the surrounding environment. However, when Ca2+ was injected into 
the egg cytosol it failed to sustain a Ca2+ response in an oscillatory pattern (Igusa 
and Miyazaki, 1983). Moreover, the factor to be proposed had to be a protein as it 
has been proved with no doubt that the factor was a protein as its activity was 
shown to be abolished after protease treatment or heat treatment (Swann, 1990, Wu 
et al., 1997). A 33 kDa glucosamine-6-phosphate isomerase, oscillin, was one of the 
early candidates proposed and was extracted from hamster sperm extracts 
(Parrington et al., 1996). Successful recording of Ca2+ oscillation following injection 
of this protein that was present in semi-purified extracts was shown and the 
oscillations mimicked those seen during fertilisation. However, when the 
recombinant protein of oscillin was injected into mammalian eggs it failed to induce 
the response expected indicating that the protein identified was not the correct factor 
(Wolosker et al., 1998).  Another candidate that attracted attention for a while was 
the truncated form of c-kit receptor known as tr-kit. About 30% of eggs injected with 
recombinant tr-kit or its complementary RNA managed to undergo the first mitotic 
division and reached the 2-cell stage (Sette et al., 1997). Criticism towards this 
proposed sperm factor was based on that there was no evidence that this factor 
could cause fertilisation induced Ca2+ oscillations and this was just one of the first 
points against this candidate. Another problem was that tr-kit was found to be 
located within the sperm midpiece which is usually not injected during ICSI and yet 
the egg still shows signs of activation. Therefore, the improper location was another 
element further eliminating this candidate as being the sperm factor. Moreover, the 
activation capability that was shown when eggs were injected with tr-kit was blocked 
with the injection of SH3 domain of PLCgamma. Injecting this construct into eggs 
that have undergone physiological fertilisation did not block the activation process, 
again indicating another mechanism of activation other than Ca2+ mediated one. All 
these combined data refuted the proposal of tr-kit as being the quested for sperm 
factor.  
Another theory that did not survive for long was the proposal of nitric oxide (NO) as 
the sperm factor. This idea was based on the detection of NO induced Ca2+ 
increases in sea urchin eggs and both this release and the egg activation were 
blocked by NO-scavanger oxyhaemoglobin (Kuo et al., 2000). However, mouse and 
38 
 
ascidian egg studies failed to demonstrate any local or global NO changes 
associated with Ca2+ oscillations. Likewise, a nitric oxide synthase inhibitor could not 
block Ca2+ oscillations induced by fertilisation (Hyslop et al., 2001). Up to this point 
all candidates proposed failed to pass the definitive test to produce the distinct 
pattern of Ca2+ changes in the form of Ca2+ oscillations that are observed during 
fertilisation. 
InsP3 was also suggested as a sperm factor. A protein binding assay demonstrated 
that InsP3 was present in a sufficient level within the sea urchin sperm that could 
activate an egg. The fact that the sea urchin sperm extracts starts to act when it’s 
present inside the egg was perfectly consistent with the primary role of InsP3 as a 
messenger (Iwasa et al., 1990). Disappointingly single injections of InsP3 failed to 
cause Ca2+ oscillations, and the only effect seen was a single rise in cytosolic Ca2+ 
levels (Igusa and Miyazaki, 1983, Mehlmann and Kline, 1994). However, PLCs are 
known to directly cause an increase of intracellular InsP3 synthesis, for that reason 
PLCs were thought to be the upstream cause of Ca2+ changes during fertilisation. A 
group demonstrated that when sperm extracts were added to a sea urchin 
homogenate, InsP3 increments and Ca2+ changes were initiated and when the InsP3 
response in the homogenate was removed it led to a blocking of the sperm extract 
induced Ca2+ changes (Jones et al., 1998a). PLCs from now on were considered to 
be the obvious candidates for being the sperm factor and there were a number of 
PLCs that are known to be expressed in within the mammalian sperm such as PLC 
beta (β1), gamma (y1), gamma (y2), delta (d1) and delta 4 (d4) (Dupont et al., 1996, 
Mehlmann et al., 1998). With the fact that PLCs works via hydrolysing PIP2 which 
produces InsP3, it has been shown that when the PIP2 is depleted from the 
homogenate the introduced sperm factor was incapable of initiating any Ca2+ 
release. But when the homogenate was rescued using external PIP2 the Ca2+ 
oscillations started at once (Jones et al., 1998a). Moreover, supporting the PLC 
theory being the cause of initiating Ca2+ oscillations is was found that when a PIP2-
PLC inhibitor (U73122) was incubated with mouse eggs Ca2+ oscillations were 
blocked after sperm addition (Dupont et al., 1996). However, recombinant proteins 
of the former mentioned PLCs that were found to be expressed in mammalian 
sperm were unable to result in any Ca2+ changes that mimicked those seen during 
fertilisation or after injection of sperm or sperm extracts (Jones et al., 2000). 
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1.12 The sperm factor, a novel PLC 
In 2002, Saunders et al identified a novel sperm specific PLC, later known by PLCζ 
(zeta), that caused Ca2+ oscillations mimicking those recorded during fertilisation, or 
after injection of sperm or sperm extracts into mouse eggs. Moreover, when the 
specific PLCζ was depleted from the sperm extract the Ca2+ oscillations were 
abolished (Saunders et al., 2002, Swann et al., 2004). Mounting evidence that the 
correct PLC isoform was the sperm factor, long quested for, came when the 
estimated amount of the novel PLC that was injected into a mouse egg and caused 
a response resembling that seen during fertilisation was comparable to the 
endogenous level of that detected in a single sperm. In both cases this found to be 
around 20-50 fg (Saunders et al., 2002). Furthermore, when cRNA encoding PLCζ 
was injected into mouse eggs it lead to activation and subsequent development to 
the blastocyst stage in rates similar to those seen during IVF procedures. 
Interestingly the newly identified PLC isoform was preserved across species, 
monkey and human PLCζ activated and supported development up the blastocyst 
stage in mouse eggs (Cox et al., 2002). Not only in mammalian species was the 
novel sperm factor preserved but when non-mammalian PLCζ from domestic 
chicken (gallus gallus) was injected into mammalian eggs (mouse) Ca2+ oscillations 
were detected as well (Coward et al., 2005).  
 
1.13 PLCs characterisation 
PLCs have been categorised into 6 different classes, delta (δ), beta (β), gamma (γ), 
…(η), epsilon (ε) and the isoform zeta (ζ) with each class having numerical 
subclasses making in total at least 13 different isoforms currently identified (Rhee, 
2001, Hicks et al., 2008). Cell PIP2 hydrolysis is the main mechanism of action for 
various PLCs, this step is critical in initiating egg activation as it is considered the 
signal transduction for this process (Fukami et al., 2010). A plethora of evidence 
shows that the phosphoinositide signalling pathway is stimulated once the Ca2+ 
oscillations commence during fertilisation which in turn leads to an increased 
production of inositol 1, 4, 5-triphosphate (IP3) (Miyazaki i, 1993). The 
phosphoinositide-specific phospholipase C (PLC) enzymes when activated can 
generate IP3 within the cell and in order to release IP3 they catalyse the hydrolysis 
phosphatidylinositol 4, 5-bisphosphate (PIP2).  IP3 thereafter binds to its receptor 
(IP3R) on the endoplasmic reticulum where a conformational change opens the 
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channel causing an efflux of Ca2+ from the internal stores (Suh et al., 2008). It has 
been shown that the series of oscillation in cytosolic Ca2+ can be blocked by 
injecting monoclonal antibodies raised against IP3 R (Miyazaki et al., 1992). 
Structurally PLC isoforms consist of various domains, some of which are highly 
conserved amongst different isoforms and some being characteristic for specific 
isoforms (Fukami et al., 2010). PLCs that have analogous domains share about 
50% of the amino acid sequence in these regions, however there is no high 
similarity in structure between isozymes (Fukami et al., 2010). The X and Y domains 
are highly conserved domains in PLCs, functionally providing the catalytic site for 
PIP2. The EF-hand motif is another example of a domain that is present in most 
PLCs as is the C2 domain (Rhee, 2001). Other domains include regulatory ones that 
can be in a different combination of forms in various PLCs.  With the exception of 
PLC ζ, they all contain a PH domain (pleckestrin homology) which is thought to be 
used in a mechanism targeting membrane PIP2 or PIP3 (Harlan et al., 1994). Ca2+ is 
considered to be a universal activator across all PLCs, PLCζ and PLCδ have shown 
great sensitivity to Ca2+ levels in the physiological range indicating a possible 
regulatory mechanism for their function. More specifically it is thought that PLCδ is 
solely controlled by intracellular Ca2+ levels (Kim et al., 1999). In brief PLCδ 
activation is initiated by interaction between its PH domain and PIP2, this will be 
followed by another interface mediated via its C2 region and the catalytic sites which 
will eventually lead to exposure of the active site resulting in the isoform activation 
and PIP2 hydrolysis (Fukami et al., 2010). Protein-protein interaction is the usual 
mechanism allowing binding of the PLCs to plasma membranes.  PLCδ is an 
exception as its PH domain binds with high specificity its target PIP2. This interaction 
comprises a lipid-protein interaction (Nomikos et al., 2007). A specific activator for 
PLCζ is yet to be discovered, however, its extreme sensitivity to resting cytosolic 
Ca2+ may be sufficient to act as an activator (Saunders et al., 2002).  
PLCs have been found to be expressed in different tissues. The brain is found to be 
the main expression site for PLCβ, while brain and lungs predominantly express 
PLCγ (Suh et al., 2008). Heart, lung and kidneys show high levels of PLCε 
expression (Song et al., 2001). On the other hand PLCδ is one of the most variable 
PLCs in terms of presence in different tissues as it can be found abundantly in brain, 
heart, lung, skeletal muscle and testes (Suh et al., 2008). PLCs that are considered 
to be more tissue specific include PLCη as it presents mainly in the nervous system 
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(Fukami et al., 2010). The novel PLCζ which at first was thought to be solely sperm 
specific has fulfilled criteria to be the sperm factor (Saunders et al., 2002). However, 
it is considered to be no longer a sperm specific phospholipase after recent 
evidence detection of PLCζ in the ovary of puffer fish (Coward et al., 2005). 
1.14 PLC ζ, Structure and Function 
Now that PLCζ has been recognised as the most promising sperm factor (Swann et 
al., 2006), research has moved on into the characterisation of this factor. The cRNA 
encoding this PLC isoform has proved to set off the Ca2+ changes similar to those 
triggered during fertilisation and can support embryo development up to blastocyst 
stage in all mammalian oocytes studied (Rogers et al., 2004). The reason behind 
the popularity of injecting cRNA encoding PLCζ is that the protein itself is a quite 
unstable in vitro, and so cRNA injection facilitated studying the characteristics of this 
PLC isoform. Amongst all PLCs identified PLCζ is considered to be the smallest 
protein (Fig. 1. 5) (Rhee, 2001). It consists of 608 amino acids to make the human 
form (Cox et al., 2002) which makes it smaller than the mouse form that comprises 
of 647 amino acids (Saunders et al., 2007). Although the human form is considered 
to be the smallest it has proved to be the most potent in inducing Ca2+ oscillations in 
mammalian eggs. The protein consists from 4 main domains. 
1.14.1 EF hands 
Phospholipase C zeta has four repeats of this motif located at the N terminus of the 
protein and they are arranged in a helix turn-helix motif (Miyazaki and Ito, 2006). 
Proteins containing EF hands upon Ca2+ binding are able to change their 
conformation. It is thought that their role in PLCs is to be responsible for the Ca2+ 
binding (Saunders et al., 2007). Initially plasma  membrane PIP2 was described as 
being the target for EF hands (Nomikos et al., 2005), however, recent reports have 
shown co-localisation of PLC zeta to intracellular vesicles within the egg cytoplasm 
(Yu et al., 2012), the precise nature of these vesicles are yet to be identified. 
1.14.2 X-Y domain 
 This domain basically consists of three regions, the X-Y linker region and the 
catalytic domains X and Y. The linker region between X and Y is variable lengthwise 
amongst species, rhesus monkeys having the longest while the shortest is in 
humans (Saunders et al., 2007). The linker region resides between amino acid 308 
and 385 with a total of 77 amino acids, it is highly variable in between PLC isoforms. 
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The nuclear localisation signal sequence is a unique structure and is located in this 
region. It is thought to be responsible for containment of PLCζ into the newly formed 
pronuclei during the fertilisation process in mice (Swann and Lawrence, 1996). The 
catalytic domains can be viewed as having a barrel shape, they are made up from 
alternating beta sheets and alpha helices (Saunders et al., 2007). 
1.14.3 C2 domain 
This particular domain is not exclusive to this protein it can be found in a variety of 
proteins such as protein kinase C with its different isoforms, phospholipase A and 
various isoforms of phospholipase C (Nomikos et al., 2011b). About 120 residues 
from this region are in almost all proteins with a C2 domain. This domain is 
structurally composed of four stranded β-sheets based in a sandwich of two each, 
their sequences show wide variation which might explain the range of lipids that they 
can interact with. Lipid interaction can take place by two different mechanisms, 
either in a Ca2+ dependent manner or a non-Ca2+ dependant interaction (Saunders 
et al., 2007). In PLCζ, the C2 domain is one of the vital components of the protein as 
versions with C2 truncation fail to induce Ca2+ oscillations in mouse eggs, despite 
preservation of its PLC activity in vitro.  The C2 domain identifies specific 
phospoinositides to interact with, it can bind with both phosphatidylinositol 3 and 5 
phosphate (Nomikos et al., 2005, Kouchi et al., 2005) while it fails to bind to 
phosphatidylserine (Saunders et al., 2007). 
 
 
Figure 1.5 A schematic for the PLC protein with the various domain (647 aa)) 
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1.15 PLCζ and its Ca2+ releasing ability 
A unique character of PLCζ, is that it is the only PLC that can induce Ca2+ 
oscillations in eggs with injected concentration of only 1-100 femtograms. A domain 
which is present in all other PLCs and only absent from PLCζ is the PH domain. 
However, the simple lack of a PH domain does not explain the superior ability of 
PLCζ to cause Ca2+ oscillations. PLCζ has also been found to be the only PLC that 
is activated at Ca2+ levels as low as 100nM (Saunders et al., 2007). The lack of the 
PH domain in PLCζ is consistent across species and a similar domain structure is 
found in the chicken, mouse and monkey (Cox et al., 2002, Coward et al., 2005). It 
seems that the potency of PLCζ is not a feature conserved across species. The 
human version has been proved to have the strongest capability of inducing Ca2+ 
oscillation when injected in cRNA form (Cox et al., 2002). The exact cause for 
human PLCζ being the most powerful amongst others species is not precisely 
known yet, it is thought that X-Y linker region may contribute to this phenomenon as 
it appears to be the shortest of the PLCζ isoforms. One reason why it is potent is 
that the target for the human form which is the human eggs is considered to be the 
largest egg, therefore requiring a potent form of the egg activator. Alternatively it 
could be that it needs to be potent because of the sensitivity of the recipient egg to 
PLCζ. For example egg may differ in sensitivity to PLCζ since   mouse eggs are 
more sensitive than hamster eggs in their response to sperm extracts (Parrington et 
al., 1996).  
1.16 PLCζ and Male Infertility 
Since it has been postulated that PLCζ is the sperm factor that causes activation of 
the egg and its release from its meiotic arrest during fertilisation, it is logical to relate 
some causes of male infertility problems to lack or deficiency of this factor.  
1.16.1 Possible genetic defects in PLCζ 
It has been established that some cases treated for infertility problems that the male 
partner had a lack of PLCζ in their sperm and the sperm failed in activating the eggs 
(Yoon et al., 2008). It was found in a single case with repeated history of failure of 
fertilisation during IVF/ICSI procedures that the sperm was globozoospermic (round 
head) and these sperms lack the acrosome in their structure. When a genomic 
analysis for the DNA of the PLCζ gene was done for this case, interestingly a defect 
in the opening frame of the DNA sequence was identified (Heytens et al., 2009). The 
defect identified was a change in the base sequence at the position 1193 of the 
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ORF, this was a change of the adenosine (A) by a cystosine (c) and this was 
predicted to be a mutation in the Y catalytic domain which could explain the infertility 
cause (Heytens et al., 2009). This point mutation has been confirmed as the reason 
of failure in causing the physiological series of Ca2+oscillations. This was shown in a 
study by Heytens et al, involving two separate injections of mouse eggs with cRNA 
encoding hPLCζ one as the wild type (hPLCζWT) while the other had the point 
mutation (hPLCζH398P). The response to these injections was clustered into two 
groups, the first group demonstrated a series of Ca2+ oscillations mimicking those 
seen during fertilisation and those belonged to the eggs injected with the wild type 
hPLCζ. The second group either revealed a very minimal response where most 
eggs did not show even a single Ca2+ spike (Heytens et al., 2009). The results of 
this study confirmed that the mutation identified obviously affects the activity of the 
protein in vivo.  
1.16.2 PLCζ, its Possible Role in Treatment of male Infertility.  
In cases of male factor infertility due to defects in PLCζ, the activating signalling 
system which is Ca2+ is the missing link to release the egg from its meiotic arrest 
and the initiate development. Therefore, it would seem reasonable to assume that if 
the egg received a dose of PLCζ during ART then the eggs would more likely be 
able to activate. Moreover, other applications would include the use of PLCζ as a 
parthenogenetic activator in nuclear transfer protocols in generating embryonic stem 
cells. The cRNA encoding PLCζ, when injected into human eggs that have failed in 
an assisted reproductive technique, demonstrated a prolonged series of Ca2+ 
oscillations and development up to blastocyst stage (Rogers et al., 2004). PLCζ in 
its unique capability of causing a physiological Ca2+ response was considered to be 
superior to other agents used in activation protocols as some of these agents can 
only induce a single Ca2+ rise such as Ca2+ ionophores (Nasr-Esfahani et al., 2010). 
However the use of a genetic based material in clinical settings is not likely to be 
accepted, moreover, the amount of protein to be expressed is unpredictable after 
the injection of the cRNA, and this could cause adverse effects (Ozil et al., 2006). 
1.17 Embryo Quality and Developmental Capacity 
The main aim of any assisted reproductive technique is to transfer blastocysts that 
would potentially implant into the recipient uterus, the current guidelines is to 
transfer a single blastocyst or maximum two at each IVF cycle to reduce the risk of 
multiple gestations (Min et al., 2006). The in-vitro culturing environment cannot 
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support developing of an embryo beyond the blastocyst stage as at this point they 
need to implant. Embryo implantation rates when transferred at the blastocyst stage 
stage are around 30% to 50% (Gardner et al., 1998). It is the quality of the 
blastocyst transferred that determines the success rate of implantation and further 
development, therefore a number of parameters have been set to determine which 
embryos that are more likely to implant (Bavister, 1995, Van Soom et al., 1997).  
1.17.1 Criteria for Embryo Quality Assessment. 
An important topic since the introduction of IVF techniques is embryo selection. 
Initially embryo morphology was the most obvious criterion to base the selection 
upon. However, selecting the most competent implanting embryo based on its 
external features has limited predictability. Invasive procedures where embryos 
undergo a cell removal at a specific pre-implantation stage was found to negatively 
impact further development (Kirkegaard et al., 2012).  What could be gained through 
analysis of cell markers from a single blastomere would be counterbalanced by the 
effect of its removal. Due to pitfalls of the invasive procedures, non-invasive 
methods seem to have wider acceptability when it comes to identifying best embryo 
for transfer in IVF clinics. However, it has to be noted that the increase in the 
number of successful pregnancies post IVF procedures has been attributed to the 
vast improvement seen within IVF protocols and not to the selection criteria 
introduced (Cohen et al., 2012).   
1.17.2 Embryo Morphology, is it a valid tool for selection? 
To select an embryo based on morphology during a single time point is subject to 
variability, as varying the time points that the embryo is examined at could reveal 
different findings (Montag et al., 2011). In an ESHRE meeting in 2011 the only 
consensus in regard to morphological based criteria that would have a valid 
prognostic marker was the presence of the smooth endoplasmic reticulum, as it 
would indicate an unfavourable pregnancy outcome (Otsuki et al., 2004). Another 
non invasive approach is to extend the period that the embryo are cultured. As most 
of the developmental blocks occur in the early stages, culturing to the blastocyst 
stage has been widely used since the enhanced medias and culturing protocols 
were introduced (Gardner et al., 1998, Summers et al., 2000). However, again this 
brings back the question over which blastocyst is more likely to implant if returned? 
Blastocysts have a more diverse appearance and several scoring systems exist 
(Dokras et al., 1993, Gardner and Lane, 2003, Gardner et al., 2015). Moreover, 
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recent studies revealed that the day 2/3 embryo produced from IVF were returned 
into the uterus were far more efficient in producing clinical pregnancies than when 
blastocyst stage was transferred (Cruz et al., 2012).  
1.17.3 Embryo Metabolic Activity. 
When extended culture media for blastocysts were designed it brought into light that 
the embryo has different needs at different times, which if not fulfilled would affect 
development and later implantation capacity (Gardner et al., 2001). Embryo 
metabolic activity was based on criteria such as oxygen consumption, nutrient 
uptake and waste production and embryo viability assessment built on this ground 
proved to be useful (Gardner et al., 1994). A number of target molecules were 
observed to have a changing pattern over development, glucose, pyruvate and 
amino acids were amongst molecules extensively studied from the media 
surrounding embryos. For instance glucose consumption positively correlates with 
progress in development and it may allow prediction of an embryo sex during the 
compaction phase (Gardner et al., 2011). Amino acids profiling on the other hand 
aided in identifying embryos with aneuploidy (Picton et al., 2010). The metabolomics 
field has attracted wide interest, but the technical difficulties and the need for high 
sample throughput questions the applicability of this method in routine clinical use 
(Gardner et al., 2015).    
1.17.4 Time-Lapse Imaging, an influential tool for embryo selection. 
Keeping the embryos from being disturbed by exposure to external environment 
during morphological evaluation was the main driver behind producing a technology 
that would efficiently reduce this concern. A further reason is that embryo 
development is a kinetically active process and the static method of monitoring once 
per day did not reflect truly the developmental process. In fact several important 
aspects to the morphology of the embryo could be missed. So the answer was 
constructing a device that could record changes without the need to be removed 
from the culturing environment. A number of experimental approaches were 
suggested (Lemmen et al., 2008), however, it was not until commercial time-lapse 
systems were introduced to the market for their full potentiality to be discovered 
(Montag et al., 2013).  Time lapse imaging per se has not caused any decline in 
developmental rates in embryos (Kirkegaard et al., 2012), in fact it has been claimed 
that successful pregnancy rates have seen a rise of about 20% since its introduction 
(Meseguer et al., 2012).  
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Time lapse cinematography is a method used to follow embryos post fertilisation. 
One of the early parameters that showed the ability to predict superior quality 
embryos for implantation was the cell cycle timings, also known as the time taken for 
cleavages to finalise (Bavister, 1995, Van Soom et al., 1997).  In cow embryos the 
fastest cleaving embryos had the highest implantation rates (Grisart et al., 1994), 
furthermore, it seems that when cleavage cycles  synchronise during the first few 
cell cycles it would predict a favourable developmental course (Cruz et al., 2012, 
Wong, 2010).  Differences do exist between embryos cultured in-vivo and in-vitro 
environments. For instance blastocyst hatching mechanism in-vitro occurs via focal 
lyses by the trophoectoderm projections while in-vivo blastocysts escape the zona 
by global dissolution (Gonzales and Bavister, 1995). However, blastocyst hatching 
criteria such as timings and dynamics is still a valid tool for assessing embryo 
quality.  
1.17.5 Apoptosis and cellular quantification 
Cytoplasmic fragmentation, also known as apoptosis, is a phenomenon observed in 
both superior and low quality embryos. However, the level of fragmentation does 
differ immensely, in excellent quality embryos it is thought that a minimal degree of 
fragmentation is required in aid of defective cells removal and to control cell number 
and growth (Hardy et al., 2003). On the other hand, where extensive fragmentation 
is present it would be associated with a reduction in the number of cells within the 
blastocysts, a decrease in the implantation rates and it has been recognised as a 
cause of a well-known phenomenon, embryonic arrest (Jurisicova et al., 1996, 
Hardy et al., 2003). The negative effect of fragmentation on the developing embryo 
could be explained in two mechanisms, first the dying cells could release toxic 
substances that could be detrimental to the healthy neighbours. Secondly, the cell 
death leads to a reduction in the amount of cytoplasmic material which means a 
potential loss of probably critical cellular components (Alikani et al., 1999). A 
plethora of quantification protocols for both embryonic cell types, the 
trophoectoderm and inner cell mass (TE and ICM) which highlights the importance 
of cell number distribution between these two cell types(Adjaye et al., 2005, Koo et 
al., 2002). A minimum number is needed for each cell type to allow normal fetal 
development (Hardy and Handyside, 1996) For instance, an increase in the ICM 
number over the TE has been linked to large offspring syndrome (Leese, 1998).  
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1.18 Embryonic Developmental Block. 
The period following the event of fertilisation is considered to be a silent phase in 
terms of transcription and early development is driven via maternal mRNAs and 
proteins which are progressively degraded following fertilisation. Egg maturation is 
the onset for the degradation process and by the 2-cell stage 90% of maternal 
mRNA is removed, however, some of maternal protein is still synthesised up to 8-
cell stage (Paynton et al., 1988, Zheng et al., 2005). The switch of the embryonic 
genome is activated at different times in different species, in humans it occurs at the 
4-8 cell stage (Braude et al., 1988), while in mice it ensues once the 2-cell embryo 
(Flach et al., 1982). Therefore the developmental block is considered to be species 
specific event and is correlated to the activation/switch on of embryonic genome 
(Minami et al., 2007).  Moreover, a number of factors seem to contribute to the 
developmental block; the strain of mice used and the culture conditions including 
medium components (Chatot et al., 1989).  
In the early efforts of embryo culture, the 8-cell embryos were cultured up to the 
blastocyst stage in a simple defined media (Whitten, 1956). The effect of media on 
embryo development was soon recognised and as protocols for media improvement 
took place the culture of early embryos was seen as well. CZB is one of the first 
media that embryos from different mice strains were successfully cultured to the 
blastocyst stage (Chatot et al., 1989). Other media quickly followed; a simplex 
optimised media (SOM) along with the version containing potassium (K+) 
supplement (KSOM) (Lawitts and Biggers, 1991, Lawitts and Biggers, 1993). Other 
factors contributed to the success of the new mediums in overcoming the 
developmental block, such as the level of osmolarity, the levels of sodium chloride 
(NaCL), glucose or phosphate levels, as well as significantly effect of altering the 
pyruvate: lactate ratio (Biggers, 1998). All of all, it seems that the in-vitro culturing 
conditions, that could be detrimental to the developmental capability of the embryos 
as well as failure of embryonic genome activation, are mechanisms that contribute 
to developmental block (Betts and Madan, 2008).  
1.19 The Mitochondria and reactive Oxygen Species. 
The mitochondria within the arrested egg have the same distinctive features as 
other mitochondria present in any other cell. They are known to have their own DNA 
that allows them to replicate independently of the cell cycle controlled via the 
nucleus. The mitochondria has two membranes surrounding its cytoplasm, the outer 
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and inner membrane with the inner membranes considered to be the main barrier as 
it is more impermeant. Two main cellular processes occur within the mitochondria, 
the tricarboxylic acid (TCA) cycle and the respiratory chain reaction. The 
mitochondria have a membrane potential of -150-180 mV which is independent of 
the cytoplasmic membrane and is negative to that of the cytosol (Duchen, 2000). 
This membrane potential is established due to proton transfer across its inner 
membrane creating an electrochemical proton gradient. The mitochondrial 
membrane potential highly influences cellular function as it produces ATP. It effects 
cytosolic Ca2+ homeostasis as it allows its movement along its electrochemical 
gradient into mitochondria (Smaili et al., 2000, Duchen, 2000).  
1.19.1 Mitochondria in eggs 
Morphologically mitochondria in eggs differ from those in somatic cells, they contain 
less cristae and are more spherical than the elongated ones present in somatic cells 
(Dumollard et al., 2004). Once primordial germ cells are formed they contain around 
10 mitochondrion, they carry on and replicate throughout maturation, and by the end 
of the maturation process the replication ends.  At this point they would have 
reached a number of several hundred thousand (Poulton and Marchington, 2002). 
The fertilised egg is supported by its mitochondria up to its blastocyst stage, 
however, fertilisation and development up to blastocyst stage is still possible even 
with suppression of mitochondrial DNA replication and translation (Huo and 
Scarpulla, 2001). The GV is the large nucleus present in the centre of the egg 
before maturation and the mitochondria during this stage will be present within the 
GV as clusters (Jansen, 2000). As soon as the meiotic spindle begins to form and 
starts to migrate the mitochondria leaves the GV and moves towards the animal 
pole (Nishi et al., 2003). During early stages of maturation the mitochondria will be 
found in close proximity to the endoplasmic reticulum which suggests an interaction 
between both organelles (Marchi et al., 2014, Sardet et al., 2007). In the metaphase 
II arrested egg the mitochondria will be accumulated around the nucleus at the 
centre and surrounding the meiotic spindle (Calarco, 1995).  
1.19.2 Mitochondria and Fertilisation 
The mitochondrial enzymatic processes are stimulated once Ca2+ oscillations start 
during fertilisation (Schomer and Epel, 1998, Campbell and Swann, 2006, 
Dumollard et al., 2008).  Experiments have  revealed that post sperm egg fusion and 
Ca2+ release, as a consequence oxygen consumption is initiated within the egg and 
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reaches a maximum  (Dumollard et al., 2003). Even though sperm egg fusion allows 
the passage of sperm mitochondria into the egg cytoplasm, these do not participate 
in supporting embryo development as they get destroyed by the egg (Sutovsky et 
al., 2000). However,  previous evidence that there are still medical cases that 
present due to inherited parental mitochondrial defects (Schwartz and Vissing, 
2002). It seems that the fertilisation process drives a structural change in the 
mitochondria as its cristae become more prominent, and during fertilisation Ca2+ 
homeostasis and ATP production are highly influenced by the mitochondria 
(Dumollard et al., 2003, Dumollard et al., 2004). Poor embryo development and 
apoptosis is seen in mammalian eggs such as human, mouse and pig that have 
mitochondria that exhibit structural or functional defects (Van Blerkom et al., 1995). 
Another vital process that mitochondria control during fertilisation is the production 
of reactive oxygen species (ROS) (Morado et al 2013). Recordings demonstrated 
that a prominent ROS, hydrogen peroxide can potentially cause a higher 
fragmentation rate which is detrimental to the embryo’s capability to develop (Liu et 
al., 2000, Kimura et al., 2010). 
1.19.3 Mitochondria and Ca2+ signalling 
The evolution of the eukaryotic cells over time has allowed development of toolkits 
specifically for Ca2+ detection and sensing. Those include specific proteins that have 
the ability to sense the changes in Ca2+ levels so signalling pathways could operate 
by detecting this change.  Ca2+ channels operate as part of a homeostatic system to 
keep control of cytosolic Ca2+ level. The level of Ca2+ during inactive periods within 
the cytosol is known as the basal cytosolic Ca2+ and what allows this equilibrium in 
the long term is the interaction of the influx-efflux rates (Berridge et al., 2000, 
Rizzuto and Pozzan, 2006). Any organelle pumps or other buffering systems only 
affect the cytosolic levels transiently. Cytosolic changes of Ca2+ are caused by either 
entry from the extracellular space or release from intracellular storage sites, or a 
combination of both. At the end of a signal Ca2+ change the basal levels have to be 
rebalanced and this rebalance occurs at the expense of energy consumption 
through the action of pumps and antiporter (Rizzuto and Pozzan, 2006).  
The endoplasmic reticulum has been long known to be the main intracellular Ca2+ 
store, however, almost all other intracellular organelles play a role in Ca2+ signalling 
such as mitochondria (Saris and Carafoli, 2005) the Golgi apparatus (Pinton et al., 
1998), secretory vesicles (Mitchell et al., 2001)and many others. Much attention has 
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been paid to the mitochondria for its unique ability to handle Ca2+ in an energy 
dependant manner. Ca2+ strongly influences the function of many mitochondrial 
enzymes within the matrix such as dehydrogenases (Denton, 2009). For an 
example, mitochondrial enzymes present on the outer surface of the inner 
mitochondrial membrane (IMM) such as glycerophosphate dehydrogenase or the 
malate-aspartate shuttle and others.  The simultaneous change of Ca2+ within the 
mitochondria associated with that of the cytosol has a wider scale of implications on 
the cell. The change within the mitochondria is in a larger range and this excess 
uptake from the cytosol can induce a bioenergetic failure through a number of 
mechanisms. Apoptosis and necrosis are means of organelle and cell death in 
cases of mitochondrial overload with Ca2+ and that is through opening of the 
permeability transition pore (PTP) and release of cytochrome c (Contreras et al., 
2010, Calì et al., 2012, Pinto et al., 2015). 
1.20 ROS and Effects on Embryo development. 
Oxidative phosphorylation is a process on which the oocyte relies on in producing its 
ATP. This form of energy production depends on oxygen as a key substrate. 
Therefore, the total usage of oxygen has been used as an indicator of the eggs 
metabolic activity (Leese, 2003). During the early cleavage cycles the mitochondrial 
activity is thought to account for at least 30% of the total oxygen consumption, this 
figures doubles as the embryo gets to the blastocyst stage (Trimarchi et al., 2000). 
Oxidative energy production is not free of risk as it comes at a cost of reactive 
oxygen species production, more specifically the superoxide anion and the hydroxyl 
radical.  Once the superoxide anion is catalysed via dismutase it produces hydrogen 
peroxide and in presence of metal ions such as iron it can yield metal-centred 
oxygen radicals, these species are detrimental to proteins and DNA (Guérin et al., 
2001). Early studies have revealed that overproduction of ROS in fertilised eggs can 
cause developmental failing (Johnson and Nasr-Esfahani, 1994). Aitekn et al in 
1989 has connected the generation of these oxidative species to the arrest of cell 
division and loss of cell function (Aitken et al., 1989). On the other hand, ROS 
production is essential for normal cellular processes to function and contribute 
positively in growth and development (Hardy et al., 2001). Necessary gene 
activation has been observed in response to alteration in the level of ROS 
production, as a result, it is suggested that it’s the correct balance between the 
production and clearing of ROS that is essential not the mere presence of ROS 
52 
 
(Burdon, 1996). During sperm penetration in bovine eggs an increase in ROS 
production has been recorded, and this increase is known as the respiratory burst 
during fertilisation (Nasr-Esfahani and Johnson, 1991). This increase in ROS 
production via increased mitochondrial activity has been suggested to be caused by 
the Ca2+ changes that occur during fertilisation. Depending on the level of oxidative 
stress it can lead to either necrosis or apoptosis (Burdon, 1996). Programmed cell 
death (PCD) could be caused by increased levels of oxidative stress as a result of 
raised levels of H2O2. Reports have shown elevated levels of H2O2 in fragmented 
human embryos (Betts and Madan, 2008). In a recent study early embryonic 
developmental arrest has been directly related to mitochondrial dysfunction (Thouas 
et al., 2004), moreover, sub-lethal doses of photosensitisation to mitochondria have 
shown delayed negative effects. The detrimental manifestations of sub-lethal 
mitochondrial damage appeared at later stage where the embryos were aborted as 
a result of implantation failure (Thouas et al., 2004). However, in the same way that 
the ROS can be present at any site in the embryo, there are defensive mechanisms 
that are present at various locations in the cell. In embryos ROS can be produced in 
mitochondria as well as the cytosol, protective enzymes found at these sites are the 
mitochondrial superoxide dismutases (Mn-SOD) and its cytosolic version (Cu, Zn 
SOD). The free radicals are converted into H2O2 which in turn is  removed via GPX 
in cytosol and mitochondria (Guérin et al., 2001).  
1.21 Hyper, A Novel Intracellular Hydrogen Peroxide detector. 
Since the 2-cell block phenomenon has been identified (Goddard and Pratt, 1983), 
unravelling the factors that could lead to it has led to a conclusion that reactive 
oxygen species particularly hydrogen peroxide are involved as one of the main 
causes for this phenomenon of cell damage in-vitro (Aitken et al., 1989). Many 
studies have been designed in an attempt to measure the level of H2O2 in individual 
living mouse eggs and embryos (Nasr-Esfahani and Johnson, 1992, Lopes et al., 
2010). The basis of most of these studies was the use of 2, 7-
dichlorodihidrofluorescein diacetate (DCHFDA) AM dyes as they are readily 
permeant into the cells where they get trapped due to the action of the intracellular 
esterases that hydrolyse these compounds yielding DCHF (Chen et al., 2010b).  
The magnitude of fluorescence resulting from oxidation of the dye by H2O2 seems to 
be linearly related to the level of H2O2 present in the cell, therefore it was suggested 
that the level of fluorescence could be used as a direct estimate of intracellular 
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H2O2. This has been shown in mouse strains that were more prone to the blocking 
such as the MF1 as well as the non-blocking strains such as F1 (Nasr-Esfahani et 
al., 1990a).  
The OxyR gene has a vital role within E.coli for its ability to activate genes that 
encode scavenging enzymes for reactive oxygen species, the conformational 
changes that occur to the OxyR protein when transformed from its reduced state to 
the oxidised state provides the means of it sensing an oxidative stress signal and 
therefore stimulates the ability of the cell to switch on the defence mechanisms 
(Christman et al., 1989). Therefore the design of this novel probe was based on the 
known properties of the E.coli protein known as OxyR and this protein is a specific 
H2O2 sensor while remaining unaffected by other reactive oxygen species (Storz and 
Tartaglia, 1992). The novel probe known as HyPer is claimed to be a specific probe 
for detecting hydrogen peroxide changes within living cells, the main component of 
this probe is the H2O2-sensing protein known as OxyR that is found in prokaryotic 
cells, and the circularly  permuted yellow fluorescent protein (cpYFP) that has been 
incorporated into this regulatory domain (Belousov et al., 2006). Within the cells the 
oxidised HyPer has shown the ability to reduce back to its initial state which is a 
main feature of the wild type OxyR. The fluorescence increase marking the reaction 
of HyPer with hydrogen peroxide comes down to its initial baseline several minutes 
following the H2O2 burst (Belousov et al., 2006).  
 
 
 
 
 
 
 
1.22 Project Aims 
In this dissertation the intention was mainly to investigate the ability of PLCζ protein 
to rescue cases of failed fertilisation. I developed a protocol that would be applicable 
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in IVF clinics to treat cases of failed fertilisation in certain cases of infertility.  The 
first aim has two facets to its purpose. The first was to create a mouse model of 
male infertility in our laboratory. The model results in a number of phenotypes of 
sperm in terms of their ability to induce Ca2+ oscillations in mouse oocytes. The next 
step further was to rescue the oocytes with PLCζ and asses the level of pre-
implantation development. In light of the fact that currently several IVF clinics are 
using a number of chemical agents in rescuing cases of failed fertilisation, a 
comparison of PLCζ to other egg activators was set as an aim as well. The second 
key aspect was to construct a complete protocol that would develop a precise 
method of injecting PLCζ in terms of identifying media properties, injection needle 
characteristics, and how to inject a therapeutic dose of this protein.  This protocol 
created is designed to be applicable to human eggs in IVF clinics.  
The final chapter was designed to investigate causes of poor development after 
activation, by examining if there is an excess of reactive oxygen species generated 
at fertilisation. The hypothesis was built around the fact that Ca2+ changes during 
fertilisation influences mitochondrial activity and that in turn could be in a positive 
(ATP production) or a negative (excess ROS) mode, depending on the frequency of 
oscillation. Reactive oxygen species were studied using a novel hydrogen peroxide 
sensor for the first time in eggs. A final separate chapter will summarise the data in 
all results chapters providing a detailed discussion of all findings in this thesis. 
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Chapter 2 
MATERIALS AND METHODS 
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2 Material and Methods. 
2.1 Health and safety and legal procedures 
All of the chemicals were handled and stored according to the manufacturer’s 
regulations recommended and all of the PLCζ RNA was handled as required by the 
Genetic Manipulation Advisory Group (GMAG). All of the experimental work was 
done in accordance to the regulations of the control of substances Hazardous to 
Health (COSHH) and Cardiff University laboratory regulations. Human egg work was 
started after obtaining a licence from the Human Fertilisation and Embryology 
Authority (HFEA). Human eggs were used to investigate the role of sperm PLCζ in 
human oocyte activation, a research licence was issued (R0161/2/c). All donated 
human eggs for scientific research were handled and treated according to HFEA 
regulations and guidelines. 
2.2 Laboratory reagents and animals 
All chemicals and reagents were obtained from Sigma UK unless stated otherwise 
and were of the best grade available such as ‘embryo tested’ or ‘cell culture tested’.  
The cRNA constructs were kindly supplied by Prof. Tony Lai and made by Michail 
Nomikos. In summary, the cRNA that was used in some experiments was 
synthesized using a well-defined protocol, the open reading frame of mouse PLCζ 
was used for this purpose. Measuring the absorbance at 260nm of each batch of 
cRNA made in a 500μl quartz cuvette and with the aid of a specific equation 
quantification of the product was possible. In-vitro protein expression was done to 
check the cRNA and that was done in a rabbit reticulyte lysate system (Promega). 
Previous publications from the group have details of this process (Saunders et al., 
2002, Nomikos et al., 2005, Swann et al., 2009). 
2.2.1 Production and purification of recombinant protein 
Protein was also made by Michael Nomikos.  In short the recombinant protein 
produced had a NusA tag to increase solubility and 6x-Histidine (6x-His) tag to allow 
purification. The relevant pETMM60 plasmid was transformed into Escherichia coli 
(BL21-CodonPlus (DE3)-RILP, Stratagene, CA, USA). The transformed E. coli were 
then cultured at 37°C before the temperature was reduced to 16°C for 18 hours 
where protein expression was induced. Once cells had been harvested they were 
re-suspended they were sonicated. The recombinant protein was then purified using 
nickel-nitrilotriacetic affinity chromatography matrix (Ni-NTA Agrose; Qiagen) which 
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selects for His tagged proteins. The protein was eluted using 250mM imidazole then 
dialysed overnight which after it was concentrated. Recombinant protein was either 
used immediately, kept at 4°C for short term storage or snap froze and stored at -
80°C for long term storage. 
2.2.2 Mice 
Female MF1 mice were bought from Harlan at about 6 weeks of age. Male mice are 
C57/CBA F1 hybrid that were obtained from (Harlan, UK Ltd.). Male mice were used 
for mating as well as retrieving sperm used for IVF and ICSI (Intra-cytoplasmic 
Sperm Injection). 
2.2.3 Hormone preparation for super-ovulation protocol 
Hormonal treatment was used to superovulate female MF1 mice which were around 
6 weeks old at the time. Hormones that were used for this purpose were given at 
two stages and are pregnant mare serum gonadotrophin (PMSG) (PMSG; intervet) 
and human chorionic gonadotrophin (hCG) (HCG; intervet). The first stage of 
ovulation induction utilises PMSG at 2-4pm (day 1) as it mimics the action of the 
follicular stimulating hormone (FSH) and it stimulates the growth and development 
of the ovarian follicles and is given as a concentration of 5-7 IU. This first injection is 
followed 48hrs later by a second intra-peritoneal injection of hCG at 6pm of day 3 as 
it mirrors the action of the luteinising hormone (LH) by promoting maturation of the 
follicles and allows their release, the concentration used for this particular hormone 
is 10 IU. 15hours post hCG injection the mice were culled for tissue harvest, 
oviducts in particular. 
2.3 Fire pulled glass pipettes 
Before performing any experiment there are tools that need to be made such as the 
glass pipettes that are used to transfer the eggs from one solution to another or from 
one dish to the other. The transferring process is carried out by attaching a 
changeable mouth piece which is a sterile 1ml plastic syringe with the plunger taken 
out to plastic tubing, the wide end of the glass pipette is connected to the tube via a 
plastic tube connecter that has a cotton wool plug. This fine bore glass pipette is 
prepared in the laboratory by holding the narrow end of a disposable glass pipette 
over a small flame of a Bunsen burner. The pipette is rotated whilst it is over the 
flame to ensure even heating of the glass, when the glass starts to melt a sudden 
and fast pull from one end of the pipette is done. Breaking the pipette at 
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approximately 5cm from its origin is the next step and this will produce an opening 
with a diameter slightly larger than that of the egg (>80µm), to allow smooth pick up 
and release of eggs. The glass pipette was changed frequently during any 
experiment.  
2.4 Collection of eggs  
The female MF1 mice that have been super-ovulated by intra-peritoneal injection of 
two hormone doses were sacrificed by the use of schedule 1 for humane animal 
killing. The mice were sacrificed in the Joint Biological Services (JBIOS) facility at 
Heath Park, Cardiff University in accordance with HM Home Office regulations. The 
CO2 chamber was used for the first stage until the mice were believed to have 
ceased spontaneous breathing then cervical dislocation was followed up to ensure 
death. Subsequently a simple dissection was done to retrieve the oviducts as shown 
in Fig.2.1. The oviducts were placed into warm M2 media (Sigma-Aldrich) and 
carried over to the lab to release the eggs. Under a dissecting microscope the 
ampullas were pierced using a 25 gauge needle while the oviduct being held by a 
forceps, the egg-cumulus complex gets releases from the tear site into dish that 
contains pre-warmed   hyaluronidase with a concentration of 300µg/ml in M2 media. 
The egg-cumulus   mass remains in the media with hyaluronidase enzyme for no 
longer than 5 minutes which allows time for denuding the eggs from the surrounding 
cumulus cells (Lawrence et al., 1997). Fig.2.2 shows the eggs before and after 
treatment with hyaluronidase, following this the eggs are washed in at least 3 drops 
of M2 media to remove any traces of carried over media with hyaluronidase. After 
this step the eggs are kept in 100µl droplet of M2 covered by embryo tested mineral 
oil and left to recover at least for ten minutes at 37 degrees before any experimental 
procedure being carried on them. In some experiments I have used GV eggs (eggs 
with germinal vesicles). Briefly, unprimed mice were used for this purpose (i.e no 
hormones were injected), oviducts were collected as mentioned before and with the 
use of a forceps and a 25 gauge needle the ovary was cut into fine pieces. With the 
use of a fine pipette, oocytes with a GV were collected and the cumulus cells 
surrounding them were mechanically removed by the use of the fine pipette as well. 
The oocytes were maintained in the GV state by incubating them in M2 media 
containing 250µM IBMX and covered with embryo tested mineral oil and kept at 37 
degrees until injection or further treatment. 
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2.5 Human Eggs  
Couples from IVF Wales clinic or Neath Port Talbot who were engaged in this 
project had a briefing about the aims of the research conducted and were given a 
consent form that described the project in detail. Only those who gave written 
consent for use of their unfertilised eggs were involved in this project. From both 
clinics eggs that had failed to fertilise after IVF or ICSI and in some instances GV 
eggs were used as well. From IVF Wales clinic,  eggs were collected personally and 
eggs from Neath Port Talbot were delivered in a heated flask to maintain the 
temperature throughout the journey. A handover protocol was followed during 
receiving and delivering the eggs. 
2.6 Sperm collection and preparation 
After male mice were sacrificed using the CO2 method followed by a confirmation 
with cervical dislocation, dissection to the lower abdominal region was done. When 
the testis per side was exposed the epididymis was collected by cutting the vas 
deferens near to the caudal epididymis using a pair of clean fine scissors and a 
forceps and kept in pre-warmed M2 media, this procedure was carried out in the 
Joint Biological Services (JBIOS) facility at Heath park, Cardiff University in 
accordance with HM Home Office regulations. The collected epididymis were carried 
over to the laboratory where sperm were squeezed from the caudal region of the 
epididymis into a dish containing about 1ml of and pre-warmed T6 media (Quinn et 
al., 1982). The T6 media after being prepared in stock and kept at 4 degrees, when 
to be used addition of 15mg/ml of bovine serum albumin (BSA) and sterile filtered 
after which it is kept overnight in a 5% CO2 incubator at 37 degrees to equilibrate to 
a pH of 7.6. The sperm, when released into the pre-equilibrated T6, are given a 
period of around 5 minutes to swim out then made up to a total of 5ml to achieve a 
required concentration to be used for in vitro fertilisation. The tube containing T6 
with sperm is returned into the incubator to allow for capacitation. If the sperm is to 
be used for ICSI experiments they are aliquot into 250µl aliquots and stored in -80 
freezer until further use. 
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Figure 2.1 Dissection of MF1 female mouse post superovulation. 
A Mouse culled via schedule 1 and positioning for dissection. B, Skin dissection and 
revealing abdominal peritoneum. C, D Peritoneum retraction and gut deflection to 
either side to reveal ovary and oviduct that will be cut out. 
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Figure 2.2  Hyluronidase treatment of cumulus masses. 
A, Cumulus masses after release from oviducts into the hyluronidase drop. B Eggs 
starting to dissociate from the mass. C, Eggs dissociating for the surrounding 
cumulus cells. D, E Free eggs are washed through several drops of M2 to remove 
62 
 
traces of hyluronidase and cumulus cells which after eggs are kept in an M2 drop 
covered by mineral oil until further use. 
2.7 Chemicals that alter intracellular Ca2+ levels and/or 
parthenogenetically activate MII eggs 
Ca2+ transients can be stimulated and detected in eggs after physiological sperm 
attachment and after ICSI. However other non-physiological methods to increase 
intracellular Ca2+ have been proposed either in a repetitive or non-repetitive manner. 
When eggs are activated without mating, or by other methods not involving 
fertilisation, this process is known as parthenogenesis. I have used the Ca2+ 
ionophore which was prepared as a 10mM stock in DMSO and a final concentration 
of 10µM was used in parthenogenetic activation protocols. During the first hour of 
fertilisation or activation the emission of the second polar body takes place to 
release half of the chromosomes making the egg ready to fuse with the male 
pronucleus that contains the other half of the genetic information required for optimal 
development. However, it is much more accurate to say that no actual merging 
takes place but when the membranes of both pronuclei dissolve, the chromosomes 
of both contributors align on the spindle apparatus at the equator. In cases of 
parthenogentic activation to ensure proper cell cycle progression this event is 
prevented by the presence of cytochalasin B or D (CB or CD). CB is a cell 
permeable mycotoxin, it strongly inhibits network formation by actin filaments and 
therefore blocks the contractility of microfilaments and cytoplasmic division. A 
5mg/ml stock was prepared in DMSO and when required it was diluted to a working 
concentration of 5µg/ml  
2.8  Media preparation 
M2 media obtained (from Sigma Aldrich) was aliquot into 10 ml test tubes and kept 
in the fridge. Every working morning one tube is taken out and placed in the desktop 
heated block for the use of that specific day and any remaining media will be 
discarded at the end of the day. Potassium chloride (KCL) Hepes buffer (100mM 
KCL and 20mM Hepes) were prepared to be used as a diluting media for reagents 
to be injected into eggs. Chelex 100 beads were used to eliminate any ions that 
were present; pH was calibrated and ensured to be at 7.5. Concentrated Hepes 
buffered potassium simplex optimized media (HKSOM) was made as a 10x stock 
and kept in the -80 freezer. 500 ml of sterile water was added to the components 
shown in Table 2.1 to make the required stock (Erbach et al., 1994). HKSOM is 
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prepared from the concentrated stock (with the use of 1ml) by adding 7.5 ml of 
sterile water and Ca2+chloride (10µl of 1.7M CaCl2) and 10 µl of 0.2 M glucose, the 
pH is adjusted to 7.4 by adding 20-30 µl of sodium hydroxide. The osmolarity is 
confirmed for each preparation made before commencing experiments to 
280mOsm/kg by using a freezing point osmometer (Gonotec Osmometres-
Osmomat 030, Germany). However, different versions of this media were made 
according to the experiment intended. 
2.8.1 Low sodium HKSOM 
The idea behind the use of a media that has almost all of the sodium being omitted 
from it is to create a hyper-osmotic media (350-400mOsm/kg) and it was used in 
some of the ICSI experiments. It was prepared in the same manner as the full 
HKSOM with replacing the sodium salts with their choline correspondents in order to 
maintain a higher osmolarity. 
2.8.2 Sr2+ HKSOM preparation 
In order to use strontium chloride as a parthenogenetic activator for eggs, Ca2+ free 
HKSOM was prepared in the exact same way as the regular HKSOM with omitting 
the Ca2+chloride component. The Ca2+ component was replaced by Sr2+ with a 
concentration of 5-10mM, as it has been reported that this concentration with 
exposure duration of 2.5 hours in mouse eggs has the best pronuclear development 
rate, blastocyst formation and cell number in parthenotes (Ma et al., 2005). This 
media has been used to parthenogenetically activate MII eggs, 2µM cytochalasin B 
was used in the media to prevent extrusion of the second polar body and produce a 
diploid embryo instead of a haploid embryo (Meinecke-Tillmann and Meinecke, 
1980). Therefore the eggs are first washed three times in Ca2+ free HKSOM to 
ensure all traces of Ca2+ are eliminated then the eggs are incubated in this media for 
about 2-2.5 hours and then removed and allowed to recover in regular HKSOM 
before culturing. 
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Chemical 
10x stock (stored 
at -80 after filter 
sterilisation) 
Working 
media (1x) pH 
7.4 
MW 
 g/500ml Ml/500ml mM g/l  
NaCl 27.75  9.5 5.55 58.44 
KCl 0.925  2.5 0.185 74.56 
KH2PO4 0.238  0.35 0.0476 228.2 
NaPyruvate 0.11  0.2 0.022 110.04 
Streptomycin 
sulphate 
0.25   0.05  
Penicillin G 0.315   0.063  
EDTA 0.019  0.01 0.0038 416.2 
MgSO4. 7H2O 0.246  0.2 0.0493 246.48 
Na Lactate 
(liquid) 
 7.37 10.0  112.1 
NaHCO3 1.68  4.0 0.336 84.01 
HEPES 23.8  20.0 4.76 238.31 
Phenol red 0.055    354.38 
L-glutamine 0.73  1.0 0.146 146.15 
 
Table 2.1 Different components of HKSOM medium. 
HKSOM medium in both forms, the 10x stock which is stored at -80 until further use 
after filter sterilisation and the working 1x prepared media. 
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2.9 Microinjection of mouse eggs 
The microinjection needles are pulled on a daily basis first to prevent any 
contamination to the tips and to ensure a sharp tip for every needle used. 
Borosilicate glass capillaries are used (Harvard Apparatus Ltd. 1.5 mm outer 
diameter and an inner diameter of 0.86 mm). These glass capillaries are 
characterised by having an internal filament which increases the capillary action and 
eases the back filling process. The glass capillaries are pulled on a vertical pipette 
puller (Model P-30; Sutter Instruments), the needles are backfilled with < 1µl of the 
injection solution using microsterile micropipettes (Ependorff). The needle is then 
fitted to a holder (ME2H25FW, World Precision Instruments) that has a silver wire 
which goes down through the needle. The needle holder has a side port that is 
connected to a picopump pressure injector (model PV820, World Precision 
Instruments) via a silicon tube. The holder then is securely attached to another 
clamp that is connected to a preamplifier of an electrometer (IE-25A, Warner 
Instrument Corporation). The preamplifier, needle holder and the holding pipette are 
mounted on hydraulic manipulators (Narashige) which are in turn fixed to an 
inverted microscope (TE2000, Nikon).  
The injection needle is directed by a manual control towards the base of the dish 
that contains the eggs to be injected. Eggs are held in position with the use of 
suction by a holding pipette that has been previously pulled from G-100 TF glass 
(Harvard Apparatus Ltd) using PN-30 pipette puller (Narashige). The holding pipette 
is attached to a syringe system (Cell Tram Air 5176, Eppendorf), each egg is held 
individually by the holding pipette through negative pressure which allows the egg to 
be sucked onto the holding pipette. The injection needle is driven towards the egg 
piercing the zona pellucida and once it reaches the cytoplasmic membrane a small 
electrical oscillation using the electrical amplifier is delivered. This oscillatory action 
allows the injection pipette to penetrate the plasma membrane without damage. 
Microinjection of the solution required is delivered by applying high pressure pulses 
to the back of injection needles (usually 20 psi for approximately 0.5seconds). The 
injected solution is estimated by the cytoplasmic displacement caused by the 
injection itself, which is estimated to be 3-5% of the egg cytoplasm volume (Larman 
et al., 2004). Wherever PLCζ recombinant protein or the cRNA were to be 
microinjected they were diluted in Hepes buffered injection buffer (KCL Hepes) and 
where Ca2+ was to be measured the diluted protein or cRNA was mixed with equal 
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parts of a Ca2+ indicator. The solution was mixed and spun to the bottom of a 0.5ml 
tube using a benchtop centrifuge (Spectrofuge 24D, Jencons) prior to microinjection. 
Injected agents will be elaborated upon in the corresponding results sections. In 
cases where multiple agents are required to be injected such as (Rhod dextran dye 
and mouse PLCζ RNA) a co-injection protocol would be carried out to reduce the 
potential damage that may be caused to the egg by multiple injections (Fig. 2.4). 
Different experiments have differing protocols so each protocol will be discussed in 
its related result section. 
 
2.10  In vitro Fertilisation (IVF) 
IVF is carried out around with eggs 16-18 hours after hCG administration. Sperm 
that has capacitated in the incubator and prepared as mentioned previously is used 
for this experiment. When Ca2+ changes during IVF are intended to be recorded the 
eggs are preloaded with 2μM of PE3 AM dye (Fura2 leakage resistant dye) as they 
are incubated for 30 minutes in the dye, washed in at least 3 drops of M2 to remove 
any dye trace, then allowed to recover in an 100µl M2 drop covered by mineral oil. 
Removal of the zona pellucida was done by a brief exposure to acidified Tyrode’s 
solution, in order to stabilise the eggs during the addition of the sperm. Sperm egg 
fusion can lead to movement and that will affect the Ca2+ traces recorded.  The zona 
free eggs are washed in three drops of M2 media before being placed in a dish with 
1ml of HKSOM or M2 and this process allows the eggs to stick to the glass cover 
slip of the dish and reduce any movement. The recording is initiated and is allowed 
to proceed for about 15 minutes first to ensure that the eggs are firmly attached to 
the bottom of the dish and secondly the base line recording of Ca2+ has been 
stabilised. A 20µl of sperm preparation is added to the dish with eggs and direct 
visualisation of the eggs is done to ensure enough sperm is available around the 
eggs to ensure fertilisation completion and then the recording is continued. When an 
IVF run is carried out to obtain embryos and follow up their development, dye 
loading and acid Tyrode’s steps are omitted. Eggs are placed in a dish with 1 ml of 
HKSOM and covered by mineral oil and 20µl of sperm preparation is added. After a 
period of 1 hour the eggs are washed in three drops of M2 and cultured. 
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2.11  Intracytoplasmic sperm injection (ICSI) 
The first generated mouse offspring from using ICSI technique was shown by 
Yanagimachi in 1995 (Kimura and Yanagimachi, 1995).  However, the 
micromanipulation technique itself was developed by Atsushi Mimatsu and 
colleagues and it utilised the piezoelectric effect (Kimura and Yanagimachi, 1995). 
The use of piezo in mouse ICSI allowed the survival rates to reach 100% when it 
rarely exceeded 50% when conventional methods were used. Naoko Yoshida & 
Anthony CF Perry provided a detailed description of the procedure (Yoshida and 
Perry, 2007), therefore I will summarise the technique that is used for the ICSI 
experiments included in some parts of this work. 
2.11.1 ICSI Microinjection needle preparation 
 Borosilicate glass capillaries (G-100 TF glass) (Harvard Apparatus Ltd) are pulled 
on a micropipette puller using PN-30 (Narashige). On a microforge the tip of the 
pulled pipette is broken by applying a brief heat (current) pulse producing a flat 
sharp end with a diameter of 6.5-8.5μm. At a distance of about 3-5 mm from the tip 
a bend of about 30o is made by gradually heating the glass pipette and stored in a 
Petri dish for later use. Figure 2.3 shows various instruments used in the make f the 
pipettes. 
2.11.2 Preparation of the workstation for micromanipulation 
The work station for micromanipulation is shown in Fig. 2.4. A pipette egg holder is 
placed on one side while the microinjection needle is mounted on the other side 
after being backfilled with Flourinert (FC-770) and ensuring no air bubbles between 
the oil and flouirnert interface. The dish preparation will depend on the type of 
experiment carried out and will be described in relevant chapters. However basically 
it will contain a drop of M2 media or/and other type of media, expelling several drops 
of fluorinert in order to wash and lubricate the interior for a smoother control of the 
material to be injected. Eggs are placed in the M2 drop ready to be injected. 
2.11.3 The injection  
The material to be injected either sperm or PLCζ is either placed in a separate drop 
or within the drop that contains the eggs. A sperm or a column of PLCζ is withdrawn 
into the injection pipette and then advanced towards the egg. Having the MII plate at 
6 or 12 o’clock position and the egg plasma membrane in sharp focus, the 
microinjection needle is advanced towards the zona pellucida and an application of 
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repetitive moderate piezo pulses will allow the needle to advance into the 
perivitelline space. The microinjection needle is then pushed towards the plasma 
membrane until it produces a deep invagination into about 90% of the egg diameter. 
A gentler single piezo pulse is given and the plasma membrane will relax and retain 
its original shape then the material to be injected can be deposited by applying 
positive pressure. The needle is withdrawn from the egg cytoplasm smoothly and 
the plasma membrane should appear intact. After finishing the injections, the eggs 
are examined and the surviving eggs are transferred into a drop of M2 and placed 
on a bench top incubator to be examined later for pronuclei development and further 
culture. If the aim of the injection was to image Ca2+ changes after injection of sperm 
or PLCζ the eggs are taken directly to a heated stage on Nikon microscope based 
fluorescence system.                                                    
2.12  Mouse embryo culture and development 
Mouse embryos were cultured in-vitro in drops of freshly reconstituted KSOM 
(Merck Millipore). The KSOM is equilibrated the night before culture in 5% CO2 
incubator at 37 degrees after being covered by mineral oil. The size of the drops are 
usually governed by the number of embryos in each drop, usually around 2-3µl of 
media per embryo. Where embryos were followed by time lapse imaging or there 
was a need to take an image on a regular basis such as in case of examining cell 
cycle division timings a Lumascope (Etaluma Inc, USA) has been used for this 
purpose. The Lumascope provides fluorescence and bright field microscopy in an 
inverted microscope and its compact size enables working in challenging locations 
including inside incubators. Easy routine inspection of eggs from within the incubator 
with its high-quality imaging minimises any photo damage that otherwise would have 
to be taken outside under a regular microscope. The Lumascope fits in incubators, 
therefore it provided a reasonable mean to image regularly (time lapse) while 
maintaining the optimal incubation environment. With just the power from the USB 
port of a laptop required, it provides a convenient portable fluorescence microscopy 
workstation. With this USB connection the images and the time lapse series are 
recorded directly on the computer. Analysis of data was done post experiment 
completion offline using Image J and Sigma plot software. 
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Figure 2.3 Instruments used in the making of various pipettes. 
A, the injection pipette puller (SUTTER Instrument Corp P-30). B, C The holding and 
ICSI pipette beveller (Intracel, Microforge, MF-900-Narishige-Japan). 
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Figure 2.4 The micro-injection system. 
A, The microinjection system, the inverted microscope (Nikon ECLIPSE TE2000_S, Japan) 
fitted with the pipette holders. B, The injection dish placed on the system, holding pipette to 
the right and the injection pipette to the left. C, D, E, Images of egg microinjection process, 
egg held in position by the holding pipette while the injection pipette advances through the 
zona pellucida and a bolus dose of Rhod-dextran dye microinjected (Rhod-dex used to show 
material delivery inside the egg). 
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2.13 Ca2+ Indicators  
A range of fluorescent Ca2+ indicators have been used to measure Ca2+ fluctuations 
(Table 2, 2). The fluorescent Ca2+ probes were either dextran linked or AM dyes, 
dextran linked dyes were microinjected directly into the cytoplasm ahead of imaging 
alone or in combination with PLCζ protein or its corresponding cRNA. 
2.13.1 Dextran linked Ca2+ Indicators 
Rhod-2 Dextran (Rhod dex) and Oregan Green BAPTA Dextran (OGBD) are 
examples of this category of indicators that has been used in some sections. These 
dyes are dextran linked yielding an indicator that is retained within the cytoplasm for 
long periods of time without compartmentalisation. These hydrophilic 
polysaccharides are biologically inert, water soluble and have low cell toxicity.  Rhod 
dextran has been preferred in a lot of experiments for measuring Ca2+, its high Kd 
(750nm) reduces Ca2+ buffering effects and it has a large dynamic range. It also has 
the advantage of being excited by green light which is less phototoxic to eggs and 
upon excitation it emits a red light which is far from the autoflourescene emitted by 
the cell.  
2.13.2 AM indicators 
In contrast, the cell-permeant acetoxymethyl (AM) esters are loaded passively into 
the egg cytoplasm, where they are cleaved to cell-impermeant products by 
intracellular esterases. The non-ionic and nondenaturing detergent PluronicR F-127 
are frequently added to help disperse the indicator in the loading medium. After an 
incubation period of 30 minutes at 37°C, the cells are washed across at least 4 
drops of M2 which is a serum-free medium as serum may contain esterase activity. 
The loading medium (M2) is also free of amino acids or buffers containing primary or 
secondary amines because aliphatic amines may cleave the AM esters and prevent 
loading. Cal-520 is an example of this type of Ca2+ indicators that has been in 
sections of this work, it has been used on both mouse and human eggs, loading 
time for human eggs is 45 minutes. Others are Fura-2 leak resistant AM dye (PE3).  
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Ca2+ Indicator Excitation (nm) Emission (nm) Kd (nm) 
Cal-520 AM 
By AAT Bioquest 
492 514 320 
Fura-2 Leak Res AM 
(PE3) By TefLabs 
335 495 145 
Rhod dextran 
By Life Technolgies 
552 581 750 
Oregon Green BAPTA 
dextran (OGBD) By 
Life Technolgies 
494 523 170 
 
Table 2.2 Various Ca2+ indicators used throughout the project. 
Different dyes used for measuring Ca2+ changes within the eggs with their excitation, 
emission wavelengths and Kd values.  
 
Figure 2.5 Schematic diagram of Epi-fluorescence using an inverted 
microscope system 
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2.14  Measurements of intracellular Ca2+ changes 
Within the laboratory there are different imaging systems and the system to be used 
is defined by the experimental design and the purpose. 
2.14.1 A Nikon microscope based fluorescence system 
An inverted epifluorescence microscope (Nikon Eclipse Ti-U microscope) that has a 
heated stage (Warner Instruments) is used for most of the fluorescence imaging 
recordings (Fig 2.5). The heated stage ensures that the eggs are maintained at 35-
37 degrees during this process. The light source for this system was either a white 
halogen lamp or an LED lamp (Optolite LED Lite, Cairns research Ltd), the light from 
the source passes through a filter of the appropriate wavelength. The filter allows 
only the light that is within the excitation spectrum of the fluorescent protein in the 
egg to pass through the objective to reach the sample after reflecting off a diochoric 
mirror. When light hits the sample the fluorescent dye or protein within the egg 
absorbs it and emits a light that has a bigger wavelength which is within the 
emission spectrum. The cooled CCD camera (CoolSNAP HQz, Photometrics) which 
is connected to the computer and In Vivo software collects the emitted light that has 
passed back through the objective and via the diochroic mirror and the emission 
filter. An optical filter changer (Lambda 10-3, Sutter Instrument Company) switches 
filters at set intervals and provides a means of automatically changing the filters, 
allowing more than one fluorescent channel to be detected during a given 
experiment. The objective used for imaging of Ca2+ fluorescence was a 20x (0.75 
N.A, Plan Apo) objective, only in some experiments where human eggs were 
imaged a 10x (0.50 N.A, Flour) objective was used. Images were taken every 10 
seconds unless stated otherwise with an exposure of 100-400 milli-seconds. To 
reduce the photo damage the light exposure was kept to a minimum by increasing 
the camera sensitivity via using a camera pixel binning of 8x8. The images were 
saved as .tif files on a computer dedicated for this purpose only, analysis of data 
was done post experiment completely  offline. 
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Figure 2.6  The fluorescence imaging system 
A, The fluorescence imaging system (inverted microscope, Nikon ECLIPSE Ti-Japan) and 
the recording of experiments. B, C Closer look of the heated stage containing the imaging 
dish. 
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2.15  Data and statistical analysis 
Data collection and initial analysis is done by specialised software dependent upon 
the system used for imaging. 
For the epifluorescent system the recordings were analysed using the acquisition 
software Image J and its multiple processing plugins, Image j has the ability to read 
.tif files which the data is stored as. The .tif files were pulled up and with the use of 
the multi-measure plugin the images were analysed as stacks, the software would 
calculate the pixel value yielding fluorescence intensities. Regions of interest (ROI) 
are drawn around the eggs with an additional area from a free space which would 
be used as the background fluorescence, this background fluorescence will be later 
subtracted from the fluorescence value of each egg to give a corrected fluorescence 
value for individual eggs. The trace representing Ca2+  changes in the egg is plotted 
against time as normalised values, to normalise fluorescence the background 
corrected fluorescence (F) was divided by the basal value (F0) giving F/F0. 
Various files from different imaging systems are imported finally into Sigma Plot 12 
Software (Systat Software inc.) for further analysis. This software allows automated 
creation of graphs through its various tab options, the large data work sheets 
accommodate any size of data sets. Statistical analysis is done by this software as 
well, as it provides descriptive statistics for the worksheet columns, it runs paired 
and unpaired t-tests between worksheet columns and error bars for graphs of 
column means or standard deviation. 
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Chapter 3 
A Mouse Model of Male Infertility 
and Rescue of Failed 
Fertilisation by PLCζ Protein. 
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3 A Mouse Model of Male Infertility and Rescue of Failed 
Fertilisation by PLCζ Protein. 
3.1 Introduction  
The intracytoplasmic sperm injection also known as ICSI is a widely accepted 
modality of infertility treatment for couples attending the infertility clinics , when 
compared to alternative options of treatment it has a superior rates of success 
specially in male factor causes of infertility (Palermo et al., 1992, Johnson et al., 
2013). Even with such a treatment that involves injecting a sperm into the egg, 
failure rates are still documented which can reach a rate of 1-5% of the cycles 
treated, meaning that all eggs collected form a women have failed to show signs of 
fertilisation (Liu et al., 1995, Yanagida, 2004). The inability of the sperm to activate 
the egg is considered the main cause of fertilisation failure in these cases and that is 
due to a lack or deficiency of factors that allow the egg to be released from its arrest 
during fertilisation leading to lack of signs of egg activation (Javed et al., 2010, 
Vanden Meerschaut et al., 2013b, Neri et al., 2014). However, it has to be said that 
these cases are rare to occur as the egg yield during a cycle of ovarian stimulation 
yields around 10 eggs to be injected in a single setting of treatment (Sunkara et al., 
2011). In case of total fertilisation failure  the couple have very limited options for 
treatment, but even with these options overcoming the problem is not always the 
possible  (Yuzpe et al., 2000, Heindryckx et al., 2005).  
 
The availability of many eggs during treatment cycles somewhat overshadows the 
failure rate of single egg injections. In cases where the apparent cause of infertility 
was a tubal factor only over 60% of the eggs managed to show signs of activation 
(Bukulmez et al., 2000) , which suggests  that about  1 in every 3 eggs the sperm 
are unable to initiate the activation process. If one takes into consideration that the 
very first IVF treatment was done on an egg that has resulted from a natural 
ovulation cycle. No hormonal stimulation protocol allows for a natural selection of 
eggs to be used for the procedure (Hillier, 2013) then the failure rates seen for 
individual eggs would be of a concern.  Moreover, the call is for the implementation 
of lighter stimulation protocols in the light of concerns raised over the cost and 
complexity (Loutradis et al., 2007). More importantly the possibility of long-term 
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health issues that might rise from the use of such high-order ovarian stimulation 
protocols (Hillier, 2013). If eggs taken from light ovarian stimulation cycles or even 
natural cycles were to be used, then if there are  a limited number of eggs from such 
cycles the overall ICSI failure rates would be more alarming (Pelinck et al., 2002). 
Fertilisation in mammals is a well-studied phenomenon and it has been found that 
Ca2+ is heavily involved in this process. In fact the activation step is dependent on 
the series of Ca2+ changes that occur in a form of a series of transients, in ICSI 
these changes were observed as well in human and mouse eggs (Sato et al., 
1999b). 
 
Due to the scarce source of human eggs and the ethical issues surrounding their 
use in research, it was mandatory to find an alternative model system that has 
similar components to human IVF. Mouse eggs have been used frequently to 
understand the mechanisms behind fertilization and have been used to study human 
IVF and ICSI as well. For instance they have been used in testing the ability of 
human sperm in causing egg activation (Araki et al., 2004, Vanden Meerschaut et 
al., 2013a). Although the frequency of Ca2+ oscillations that occur due to injecting a 
human sperm into a mouse egg is higher when compared to the oscillations seen in 
human eggs, it is still a reliable method of examining the ability of the sperm in 
activating the eggs (Yoon et al., 2012, Nikiforaki et al., 2014). It was found that 
human PLCζ is about 10 times more potent than mouse PLCζ (Yu et al., 2008). It is 
known that human sperm devoid of PLCζ or with mutations of PLCζ when used to 
perform ICSI in mouse eggs it has a reduced ability to cause mouse egg activation 
(Heytens et al., 2009, Kashir et al., 2011, Kashir et al., 2012).  That is a reasonable 
conclusion since PLCζ is the main drive behind egg activation during fertilization. 
However, a striking result came up in a study by Vanden Meerschaut et al in 2013, 
where it was found that only 55% of the sperm from fertile men had the ability to 
cause high frequency Ca2+ oscillations that would be consistent with a physiological 
pattern of oscillations in human eggs (Vanden Meerschaut et al., 2013a, Nikiforaki et 
al., 2014). The data from previous studies suggests that fertilization failure is a 
consequence of a lack or diminished Ca2+ oscillations and that this is most likely to 
be caused by an abnormal quality or quantity of PLCζ in sperm.  Currently most IVF 
clinics treating cases of fertilization failure are using a method known as artificial 
activation to overcome this problem. This includes exposing the eggs post ICSI to 
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an agent that would cause an artificial rise of intracellular Ca2+ such as Ca2+ 
ionophores. An example of these agents is A23187 and ionomycin, it is found that 
such treatment has been successful in treating some cases of ICSI failure (Kyono et 
al., 2012). It should be noted that Ca2+ ionophores causes a single Ca2+ transient 
that has no resemblance to the sustained series of physiological Ca2+  oscillations 
seen during fertilisation (Rinaudo et al., 1997). The repetitive nature of the Ca2+ 
changes during fertilization seems to be favorable for optimum activation of 
mammalian eggs and embryo development (Ozil and Swann, 1995, Ducibella et al., 
2002). Strontium chloride (Sr2+) is an agent that showed promising results specially 
in mouse eggs and other mammalian eggs, by its ability to cause Ca2+ oscillations 
that mimic those of natural fertilistaion (Méo et al., 2005, Ma et al., 2005). However, 
it failed to elicit the same outcome when applied to human eggs (Rogers et al., 
2004). PLCζ is yet to be matched in its ability to cause Ca2+ oscillations that are 
indistinguishable from those that take place during fertilization in mammalian eggs 
including human eggs (Ito et al., 2011, Nomikos et al., 2013, Kashir et al., 2014). It 
has been previously suggested that PLCζ levels could be an effective indicator of 
sperm quality (Kashir et al., 2013). Collectively, all of this data has paved the way for 
potential clinical application of PLCζ to be proposed. It appears that a reduced PLCζ 
concentration, as well as the discovery of certain point mutations in the gene 
encoding the protein in human sperm can be correlated with the failure of sperm to 
activate the egg during fertilization.  
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3.2 Aims of the chapter 
In previous studies it has been proposed that PLCζ can be a potential and promising 
tool of treating cases of failed fertilisation (Nomikos et al., 2012a). In this section of 
the project I will be looking into the efficacy of PLCζ in rescuing scenarios of 
compromised development that we have created in our laboratory. The 
compromised scenarios were created using heated sperm, the model is explained in 
the corresponding result chapter. To determine if PLCζ can be used as a therapeutic 
tool it will have to have the ability to improve rates of development up to the 
blastocyst stage and these rates should be superior to other current used modalities 
of artificial activation of eggs. Furthermore, it’s also necessary to test that treatment 
with our tagged recombinant PLCζ protein to show that it would not compromise 
embryo development in comparison with normal ICSI with sperm that has normal 
parameters. Currently there is no method of identifying the level of PLCζ protein in 
an individual sperm before being used for ICSI. Therefore, I wanted to investigate if 
a dose of PLCζ protein given in cases of ICSI with normal sperm would have any 
detrimental effects on embryo development up to the blastocyst stage. 
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3.3 Results 
3.3.1 Sperm heat treatment and Ca2+ oscillations after ICSI.  
A plethora of studies have shown that PLCζ can cause Ca2+ oscillations when 
injected into both human and mouse eggs. Unlike many IVF treatments the single 
mouse sperm used for ICSI does not necessarily need to be motile or even living. 
Moreover, previous studies have shown that pretreatment of sperm with heat-drying, 
sonication and even freeze thawing without any cryopreservation could still lead to 
normal embryo development although in reduced rates (Wakayama and 
Yanagimachi, 1998, Kwon et al., 2004, Chao et al., 2012). Data shows that mouse 
sperm when heated to a certain degree and used for ICSI eggs failed to show sign 
of activation. However, when eggs injected with the same sperm and 
parthenogenetically activated using Sr2+, only then embryo development was 
achieved in rates comparable to that of fresh sperm (Cozzi et al., 2001). PLCζ like 
many proteins is shown to be heat sensitive (Perry et al., 1999), therefore we 
created our own mouse model of male infertility.  To determine if the duration of heat 
treatment had any effect on the ability of sperm to cause Ca2+ oscillations, mouse 
sperm post collection was exposed to mild heat treatment at a temperature of 56Co 
for various time points starting for 2.5 minutes, 5 min, 10 min, 20 min and finally for 
a period of 30 minutes. Figure 3, 1 shows the protocol that we have used for the 
heat treatment which is followed by a brief sonication to separate the sperm heads 
from the tails for the ease of use during the procedure.  
 
Figure 3.1  Sperm heat treatment protocol.  
Sperm after being collected are aliquot as 250µl and stored at -80, prior to use the aliquot is 
allowed to thaw (A). (B) Sperm is place on a floating rack in a water bath heated to 56oC and 
kept for the required duration. (C) The sperm after cooling on ice, they are subject to a brief 
period of sonication 2-4 pulses. (D) Sperm post treatment is kept on ice until use for a same 
day ICSI procedure. 
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Figure 3, 2 illustrates the  Ca2+ oscillations recorded after injecting the eggs with (A) 
fresh sperm, (B) sperm treated for 5 minutes, (C) 20 minutes and finally (D) for 30 
minutes.  
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Figure 3.2 Pattern of Ca2+ oscillations post ICSI treatment with various heat 
treatments.  
Ca2+ oscillations were recorded for the eggs post ICSI with sperm that had (A) No heat 
treatment. (B) A representative trace for Ca2+ oscillations after heat treatment of sperm for 5 
minutes. (C)  Heat treatment duration of 20 minutes. (D) Ca2+ spikes for sperm heat treated 
for 30 minutes. All recordings were continued for 2 hours. 
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All recording were continued for 2 hours for statistical purposes. In the case of the 
fresh sperm ICSI we can see a trace of what represents a physiological pattern of 
Ca2+ oscillations. However, as the duration of heat treatment increases the number 
of Ca2+ spikes detected is significantly reduced in parallel over the 2 hour period of 
recording (Figure 3.3). The findings indicate that even a short duration of 2.5 
minutes of heat treatment led to a significant reduction in the number of Ca2+ spikes 
recorded. However, the freeze-thawing process, without the use of any 
cryopreservants, has not influenced the ability of the sperm injected to cause Ca2+ 
oscillations.  The number of Ca2+ oscillations detected in the freeze-thawed sperm 
group was not significantly different from those seen produced by injecting fresh 
sperm into mouse eggs. Figure 3.3 shows that the numbers of Ca2+ spikes are 
reduced with increasing the duration of heat treatment. There is a point reached 
where the sperm is no longer able to elicit any Ca2+ changes in the form of spikes. 
That is found to be at the 30 minute time point of heat treatment (Figure 3.2 D). 
Therefore our data suggests that the sperm’s ability to trigger Ca2+ oscillations is 
heavily influenced by the duration of heat treatment at 56oC, and the longer the 
treatment the greater the reduction in the number of Ca2+ spikes detected.  
  
3.3.2 Sperm heat treatment and the effect on egg activation and 
embryo development after ICSI.  
Previously it has been shown that embryo development is influenced by the 
surrounding environmental factors. In fact in vitro manipulations have been 
suggested to be a source of epigenetic modifications as well as it could affect the 
competency of embryo development (Fleming et al., 2004). In a study by Chao et al 
2012 it was shown that heat treatment affected the ability of sperm injected during 
ICSI to cause egg activation and subsequent embryo development in mouse eggs 
(Chao et al., 2012). However, the study only investigated the effect of various 
temperature levels and not the duration of exposure to the heat. As it has been 
shown in the previous section that the sperm heat treatment affected the number of 
Ca2+ spikes recorded after ICSI, it was only logical to investigate whether this 
reduction would influence the capacity of the heat treated sperm to maintain egg 
activation and subsequent embryo development.  
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The eggs that have been used for all sets of our experiments were from the MF1 
strain which has a control rate of development post fertilization of around 50% (Ozil 
and Swann, 1995, Ducibella et al., 2002).  
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Figure 3.3 A bar graph representing the number of Ca2+ oscillations recorded 
post ICSI with heat treated sperm. 
The ICSI procedure was done using sperm that was heat treated for various time 
points and the resulting number of Ca2+ spikes was compared to that of a control 
using fresh sperm and frozen-thawed sperm. 
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The rate of egg activation has been taken as the percentage of eggs that develop 
pronuclei post ICSI in comparison to the number of the surviving eggs post 
procedure. As expected the fresh sperm managed to activate 100% of the survived 
eggs after ICSI. A non-significant difference was found between the fresh and the 
freeze-thawed sperm in terms of pronuclear formation. Table 3.1 shows the 
percentages of development for each stage and as we can see a small but 
progressive decrease in rate of activation is detected up to the 10 minute heat 
inactivation time point. A dramatic decline starting from the 20 minute heat treatment 
group has been seen which was significant when compared to the fresh sperm 
activation rate, this significance level was increased for the 30 min group. In a 
similar manner the rates of blastocyst development have seen a progressive 
reduction as well. However, the dramatic reduction was seen in an earlier time point 
(5 min) of heat treatment in comparison to what was detected for the activation 
stage of development. Between the fresh sperm and the freeze-thawed sperm there 
was a non-significant difference (P = 0.268), but as soon as the heat treatment was 
started for 2.5 minutes a significant difference in blastocyst rate development was 
detected (P = 0.0.0197). Figure 3.4 demonstrates the progressive decline in 
development for all stages in parallel with the increase in time that the sperm is 
being heat treated at 56oC. Table 3.1 demonstrates the numbers of embryos at each 
development stage during in vitro culture of embryos. To ensure that there were no 
confounding factors, each set of experiment was done with a new sperm preparation 
that was heated for the specific duration required for that experiment and no 
extension of heating was practiced for the same sperm once used. 
 
From this and the previous set of results we can conclude that the progressive loss 
of Ca2+ oscillations inducing ability of sperm is accompanied by a parallel loss in 
rates of various development stages after ICSI. Therefore the thermal impact on the 
sperm function as regards to Ca2+ oscillations appears to have been translated into 
the fertilization rates. Moreover, the effect in some conditions extended to cause 
fertilization failure, which mimics the clinical scenarios encountered in infertility 
clinics after some treatment cycles. 
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Method of 
activation 
No. of 
surviving 
eggs 
(exp.) 
No. of eggs 
activated 
(PN %) 
No. of embryos developing to 
(%) 
2-cell Blastocyst 
ICSI with fresh 
sperm 
43 (3) 
43 
100% 
36 
83.7% 
22 
51.2%a,b,c,d,e,f 
ICSI with frozen 
sperm 
45 (3) 
41 
91.1% 
38 
84.4% 
12 
26.7%a 
2min 30 sec* 27 (2) 
23 
85.2% 
18 
66.7% 
6 
22.2%b 
5 minutes* 47 (3) 
38 
80.9% 
28 
61.7% 
8 
17%c 
10 minutes* 49 (3) 
38 
77.6% 
33 
67.3% 
3 
6.1%d 
20 minutes* 48 (3) 
13 
27% 
11 
22.9% 
2 
4.1%e 
30 minutes* 47 (3) 
8 
17% 
1 
2% 
0f 
Table 3.1 Developmental rates for mouse embryos after ICSI with heat 
inactivated sperm heads for various time points. 
*Inactive ICSI= Heat treatment at 56oC. a, non-significant difference P= 0.268 b, c, 
d, e, f, represent a significant difference. (P= 0.0197, 0.007, 0.0038, 0.0023, 0.000) 
respectively.  
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Figure 3.4 Developmental capacity for embryos after ICSI with heat treated 
sperm for various time points. 
Embryo development was followed post ICSI. Each sperm heat treatment time point 
was evaluated in regard with its ability to support embryo development up to the 
blastocyst stage. The bar chart illustrates the significant difference of blastocyst 
rates for each of the heat treatment time points (10, 20, 30min) compared to that of 
ICSI with fresh sperm. (Student’s t-test pairwise between the control and each HT 
group, P= 0.0038, 0.0023, and 0.000 respectively) Error bars are SEMs. 
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3.3.3 Is embryo development after ICSI influenced by the number of 
Ca2+ oscillations? 
It has been shown that the number of Ca2+ oscillations during parthenogenetic 
activation of eggs, specifically with the use of electric field pulses, does influence the 
progression of egg to embryo development (Ducibella et al., 2002). The mechanism 
of this activation was entirely dependent on influx of Ca2+ from the extracellular 
environment. In light of this result, we wanted to evaluate whether differences in 
number or pattern of Ca2+ oscillations induced in a relatively similar manner to those 
seen during fertilisation, would have a relative influence on the ability of the embryo 
to further develop. Furthermore, we wanted to explore whether Ca2+ oscillations 
measured in the same eggs could be seen to have an effect on embryo 
development progression. MII eggs of MF1 mice were first injected with 30 min heat 
inactivate sperm as described above. Then they were microinjected with untagged 
human PLCζ cRNA at a pipette concentration of 0.15µg/µl which was mixed with the 
Ca2+ indicator Rhod-dextran, so Ca2+ changes may be recorded. The eggs 
microinjected would express endogenously the PLCζ protein, for that the initial level 
of protein would be expected to be at zero and would build up over time. By using 
this technique, we ensured that the very first Ca2+ spike will be recorded. It has been 
suggested that haploid status of the genetic material is the cause of reduced mouse 
embryo development rates rather than being caused by parthenogenetic activation 
(Liu et al., 2002). Therefore, in this experiment it was important that they were 
subject to ICSI using an inactivated sperm. That would allow for development of 
diploid embryos that would not have compromised developmental rates. This 
experiment was done in very small batches (maximum of 14 eggs for each run) as it 
would include transfer of PLCζ RNA activated eggs into another drop of KSOM that 
has previously been equilibrated in the incubator. The transfer of eggs is a 
technically demanding experiment, it was done after spontaneous cessation of Ca2+ 
oscillations that were recorded. The eggs transferred in such a manner such that 
could be cultured for development and later individual embryos could be related to 
their corresponding set of oscillations. This was achieved by exposing embryos to 
time lapse imaging with an image taken every 10 minutes to enable division timing 
calculation.  
The vast majority of eggs arrested at the 2-cell stage were the eggs had a mean 
number of Ca2+ spikes of 21.4 with Std of 10.65 (n = 13), while the eggs reaching the 
morula stage had a mean number of Ca2+  spikes of 15.27/ 4hours  and a Std of 1.68 
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(n = 9) (Table 3.2). We have used a 4 hour period as a cut-off point as a significant 
number of eggs stopped oscillating before the 5 hour mark 19/35 which was about 
54.3% of eggs. The mean values for the Ca2+ spikes between the 2-cell stage and 
the morula stage were significantly different (Figure 3.5), P = 0.002. The 2-cell stage 
arrest was significantly different from the control group where eggs were injected 
with fresh sperm by ICSI, P = 0.006. Moreover, a significant difference was detected 
in the morula rate between the group that was imaged and the control group (P = 
0.000). It has to be noted no blastocysts have developed from all imaged 
experimental runs. Other embryos were arrested at the 4-cell and the 8-cell stage, 
and no difference was detected when compared to other groups (Figure 3.5).   
The results presented indicate that the number of Ca2+ oscillations induced via PLCζ 
protein can influence the ability of the embryo to carry on development at least to 
the morula stage. However, it has to be mentioned that the overall developmental 
rates has been compromised in relation to previous parthenogenetic protocols 
presented in this section. The explanation for such a result could be the amount of 
light that the embryos have been exposed too.  Initially the embryos were imaged for 
4 hours to capture the Ca2+ oscillation pattern, and then the imaging system was 
changed as was the light. The long term imaging was done via an ordinary white 
lamp and an image was snapped every 10 minutes, the total duration was for about 
4 days.  
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 End stage 
development  
of embryo 
Mean no. of Ca2+ spikes/4hours 
2 cell 21.4 (Std 10.56) 
4 cell 15.00 (Std  6.69) 
8 cell 14.44 (Std  5.43) 
Morula 15.27 (Std 1.68) 
 
Table 3.2 (A) Table representing mean Ca2+ spikes/4hrs and the corresponding 
developmental stage at which the embryo arrested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 (B) End stage development and their mean Ca2+ spike number in the imaged 
group.  Error bars are of Std. 
A significant difference was detected between the Ca2+ spikes for the embryos that arrested 
at the 2cell stage and the spikes for those arresting at the morula stage. (*P = 0.002). 
Developmental stage
2 cell 4 cell 8 cell Morula
M
ea
n 
nu
m
be
r o
f C
a2
+  o
sc
ill
at
io
ns
 /4
 h
ou
rs
0
5
10
15
20
25
30
35
*
n= 11 
n= 9
n= 6
n= 10
A 
B 
91 
 
A B
C D
 
 
 
Figure 3.6  DIC images for embryos developing in vitro after imaging Ca2+ 
oscillations. 
Images are snap shots for embryos taken during development in the incubator. (A) An image 
for the embryos at the start of imaging showing the PN. (B) 24hrs post ICSI and hPLCζ 
injection the embryos reach the 2cell stage. (C) The 4 cell stage, with some embryos 
arresting at the 2 cell stage. (D) At the end of imaging only 1 embryo (arrow) managed to get 
to the morula stage in this. 
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3.3.4 Does the pattern of Ca2+ oscillations have the ability to affect cell 
cycle timings?  
In 1984 Edwards et al reported that early cleavage of embryos has an impact on the 
rate of pregnancies (Edwards et al., 1984), as it was shown in his study that the 
embryos that started to cleave first had a higher success rate of implantation. Since 
then many studies have looked into the cell cycle timing as a non-invasive tool for 
determining the quality of embryos and to use as a criteria for choosing superior 
embryos for transfer (Sakkas et al., 1998, Lonergan et al., 1999, Wong, 2010). In 
the previous set of results we have shown that the number of Ca2+ oscillations is 
affected by the duration of sperm heat treatment, which subsequently influences the 
developmental rates negatively. Here we wanted to investigate does this reduction 
in the number of Ca2+ oscillations have any effect on another marker of embryo 
quality which is the cell division timings. In this set of experiments, ICSI was 
performed using 4 groups of sperm that was heat treated (2.5 min, 5 min, 10 min 
and 20 min). The 30 minute heat inactivated sperm was not used as we have 
previously shown that it does not cause Ca2+ oscillations or egg activation. The 
control groups were 2 sets, first was the ICSI using fresh sperm and the second was 
the embryos resulting from in vivo mating after super-ovulation of female mice. After 
ICSI was completed the eggs were allowed to recover from the procedure and were 
incubated and checked after 4hours every half an hour until the pronuclei were 
formed. Once pronuclei were formed in any of the embryos, they were moved into a 
culture dish with pre-equilibrated KSOM media. The dishes containing the embryos 
were placed on the Lumascope stage which was placed within the incubator which 
was set to 5% CO2 and 37.5oC. In order to determine the exact timing of each cell 
division, images were automatically acquired every 5 minutes at a resolution of 20x 
until about 48hrs post fertilisation. The first cell cycle duration was taken as the time 
from pronuclear formation until the start of cleavage, while the second cell cycle 
timing was taken as the time from the completion of the first cell cycle with the 
formation of two separate daughter cells until the start of the  second division. 
Embryos that did not manage to complete the second cell cycle by dividing into 4 
daughter cells were excluded from the analysis.  
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The analysis was done in a retrospective manner with the use of image-J software, 
all embryo events were noted and the timing of events as recorded. Figure 3.7 
shows a progressive prolongation of the duration taken to complete the first cell 
cycle in all time points of heat treated sperm. All groups were significantly different 
from the controls, the 10 minute heat treatment time point was significantly different 
from the 2.5 minute and 5 minute heat treatment timing. Again the recordings for the 
second cell cycle timing also revealed the same pattern of prolongation.  Time taken 
to form the 4 daughter cells was increasing in parallel with increasing the duration of 
heat treatment. All groups were significantly different from the controls. The 10 
minute time point showed a more pronounced effect on the second cell timing 
duration in comparison to the other heat treatment time points (Figure 3.7). Although 
differences were detected we could not detect any significant differences in between 
both of the controls in any of the cell cycles. These data suggest that the number of 
Ca2+ oscillations could play a role in influencing the cell cycle timings for embryo 
development. 
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Figure 3.7  Bar graphs representing the timings for the first and second cell 
cycle division. 
(a)The first cell cycle was observed as the period from the pronuclei formation until complete 
separation of the two daughter cells One way-ANOVA  indicates significant differences 
between the means of the independent groups P<0.001. (b) The second cell cycle was the 
time taken after completion of the first cell cycle until full separation of the f daughter cells. 
The 2nd cell cycle timing showed no significant difference between the in vivo fertilisation and 
ICSI with fresh sperm. The second cell cycle timing was significantly different between the 
ICSI with fresh sperm and the other groups. 
*P=0.01, **P= 0.008, ***P= 0.0062, ****P= 0.000, *****P= 0.000  
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3.3.5 Ca2+ oscillations are restored with PLCζ following ICSI with 
sperm which is unable to do so.  
Following the introduction of ICSI into the IVF world, increased success rates of 
fertilization up to 80% and clinical pregnancies detected in 45% of cases treated. 
Therefore, the need for using donor sperm insemination for couples with severe 
male factor infertility has been reduced quite dramatically (Palermo et al., 1992). 
Despite the significant success in rates of fertilization with ICSI, there are cases of 
total fertilization failure reported as 1-3% of all ICSI treatments see this lack of 
success (Esfandiari et al., 2005). Following ICSI, if fertilization failure occurs, the 
most common cause is failure of egg activation (Liu et al., 1995). Other less 
common causes could include egg spindle defects (Swain and Pool, 2008). A 
number of reports have showed that these couples have benefited from a 
combination of ICSI followed by artificial egg activation (Heindryckx et al., 2005, 
Montag et al., 2012). The most common method currently used is exposing eggs to 
Ca2+ ionophores post ICSI (Nasr-Esfahani et al., 2010). In light of the artificial 
activation protocols used on human eggs, we wanted to explore and compare the 
efficacy of PLCζ to other activators in eliciting Ca2+ oscillations after ICSI with sperm 
that is incapable of doing so. Figure 3.8 demonstrates the Ca2+ changes recorded 
after exposing the eggs to an artificial activator subsequent to injecting a sperm heat 
treated for 30 minutes at 56oC (previously we showed it cannot elicit any Ca2+ spikes 
in eggs).  In figure 3.9(A) we can see a single short lived Ca2+ rise induced by the 
action of 5µM of ionomycin which does not resemble the physiological series seen 
during fertilization. The ionomycin has been added to the media surrounding the egg 
and washed out after a period of 5 minutes to mimic the protocol used in IVF clinics 
(Rinaudo et al., 1997). In figure 3,9 (B, C) Ca2+ traces are recorded for eggs 
undergone ICSI with a 30 minute heat inactivated sperm followed by either a Sr2+ 
treatment or an injection of PLCζ. Both traces show a Ca2+ change that is similar to 
the physiological oscillations seen in fertilization. In fact the PLCζ trace is 
indistinguishable from the physiological trace. The Sr2+ media caused a series of 
Ca2+ oscillations (with a mean of 7.91 Ca2+ spikes/ 2 hours with a standard deviation 
of 2.64 (n = 15)) following ICSI using a sperm that has been heat treated for 30 min. 
However, Sr2+ is unable to generate any Ca2+ changes in human eggs and since we 
are aiming to reproduce our results in human eggs we used PLCζ protein for most of 
the studies. Once mouse eggs were injected with a 30 min heat treated sperm a 
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subsequent injection with PLCζ was done, the amount of protein used for this 
rescue was comparable to what has triggered a physiological Ca2+ response.  
These experiments show that in eggs that have been injected with sperm which lost 
its ability to elicit Ca2+ oscillations, the Ca2+ signal was restored by the use of a 
number of agents such as ionomycin and Sr2+ . Both previous agents were added 
externally to the surrounding media. Signal restoration was achieved by giving a 
dose of PLCζ protein internally through micro-injection.   
2hrs
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(Fresh)
Heat treatment
(56 oC for 30 
min)
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Figure 3.8 Traces are a representation of Ca2+ changes following a rescue 
hPLCζ micro-injection. 
A, ICSI with fresh sperm. B, ICSI with HT sperm at 56oC for 30 minutes and finally, C, 
restoration of the Ca2+ oscillations post ICSI with an injection of hPLCζ 
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Figure 3.9  Ca2+ changes in mouse eggs in response to a number of artificial 
stimuli. 
The use of different artificial stimuli to activate mouse eggs after ICSI with a heat inactivates 
sperm for 30 minutes. The Ca2+ changes were recorded during/following their application. 
(A) Eggs were treated with 5mM ionomycin the trace represents n=21, the bar indicates the 
start of the application and the wash out of the ionophore. (B) Sr2+ was applied to the eggs 
after ICSI, n=12. (C) A representative trace for an injection of hPLCζ following ICSI with a 
sperm subjected to 30min HT.  
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3.3.6 PLCζ is superior to other artificial activators in rescuing eggs 
post ICSI with incompetent sperm.  
In light of the previous set of results, we wanted to explore the developmental effect 
of the Ca2+ signals that were restored by introducing ionomycin or Sr2+ to the media 
or injecting PLCζ into the eggs that had ICSI with a sperm that was heat treated for 
30 minutes. In order to ensure that the rescue was extended to the developmental 
capacity of the embryos as well, we injected groups of eggs with sperm that was 
heat treated for 30 minutes which was followed by an artificial activation stimulator. 
The first group had an exposure to 5µM ionomycin for 5 minutes then washed out in 
M2 and cultured in KSOM, the second group had the same ICSI treatment then 
incubated for 4 hours in Ca2+ free HKSOM containing 7.5 mM Sr2+  which after they 
were washed out in M2 then cultured as well in KSOM. The last group had ICSI with 
the same sperm and were subsequently injected with a dose of Nus-A tagged 
hPLCζ at a pipette concentration of 0.01mg/ml then cultured in KSOM once 
pronuclei develop and that was the case with the other two groups as well. 
Following introducing the artificial activators we monitored the activation of eggs 
which was taken as the development of pronuclei, subsequent stages of 
development were monitored and documented as well. Control groups were eggs 
that have been injected with fresh sperm and eggs that had ICSI with frozen-thawed 
sperm. Figure 3.10 shows that following the ICSI procedure in the case of ionomycin 
activator the pronuclear development was comparable to other protocols (80%). 
However, by the blastocyst stage we saw a dramatic reduction to down to only 
13.3% of the eggs injected (Figure 3.10). In contrast, when activators that could 
trigger repetitive Ca2+ oscillations were used as opposed to ionomycin that gave a 
single Ca2+ rise, the blastocyst developmental rates were significantly improved, 
34.1% and 36.3% for Sr2+ and PLCζ respectively. The difference in blastocyst 
development was not significantly different between Sr2+, hPLCζ and the rates 
resulting from injecting fresh sperm (P = 0.079). However, ionomycin treatment 
resulted in a significant reduction in the numbers of blastocysts when compared to 
ICSI with fresh sperm or rescue with hPLCζ (P = 0.009, 0.0.008 respectively). The 
use of frozen-thawed sperm in contrast to its similar ability to elicit Ca2+ oscillations 
in mouse eggs, failed to yield blastocysts in rates similar to that of fresh sperm 
26.7% compared to 51.2% for fresh sperm (Table 3.3). These results indicate that 
artificial activators that can trigger Ca2+ oscillations such as recombinant hPLCζ can 
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provide an effective and reliable mean of rescuing eggs that have failed to activate 
post ICSI. 
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Figure 3.10 Bar chart representing developmental rates for various stages of 
the mouse embryo following various activation protocols after ICSI with HT 
sperm for 30 min. 
The blastocyst development difference rates were insignificant between fresh ICSI (control) 
and rescue ICSI with hPLCζ protein injection. While hPLCζ ICSI rescues was superior to egg 
activation using ionomycin.* P = 0.079, ** P = 0.008, *** P = 0.093. 
 
100 
 
 Table 3.3 Developmental rates for mouse embryos after various activation 
protocols post ICSI with HT sperm for 30 min. 
Details of developmental stages for the mouse embryos following egg activation protocols, 
the significant difference detected between the fresh ICSI and the ionomycin activation 
protocol (P= 0.009), Fresh ICSI and hPLCζ rescue had no significant difference in blastocyst 
rates  (P = 0.079) .  d significantly different (P = 0.008), e significantly different (P =0.059). 
ICSI method 
No. Of 
surviving eggs 
(exp.) 
No. Of eggs 
activated 
(PN) 
No. Of embryos developing to 
(%) 
2-cell Blastocyst 
ICSI with fresh 
sperm 
43 (3) 
43 
100% 
36 
83.7% 
22 
51.2% a  c  
ICSI with 
frozen sperm  
45 (3) 
41 
91.1% 
38 
84.4% 
12 
26.7% 
Inactive ICSI* 
& 5µM 
Ionomycin 
45 (3) 
36 
80% 
26 
57.8% 
6 
13.3%a d e  
Inactive ICSI* 
& 5mM 
Strontium 
44(3) 
40 
90.9% 
40 
90.9% 
15 
34.1% e 
Inactive ICSI & 
Nus-A hPLCζ 
injection 
80 (3) 
77 
96.3% 
68 
85% 
29 
36.3% c d 
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Figure 3.11  Images for in vitro development for various activation protocols. 
The DIC images were taken at day5 post ICSI with a HT sperm at 56oC for 30 minutes 
followed by egg activation using (A) hPLCζ protein. (B) Sr2+. (C) 5µM Ionomycin. 
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3.3.7 Does a dose of hPLCζ injected into mouse eggs after ICSI with a 
fresh sperm effect the Ca2+ oscillations or subsequent 
development? 
Although success has been reported with artificial activation of eggs after fertilisation 
failure, rates still have a tendency to be unsatisfactory. This may involve a number 
of issues such as those related to the time gap between the identification of the 
failure to fertilise and the application of the artificial activator (Rybouchkin et al., 
1997). In normal fertilisation, the activation occurs once the sperm releases the 
sperm factor into the egg cytoplasm, therefore it would make more sense that 
artificial activation to be applied during or immediately after the ICSI procedure. 
However, it is quite difficult to predict cases of egg activation failure, especially in 
cases where the cause is deficiency in the sperm factor (Kashir et al., 2010). In light 
of the importance of enhancing the fertilization rates after ICSI and to maximize 
blastocyst developmental rates, we decided to inject a fresh sperm into an egg that 
would cause normal activation and then subsequently inject a dose of hPLCζ on top. 
A double injection technique was followed and the Ca2+ oscillations were recorded to 
identify any deviation from the pattern detected during normal fertilisation. The 
traces recorded revealed a frequency of Ca2+ oscillations that was similar to those 
seen in ICSI (Figure 3.12 A), or with ICSI using frozen-thawed sperm. It has to be 
said that we could not identify how much of contribution hPLCζ made to the 
frequency of Ca2+ oscillations between the four groups injected. But we could not 
detect any significant difference in terms of number of Ca2+ spikes recorded in the 
trace (P = 0.169) (Figure 3.12 B). In previous results we have shown that we can 
restore development capability of eggs that were injected with heat treated sperm 
for 30 min. In order to identify if the extra dose of hPLCζ injected into the eggs 
undergone ICSI with a fresh sperm does not have detrimental impact on embryo 
development, it was essential to follow development in these embryos. We noted 
that the extra dose of hPLCζ in addition to what was in the fresh sperm was not 
detrimental to egg activation (97.3%), 2-cell embryo (78.4%) and blastocyst 
formation (45.9%). A P value of 0.097 indicated that there was no significant 
difference between the groups (Figure 3.12 C & Table 3.4).  From this set of data we 
can see that injection of the Ca2+ oscillation inducing agent hPLCζ does not appear 
to impinge on the frequency of Ca2+ oscillations, nor does it negatively influence pre-
implantation development even when ICSI is performed with what seems to be a 
normal sperm. 
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Figure 3.12  Intracellular Ca2+ measurements for eggs following ICSI with their 
corresponding developmental rates. 
(A) Representative Ca2+ trace for egg post ICSI with fresh sperm followed by a dose of 
hPLCζ (B) The bar chart shows the mean Ca2+ spike number post injection with fresh sperm 
and frozen sperm, fresh sperm and frozen sperm followed by hPLCζ one way ANOVA shows 
no significant difference between groups (P =0.169). (C) The bar chart represents 
developmental rates post ICSI with fresh and HT sperm and followed by hPLCζ injection, 
one-way ANOVA reveals no significant difference in the blastocyst rates (P = 0.097). 
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 Table 3.4 Developmental rates for mouse embryos at various stages post ICSI 
with fresh/frozen sperm followed by hPLCζ injection. 
The table represents the rates of development up to the blastocyst stage for mouse embryos 
that had ICSI with fresh and frozen sperm that was followed by a dose of hPLCζ. The rates 
were compared to that of ICSI with fresh and frozen sperm alone. The PLCζ injection 
following fresh sperm ICSI had no effect on developmental rates up the blastocyst stage (a 
no significant difference (P = 0.068)). The frozen sperm ICSI had an improved blastocyst 
development rate post hPLCζ injection (b, P = 0.024). 
 
 
 
ICSI method 
No. Of 
surviving 
eggs 
(exp.) 
No. Of eggs 
activated 
(PN) 
No. Of embryos developing 
to (%) 
2-cell Blastocyst 
ICSI with 
fresh sperm 
43 (3) 
43 
100% 
36 
83.7% 
22 
51.2%  a  
ICSI with 
frozen sperm  
45 (3) 
41 
91.1% 
38 
84.4% 
12 
26.7% b 
ICSI fresh 
sperm & Nus-
A hPLCζ 
injection 
37 (3) 
36 
97.3% 
28 
78.4% 
17 
45.9% a 
ICSI frozen 
sperm & Nus-
A hPLCζ 
injection 
38 (3) 
35 
92% 
29 
76.3% 
17 
44.7% b 
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3.3.8 The Nus-A tag of hPLCζ, shows no detrimental effects on Ca2+ 
oscillations or subsequent development. 
 
The N-utilising substance A protein (Nus-A) has been used for its ability to keep the 
partner protein in heterologus expression soluble (Davis et al., 1999). It was found 
that it can act as a molecular chaperone that inhibits protein aggregation in 
conditions of stress such as high temperatures and presence of toxic chemicals (Li 
et al., 2013). As this tag is currently unavoidably micro-injected into eggs along with 
the hPLCζ protein, it was necessary to determine whether this transcriptional factor 
would affect the resulting Ca2+ oscillations or influence subsequent pre-implantation 
development in mouse eggs.  
Following ICSI with a fresh sperm, Nus-A at a pipette concentration of 0.01mg/ml 
was microinjected into these eggs and the Ca2+ oscillations resulting were recorded 
and compared to a parallel group of eggs injected with fresh sperm only. Ca2+ 
oscillations were recorded for 2 hours and the mean spike number/2hours were 
calculated for each group. No significant difference was found between these two 
groups (P = 0.098). A 10 fold increase in concentration was tested as well, and 
again no significant difference was detected (P = 0.086). A follow up of development 
up to the blastocyst stage was done. A control group that was injected with KCL 
Hepes following ICSI with fresh sperm was also added. All groups were observed in 
regard to their developmental capacity. In regard with activation rates there was no 
difference detected between groups. Table 3.5 shows the insignificant rates 
between groups. Pronuclear formation was 96.5%, 89.4% and 90.7% for KCL 
Hepes injection, Nus-A (0.1mg/ml) and Nus-A (0.01mg/ml) respectively. However, 
only 10.6% of the embryos managed to further develop to blastocysts in the Nus-A 
group of (0.1mg/ml). Whereas 34.9% of the injected eggs developed into blastocysts 
in the Nus-A (0.01mg/ml) group and the difference was significanct (P = 0.007). 
Furthermore, when the Nus-A (0.01mg/ml) blastocyst developmental rate was 
compared to that of KCL Hepes injection no significant difference was found (P = 
0.093) and again no statistical difference was detected between the (Nus-A 
(0.01mg/ml) group and the blastocysts resulting from eggs injected with fresh sperm 
(P = 0.085). The above data reveal that the Nus-A tag for the PLCζ protein is not 
detrimental to development in the concentrations that are present with the 
recombinant hPLCζ protein used. 
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ICSI method  
No. of 
surviving eggs 
(exp.) 
No. of eggs 
activated 
(PN) 
No. of embryos developing to 
(%) 
2-cell Blastocyst 
ICSI with fresh 
sperm 
43 (3) 
43 
100% 
36 
83.7% 
22 
51.2%a 
ICSI with fresh 
sperm and KCL 
hepes injection 
41 (3) 
37 
96.5% 
33 
79.6% 
18 
43.9%b 
ICSI fresh 
sperm & Nus-A  
injection 
(0.1mg.ml) 
38 (3) 
33 
89% 
13 
32.5% 
4 
10.6%c 
ICSI fresh 
sperm & Nus-A 
injection 
(0.01mg/ml) 
36 (3) 
33 
90.7% 
28 
78.3% 
13 
34.9%a, b, c 
 
Table 3.5  Nus-A injection effect on the developmental ability of mouse 
embryos. 
The table represents the developmental capacity of mouse embryos post ICSI with fresh 
sperm and an injection of 2 different concentrations of the Nus-A tag (0.1mg/ml, 0.01mg/ml). 
The control groups were ICSI with fresh sperm and ICSI with fresh sperm with a KCL-hepes 
injection. No significant difference between the Nus-A 0.01mg/ml injection post ICSI and the 
fresh ICSI, ICSI with KCL-hepes, (P = 0.085, 0.093 a, b respectively). A significant difference 
in the blastocyst development rate was detected between the concentration of Nus-A 
injections (P = 0.007). 
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Discussion 
Occasionally during IVF treatment cycles including ICSI, cases of total fertilisation 
failure are reported. Either sperm or egg related causes could be the origin of this 
failure. However, the most common cause is due to egg activation failure (Nasr-
Esfahani et al., 2010, Javed et al., 2010). In the study presented, we have shown 
that the mouse model of male infertility that we generated had an effect on its ability 
to induce Ca2+ oscillations in mouse eggs. The model was generated via exposing 
the sperm to mild heat treatment of 56oC. This level of heat treatment has been 
shown not to have any influence on the genetic material such as causing DNA 
damage (Perry et al., 1999). Not only DNA is not affected, no detrimental effects on 
embryo development were found in cases where independent activation protocols 
were applied to the eggs. Though the importance of Ca2+ oscillations for egg 
activation is undisputed, there is still some debate about the identity of the cause 
behind the trigger of these changes. However, the most widely accepted view is that 
the sperm specific PLCζ, which is released into the eggs during fertilization triggers 
the series of  Ca2+ oscillations via IP3 Ca2+ induced release (Saunders et al., 2002). 
In addition multiple independent research teams have established that this protein 
has the ability to trigger the release of Ca2+ in mammalian eggs (Kurokawa et al., 
2004, Miyazaki and Ito, 2006, Nomikos et al., 2014). This factor, initially described 
as the SOAF (sperm oocyte activating factor) has been previously identified to be 
within the sperm perinuclear theca, it has been shown that this protein is heat labile 
in earlier reports of mouse ICSI (Perry et al., 1999).  
Our data is in agreement with all these previous findings. The results presented 
have shown that the triggering ability for Ca2+ oscillations after ICSI is affected when 
sperm are exposed to mild temperatures (56oC) for 30 minutes. Furthermore, not 
only did the heat treatment influenced the activity of PLCζ, but the process of freeze-
thawing of sperm with no cryopreservation has been shown to negatively affect the 
protein activity as well and this was the findings in a study by (Kashir et al., 2011). 
The freeze thawing cycle has led to a reduced cell numbers at different 
developmental rates up to the blastocyst stage in comparison to those seen when 
fresh sperm was used, and yet, no statistical significance was detected. The partial 
loss of protein activity could be related to either an inactivation process or due to a 
reduction in the quantity of protein within the sperm during the course of freeze-
thawing procedure. Whatever the cause of this reduction in activity, our current 
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concern was to focus on the consequences of this activity reduction if the sperm 
was to be used to fertilise eggs. In this sense, the slight reduction in activity with 
frozen sperm has been beneficial for this project as it has provided a means to 
mimic clinical scenarios presented to the IVF clinics where there is only a very slight 
loss of sperm factor activity.  
  The MF1 mice used for our experiments have a known rate of blastocyst 
development of around 50% in vitro.  This is unlike the F1 hybrid mice which have a 
higher rate of blastocyst developmental rates exceeding 90%. This lower rate of 
blastocyst development was again useful in our studies, since this level mirrors the 
rates that are reported in human eggs (Loutradi et al., 2006). When sperm was 
treated at 56oC for different time points it led to a stepwise reduction in the number 
of Ca2+ oscillations resulting when eggs were injected, enabling us to create a range 
of affects seen later in embryo development. The increasing duration of heat 
treatment that was applied to batches of sperm had parallel affects which were seen 
on activation rates and further embryo development up to the blastocyst stage. In 
fact the complete loss of Ca2+ oscillations triggering ability of sperm, when heat 
treated for 30 minutes, saw an exact match of 0% blastocyst developmental rate 
after ICSI. A 50% reduction in the blastocyst developmental rate was seen when the 
shortest duration of heat treatment was applied (2.5 min), however that again was 
seen in the corresponding number of Ca2+ oscillations for that group. To sum up, it is 
evident that a significant reduction of Ca2+ oscillations is accompanied by a 
significant reduction in blastocyst developmental rates. That is in agreement with 
previous studies suggesting that each stage/event of embryo development is 
influenced by the number of Ca2+ oscillations (Ducibella et al., 2002).  
It is noteworthy that the Ca2+ oscillations induced in our study are of a physiological 
nature unlike the study mentioned where the Ca2+ transients were induced via 
electro-permeabilisation, hence the lack of the signature first Ca2+ spike which is 
specific to fertilisation. An interesting finding was in a study by F. Vanden 
Meerschaut et al 2013, where human sperm that failed to fertilise eggs after ICSI 
were injected into mouse eggs. In general a very low frequency or defective Ca2+ 
oscillatory pattern was the case (Vanden Meerschaut et al., 2013a). These findings 
have the strength to reveal that the Ca2+ oscillatory pattern has the ability to predict 
egg activation failure and subsequent diminished rates of further embryo 
development. When a clear correlation was made between fertilization failure and 
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the lack or deficiency in Ca2+ oscillations, a treatment option was to consider an 
artificially induced  cytosolic Ca2+ change via Ca2+ ionophores (Neri et al., 2014). 
There are cases of success that have been reported using this method of treatment 
after a history of complete fertilization failure, not just clinical pregnancies were 
documented but live births have been recorded (Eldar-Geva et al., 2003, Murase et 
al., 2004, Yanagida et al., 2008). Although these chemicals allow intracellular Ca2+ 
release, they only cause a single large transient. In order to mimic fertilization these 
will have to be applied multiple times or in combination protocols with Ca2+ injection 
(Heytens et al., 2008, Nasr-Esfahani et al., 2010). However, concerns are 
continuously raised over the use of such chemical agents as they could possibly be 
detrimental to the embryo if not immediately, then later during development. The 
only agent reported that can cause Ca2+ oscillations, is Sr2+ and it has a variable egg 
activation success rates reported depending on the species used (Yanagida et al., 
2008) with low success reported on human egg activation (Chen et al., 2010a). 
Ionomycin has been used in this presented study as a fertilization failure rescuer 
where ICSI with heat treated sperm for 30 minutes was used. Activation rates were 
successfully restored to rates of 80% yet still was significantly different to that of 
ICSI with fresh sperm (100%).  When Sr2+ was used as an artificial activator it was 
superior to ionomycin in both activating eggs and the blastocyst development rate 
(90.9%, 34.1% respectively). When cRNA encoding the full length of PLCζ protein 
was injected it was found that induced Ca2+ oscillations equivalent to that triggered 
by fresh sperm (Cox et al., 2002, Saunders et al., 2002). These oscillatory patterns 
induced had the ability to support embryo development up to the blastocyst stage 
(Rogers et al., 2004). However, injecting PLCζ cRNA will prove to be clinically 
unacceptable,  it is genetic material and human reverse polymerase could convert it 
into cDNA which subsequently be a part of the human genome (Spadafora, 2004). 
Furthermore, Yu et al (2008) found that activation of eggs can be induced by a wide 
range of PLCζ concentrations but for successful preimplantaion development it was 
not the case. In this previous study it was shown that injecting high concentrations of 
PLCζ leads to a high frequency of an oscillatory Ca2+ patterns and this leads to 
cleavage arrest. It appears that there is a window of PLCζ concentrations that would 
give preimplantaion developmental rates similar to that of normal fertilization (Yu et 
al., 2008). However, PLCζ recombinant protein has been successful in activating 
human eggs that were subject to ICSI and failed to fertilise (Yoon et al., 2012). The 
previous results have set a stage for the use of recombinant PLCζ protein to be 
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used as a therapeutic agent for fertilization failure. However, there have been no 
reports of its comparison to other artificial activation protocols and agents.  
In my  results I have shown that hPLCζ protein when used for activating eggs that 
were injected with a 30 minute heat inactivated sperm, the success of rescue was 
almost as that for ICSI with fresh sperm (96.3% vs 100%). It is noteworthy that Sr2+ 
showed no difference to PLCζ’s ability in activating eggs that were otherwise 
destined for failure of fertilization. But the questionable applicability and efficiency of 
Sr2+ on human eggs renders PLCζ in a stronger position. However, the effects of 
Sr2+ emphasize that the rescue of activation is entirely due to Ca2+ signals. In this 
protocol of rescue, PLCζ protein was microinjected into the egg using a high 
pressure injection system after the ICSI procedure. This method of injecting the 
eggs twice has been used at least in another setting to inject Ca2+ after injecting a 
sperm via ICSI as a part of a rescue protocol (Vanden Meerschaut et al., 2013b). It 
is more likely that human eggs would manage to endure a second injection more 
that mouse eggs as they are more robost. For example, in mouse ICSI a piezo 
device is to be used to enhance survival rates form 50% to 90% whereas human 
ICSI needs no such special equipment to obtain high survival rates (Swann, 1990, 
Yoshida and Perry, 2007). Therefore, it would not be expected that the second 
injection would be detrimental to pre-implantation development in human eggs. The 
concern over the use of artificial material in activating eggs would not be of much a 
concern, due to the fact the protein is an endogenous protein in sperm (Perry et al., 
1999). Moreover, the pattern of Ca2+ changes induced by PLCζ protein is identical to 
that seen at fertilisation.  
As shown in a study by Vanden Meerschaut in 2013, sperm of fertile men who were 
considered as controls showed that only above 50% of their sperms produced the 
pattern of oscillation that was considered sufficient for successful fertilization 
(Vanden Meerschaut et al., 2013a). Moreover, immuno-cytohistochemistry studies 
have shown that the level of PLCζ protein in human sperm could be quite variable 
within the same sample of ejaculate (Kashir et al., 2013). The ICSI procedure 
includes selection of sperm to be used for the procedure, the selection criteria 
include morphology and motility (Antinori et al., 2008). To assess the ability of any 
given sperm to trigger the necessary Ca2+ oscillations for successful fertilization, 
currently it is unfeasible for the embryologist to recognize. Therefore, it is a 
possibility that a number of eggs will get some PLCζ protein from sperm on top of 
111 
 
the dose from the recombinant PLCζ protein injected. From this perspective we 
investigated this scenario. Eggs that had ICSI with a fresh sperm had a second 
injection of recombinant PLCζ protein in a dose that is sufficient to cause a 
physiological pattern of Ca2+ oscillations. We also applied the same protocol to eggs 
that have been injected with a freeze-thawed sperm, which causes a non-significant 
reduction in Ca2+ oscillations when compared to fresh sperm. In both scenarios we 
found that this extra dose of PLCζ had no detrimental effects neither on activation 
nor blastocyst development rates. This might seem surprising in light of previous 
studies, which revealed that high frequency oscillations due to protein over-
expression led to poor preimplantation development (Yu et al., 2008). However, this 
injection is still within limits of the window identified for tolerance which involves 
about a fourfold difference in PLCζ concentrations (Yu et al., 2008).  My results are 
also in agreement with studies showing that the fusion of two sperms  with an egg 
as opposed to a single sperm showed only a very small change in the frequency of 
Ca2+ oscillations (Faure et al., 1999). The presented data suggests that the injection 
of PLCζ after ICSI as a protocol for rescue of activation failure is a viable alternative 
to those currently used in the IVF clinics. Moreover, it could be applied without 
causing any detrimental effects on embryo preimplantaion development. 
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4 A comparison of injecting PLCζ protein into mouse eggs 
and human eggs and the search for an alternative method 
of injection.  
4.1 Introduction 
The pattern of Ca2+oscillations induced by an injection of hPLCζ into mouse eggs 
was indistinguishable from those induced by fertilisation. The Ca2+ oscillations were 
able to support embryo development up to the blastocyst stage (Saunders et al., 
2002). Yu et al provided further support by injecting hPLCζ cRNA into mouse eggs, 
and he showed that the best blastocyst developmental quality and quantity fell within 
a specific range of the expressed protein (Yu et al., 2008). Rogers et al published 
the first data showing the ability of PLCζ cRNA to induce long lasting series of Ca2+ 
oscillations in aged human eggs. The groups work was the first to show that PLCζ 
protein was able to trigger Ca2+ signal that supported development to the blastocyst 
stage in human eggs that have failed a fertilisation procedure (Rogers et al., 2004). 
My work presented in chapter 3 and published recently, compared the 
developmental capacity of mouse embryos activated parthenogentically via different 
means. The study revealed that hPLCζ protein injection had a comparable rate of 
blastocyst developmenta to that of fertilisation and was superior to other methods of 
activation (Sanusi et al., 2015).  
 IVF programmes are currently looking into ways to overcome potential fertilisation 
failure that has been documented in some cases (Palermo et al., 1992). Since the 
ICSI technique has been introduced, some causes of male infertility problems have 
been treated. However, not all cases have been successful (Yoon et al., 2012). The 
literature has a plethora of studies highlighting the potential of assisted activation 
protocols in overcoming egg activation failure post IVF. The methodology basically 
is dependent on creating a single or multiple Ca2+ transients during the IVF 
procedure, by the use of Sr2+ treatment or by other chemical agents as Ca2+ 
ionophore (Borges Jr et al., 2009a, Taylor et al., 2010, Chen et al., 2010a). The 
concept of assisting the process of fertilisation by the use of chemical agents that 
essentially trigger Ca2+ signalling within the egg, has been questioned in terms of 
their safety (Nasr-Esfahani et al., 2010). Sr2+ was the only agent that managed to 
trigger Ca2+ transients similar to that caused by fertilisation but this response was 
only shown in mouse eggs. Sr2+ has never been found to cause Ca2+ oscillations in 
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human eggs. The successful demonstration of Ca2+ oscillation triggered by the use 
of Sr2+ has been limited to rodent models. In humans eggs Sr2+ application has only 
been reported as case reports of successful human egg activation and no traces 
representing the Ca2+ oscillations have been shown (Nasr-Esfahani et al., 2010). 
Moreover, there have been two reports linking repeated failed fertilisation after ICSI 
to a maternally inherited point mutation in hPLCζ (Heytens et al., 2009). Further 
support has been provided in a study by Nomikos et al 2011 when injection of a 
cRNA encoding the point mutation failed to induce a series of Ca2+ oscillations in 
mouse eggs (Nomikos et al., 2011a). It is only fair to mention other proposed sperm 
factors that were put forward as potential candidates for rescuing egg activation 
failure. Another sperm protein known as PAWP (post-acrosomal WW domain-
binding protein) was described by Arabi M in 2014 as being a candidate that could 
fulfil the requirements for being an egg activator during fertilisation (Aarabi et al., 
2014a). However, a series of studies challenged that proposal and it seemed that 
the sperm PAWP hypothesis has not stood the test of time (Nomikos et al., 2015, 
Escoffier et al., 2016). For those reasons, it would appear that the only available egg 
activator is PLCζ.  
Injecting cRNA encoding PLCζ into human eggs would face legal issues since cRNA 
is genetic material. The other problem that would encounter such a protocol is the 
inability to identify the precise translation capability of the injected cRNA into human 
eggs. For both mentioned reasons the use of PLCζ cRNA in infertility clinics is highly 
unlikely. For that, research has led on to a search for a more natural form of egg 
activation, and this led to idea of using recombinant PLCζ protein. While the 
purification and stability of the synthesized protein is still under scrutiny, the protein 
has been injected into human eggs that have previously failed to show signs of 
fertilisation post ICSI and as a result they developed 2PN (when they were injected 
with 1μ/µl of PLCζ protein) (Yoon et al., 2012). This potential therapeutic molecule 
has high chances of being used with success within infertility clinics. Studies so far 
have been focusing on the variations in PLCζ between different species in terms of 
their ability to cause Ca2+ oscillations (Cox et al., 2002, Coward et al., 2005). The 
functionality of the sperm specific phospholipase as an enzyme has attracted 
attention as well (Kouchi et al., 2005, Nomikos et al., 2005). Research into egg 
sensitivity of different species when injected with other species PLCζ was another 
aspect of interest (Rogers et al., 2004). All previous studies investigated the effect of 
PLCζ on various species done after a procedure that utilises a high pressure 
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injection system. Despite the attention that PLCζ has attracted, there were little or 
no studies investigating the differences  in settings for PLCζ injection that exist 
between scientific laboratories and that of infertility clinics who almost exclusively 
use low pressure injection systems. The only low pressure systems used in 
laboratories use an oil drop to separate the culture media from the injection solution. 
This results in a drop of oil being injected into the egg, which is probably not 
acceptable in a human egg in an IVF clinic.    
4.2 Aims 
The aim of this chapter is twofold, firstly to investigate further the effectiveness of 
injecting Nus-A tagged hPLCζ recombinant protein into human eggs that have 
undergone an IVF procedure and failed to fertilise. Moreover, to observe the 
triggered series of Ca2+ oscillations in human eggs and compare them to those 
resulting from the same dose injected into mouse eggs. That would possibly allow 
for a dose calculation that would be suitable to trigger an appropriate Ca2+ response 
in human eggs. The aim was to elicit a Ca2+ response that has the ability  to trigger 
egg activation and support embryo development afterwards. Secondly, I also 
investigated an alternative method to a double injection of eggs if PLCζ is to be 
applied after ICSI. To my knowledge I also carried out the first attempts to inject the 
Nus-A tagged hPLCζ protein simultaneously with sperm during ICSI. In this chapter, 
I also succeeded in showing that the protein is stable after being freeze dried.  This 
would benefit the supply and transport of this material to IVF clinics as opposed to 
its original liquefied state. This method of transportation and storage would likely 
reduce the cost of protein use. The experiments presented here show a systematic 
approach, by testing various mediums and injection pipettes, which could potentially 
be used on a regular basis in infertility clinics. The human eggs that were used in 
this part of the study were donated kindly by patients being treated at the infertility 
clinic in Neath Port Talbot and Wales infertility institute at Cardiff. The project was 
approved by the UK Human Fertilisation and Embryology Authority (HFEA) (R0161).  
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4.3 Results 
4.3.1 Human PLCζ recombinant protein induces long lasting Ca2+ 
oscillations in mouse eggs and human eggs that have failed to 
fertilise post IVF. 
Rogers NT et al in 2004 showed that aged human eggs that have failed to fertilise 
during an IVF procedure including ICSI, have responded to an injection of PLCζ 
cRNA when various pipette concentrations were used. The range of PLCζ RNA 
concentration was (0.1µg/ml-1mg/ml) and all triggered repetitive Ca2+ oscillations 
with differences detected in frequency. Higher concentration of cRNA tended to 
induce a higher oscillation frequency (Rogers et al., 2004). Therefore, in the 
upcoming set of experiments, Nus-A tagged recombinant hPLCζ protein has been 
used as an alternative to mimic the expected scenario in clinical settings. Human 
eggs that have failed an IVF procedure ICSI either IVF or ICSI (day 1 post IVF) have 
been used in this set of experiments. These human eggs were loaded with an AM 
dye (Cal-520) for a duration of 45 minutes at 37oC and allowed to recover for about 
10 minutes before being injected with a dose of PLCζ protein. Cal-520 Ca2+ dye 
indicator requiring an excitation wavelength of 480nm and has an emission of 
514nm with a Kd for Ca2+ of 320nm. 
The Ca2+ oscillations resulting were measured against those triggered in a parallel 
set of mouse eggs injected with the same dose of Nus-A hPLCζ protein in the same 
day. In individual eggs the injection dose was identified to be sufficient when a 
cytoplasmic displacement of 3-5% was seen during the injection. However, due to 
size and volume differences between both species, dose control was essential to 
provide comparable information for the resulting Ca2+ spikes. To achieve this, a co-
injection of a fluorescent dye known as Alexa dextran 568 along with the protein was 
done, and this allowed for measurement of mean fluorescence intensity of the 
injection solution. Alexa dextran 568 is known to be greatly resistant to photo-
degradation and pH insensitive over a large range (4-10) (Panchuk-Voloshina et al., 
1999). A total of 40 human eggs from 14 different patients were made available to 
the project by the end. A breakdown of egg types and the IVF procedures that have 
been done for used eggs are presented in table 4.1 and table 4.2. 
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Egg type Age Number 
MII Day 1 post IVF 28  (70 %) 
MI Day 1 post collection 3   (7.5%) 
GV Day 1 post collection    9   (22.5%) 
Total 40 eggs 
 
Table 5.1 Categorisation of human eggs used in the project. 
The above shown table represents the breakdown of the human eggs that were used for this 
part of the project. They ranged from MII eggs, MI and GV eggs. About 70% of the eggs 
were MII. 
 
Egg type IVF ICSI No procedure 
MII 13 10 - 
MI - - 3 
GV - - 9 
 
Table 5.2  IVF procedure type applied to human eggs prior to micro-injection. 
This table represents the type of IVF procedure that the eggs used were exposed to all eggs 
that were used were Day 1 post procedure. MI and GV eggs had no procedures applied to 
them. 
 
As seen from the tables above, most of the human eggs were MII. Out of the 28 
available MII eggs, 5 were received damaged or else in a poor state and were 
discarded as per the approved protocol. In this set of experiments, eggs were 
injected with a pipette concentration of Nus-A hPLCζ (0.125mg/ml) mixed with the 
Alexa dextran dye (0.2mM) as a co-injection solution. All eggs were imaged for a 
period of 10 hours and kept on the imaging system on the heated stage to follow 
any developmental changes the next morning. The response of injecting Nus-A 
hPLCζ into human eggs was variable. There was no specific pattern regarding the 
Ca2+ oscillations that were triggered. Except for the first experiment on human eggs, 
all human eggs and mouse eggs were injected with the same batch and 
concentration of Nus-A hPLCζ protein (1.25mg/ml). The MII human eggs exhibited 3 
main categories of response. The first, was an instant start of high frequency 
oscillations (4-74 Ca2+ spikes) in the first 4 hours and it showed in 5/28 MII eggs 
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(17.9% of MII eggs), the next was a single/few Ca2+ spikes that started immediately 
(1-5 Ca2+ spikes) in the first 4 hours. This response was detected in 7/28 of the MII 
eggs (25% of MII eggs). In the second group there was only one egg that had a 
delayed start after 3.07 hrs.  
The last group of eggs showed an atypical response in which mostly it had a 
delayed start (8/28, 28.6% of the MII eggs). In this group, the Ca2+ baseline was 
increasing throughout the imaging period and did not come back later. The Ca2+ 
traces of the last group bear a resemblance to that from the MII egg that were not 
injected and were imaged as controls. Out of the 28 MII eggs 6 were not alive the 
next morning (21.4%). Unfortunately, only two eggs (both were post ICSI) managed 
to reach a 2-cell stage the next day, 9/28 (32.1%) formed pronuclei and the rest 
(11/28, 39.3%) had no signs of any developmental progression (Fig.4.1, 4.3, 4.4). All 
MI eggs (3/40) had an atypical response where there was an ever increasing level of 
the baseline Ca2+ level, but all 3 remained alive the next morning (Fig.4. 2).  
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Figure 4.1 Ca2+ traces representing oscillatory pattern detected following a 
microinjection of hPLCζ into MII human eggs.  
Nus-A hPLCζ was micro-injected in a concentration of 0.125mg/ml in all eggs.  
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Figure 4.2 Traces of the Ca2+ indicator detected in human MI eggs post hPLCζ 
microinjection. (Nus-A hPLCζ conc. 0.125mg/ml). 
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Figure 4.3 Effect of hPLCζ microinjection into MII human eggs. 
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Figure 4.4 Ca2+ response after a micro-injection of Nus-A hPLCζ in M2 eggs 
(Human and mouse). 
Human eggs (A) and mouse eggs (B) were micro-injected with the same dose of the protein 
(0.125mg/ml). The traces were cut after the first hour of imaging to reveal the difference 
visually. Bar scale=15 minutes. 
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4.3.2 Do human eggs arrested at GV stage have a specific response to 
a PLCζ protein injection? 
The GV stage is one of the two physiological arrests that occur in mammalian 
oocytes (Mehlmann, 2005). A number of approaches have been attempted to 
release the human GV’s from their arrest such as extending the period from hCG 
until retrieval, increasing the hCG dose and extending the period of in-vitro culture 
(Chian et al., 2000, Chian et al., 2004). In some mammalian models the size of the 
follicle during collection would indicate its ability to mature in-vitro (Motlik et al., 
1986). However, in a human egg that is not always the case, as the follicle could be 
in the appropriate size range while the egg could be still developmentally retarded 
(Chen et al., 2010c). A number of studies reported on the effect of injecting either 
PLCζ cRNA or the sperm factor in mouse GV oocytes. The injection of cRNA led to 
a diminished response in triggering Ca2+ oscillations.  The sperm factor injection was 
reported to be more successful in stimulating a response similar to that seen during 
fertilisation (Abbott et al., 1999, Wakai et al., 2013).    
No studies on human GV oocytes exist in this regard. Therefore, with the remaining 
eggs which were at the GV state (9 oocytes) which were almost 25% of the total. It 
was thought of studying the effect of injecting them with Nus-A hPLCζ recombinant 
protein. It is acknowledged that the number of GV oocytes will not be sufficient to 
build any conclusions. However, the results will aid in planning any future projects. 5 
oocytes that were at the GV state had an atypical response in which there were no 
Ca2+ oscillations while the baseline was drifting upwards during the period of 
imaging, the next day 4 GVs were not alive and one still had an intact GV.   The next 
response that was noticed was when a GV started off oscillating in a manner seen 
during fertilisation with an initial 3 Ca2+ spikes. This pattern did not last, as 
afterwards it went into a heavy low amplitude oscillatory pattern. This pattern could 
probably be explained by the diminished internal Ca2+ stores present in this type of 
oocytes. The next day the GV remained alive with an intact germinal vesicle. The 
most interesting finding in this particular group was seen in one GV oocyte. Initially 
the oocyte responded with a first Ca2+ spike and then it remained in a quite phase 
for about 2 hours, after which it returned to oscillate in very similar pattern to that 
seen during fertilisation (Fig.4. 5). A total of 7 spikes were recorded during a period 
of 10 hours, the next day the GV had matured into an MII. Unfortunately, whether 
the oscillatory pattern was related to the GV breakdown or not, such a conclusion 
was not possible to make.  DIC images were not taken alongside the fluorescence 
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imaging as it was thought that the extra exposure would lead to more stress on the 
oocytes.   
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Figure 4.5 representative traces for Ca2+ changes detected in human GV 
oocytes following a microinjection of hPLCζ. 
The GV oocyte with the middle trace was followed the next day and found to have 
matured into an MII. The dose of hPLCζ micro-injected was 0.125mg/ml in all GV 
oocytes.   
124 
 
AB
 
Figure 4.6 DIC images are for human eggs 24hrs post injection with hPLCζ 
protein.  
A). The egg on the top left hand is showing signs of degeneration, while the egg with the 
black block arrow has gone through the first division into 2 daughter cells as a response to 
protein injection, the other two eggs have remained stationary.B).In this image the open 
black arrow shows a human GV oocyte that has been injected but remained post injection in 
the GV state, while the open arrow shows an MII egg that formed a pronucleus post 
injection. 
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4.3.3 A comparison of injecting a dose of hPLCζ protein into mouse 
eggs and human eggs that failed to fertilise. 
A number of tests are available to assess the functionality of sperm after cases 
reported with fertilisation failure especially following an ICSI procedure. These tests 
include injecting sperm into other mammalian eggs such as mouse eggs (mouse 
oocyte activation test, MOAT). In this test the eggs are imaged to examine the 
pattern of Ca2+ oscillations as well as to check for pronuclei development in some 
instances. Three main categories were listed following such an examination, low, 
intermediate and high levels of activation capacity of the sperm (Heindryckx et al., 
2005, Heindryckx et al., 2008). One main point was taken into consideration when 
analysing such results, that is the human PLCζ has greater potency than the mouse 
version (Nomikos et al., 2012a).  In this set of experiments hPLCζ protein was 
injected into mouse eggs on the same day that the human eggs were injected. The 
exact same protocol used on human eggs was applied to mouse eggs. PLCζ protein 
was kept in -80oC and only thawed prior to the experiment to prevent any decay in 
the activation capacity. A pipette concentration of PLCζ (0.125mg/ml) mixed with 
Alexa dye (0.2mM) was used to inject mouse eggs. Each experiment conducted on 
human eggs had a parallel experiment on mouse eggs using the same batch of 
hPLCζ (Fig.4. 7). The difference was that mouse eggs experiment was done on the 
morning using freshly ovulated mouse eggs. The human eggs were received usually 
at Day1 post IVF procedure at around 2pm (around 30hrs after collection). Each 
mouse egg experiment included between 6-9 eggs being injected and imaged.  A 
total of 72 mouse eggs were injected and analysed. All mouse eggs responded to 
the Nus-A hPLCζ protein injection (Fig.4. 7 A). The injection process for 6-9 mouse 
eggs usually takes less than 1minute, the response was mainly characterised by a 
high frequency of Ca2+ oscillations. The mean spike interval of the oscillation was 
4.3+_ 0.48 (s.e.m) mins (Table 4.3) and there was no gap or delay between placing 
the eggs on the imaging system and the start of the Ca2+ oscillations. In most mouse 
eggs the first Ca2+ spike was missed due to the rapid onset of action of the protein. 
In about 28/72 (38.9%) of the mouse eggs the high frequency of Ca2+ oscillations 
showed an abrupt cessation after about 2.5hours without any reduction in the 
amplitude or frequency beforehand. Along with the Nus-A hPLCζ, 5μMAlexa 
indicator was co-injected to allow for measurement of fluorescence intensity in eggs 
that have been micro-injected. The fluorescence intensity of the Alexa dye was used 
to compare the amount of the protein injected in human and mouse eggs. Figure 
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4.7(C) demonstrates that the amount injected into mouse eggs (12.9-31.5) was 
about half of what was injected into human eggs (39.7-66.2).  add to disc why  
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Figure 4.7 A comparison of Ca2+ oscillations between mouse and human eggs 
following a micro-injection of hPLCζ. 
Both egg types received an injection of hPLCζ of 0.0125mg/ml. (A, human egg. B, mouse 
egg). C, The bar chart reveals a significant difference between the amount microinjected into 
both eggs (P= 0.000). 
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4.3.4 PLCζ protein activation capacity can be preserved by freeze 
drying. 
Until now the evidence compiled from the work on PLCζ is strongly indicating that it 
can be used as an alternative for assisted activation protocols in IVF clinics in the 
near future. However, the protein has been studied in its solution form in terms of 
duration of activity when taken out of -80oC.  If the protein is to be used as a 
therapeutic agent it will need to be distributed and in its current form it will need a 
reliable cold storage which in part could be expensive and not always available 
especially in developing countries. Freeze-drying has been used for decades as a 
process for concentrating or drying biologically active enzyme/protein based 
materials. Freeze-drying also offers a big advantage when it comes to 
shipping/distribution and storage (Roy and Gupta, 2004). However, recently it was 
noted that the reduced activity of some enzyme powders was related to the freeze-
drying process. It is of great importance to ensure the stability of PLCζ protein 
during this process of form modification, transport and storage. In view of these 
concerns it was mandatory to test the effect of freeze-drying on PLCζ protein and its 
potential for recovery after reconstitution.  
For this preliminary test of freeze-drying of Nus-A hPLCζ protein 2 new stocks were 
made for this purpose. The first was to test for Ca2+ releasing activity post freeze-
drying and the second was to test if storage effects on egg activation capability of 
the protein. First was a batch that had a concentration of 0.9mg/ml, which was 
divided into aliquots of 5µl each. It was tested on the same day of purification at a 
concentration of about 0.01mg/ml (group 1). The rest of the aliquots were subject to 
freeze-drying on the same day and were kept at 4oC for less than 24hrs (16hrs +/- 
4hrs). The next day the protein was reconstituted and divided into two aliquots, one 
aliquot was used to inject eggs after a period of 1hour while the other was kept at 
4oC (group 2).  Next, mouse eggs were injected with hPLCζ protein that remained at 
4oC after reconstitution, the protein was diluted to the required concentration 
(0.01mg/ml) before injection (group 3). Table 4.3 summarises the result of the 
pattern of Ca2+ oscillations for the three groups injected. When comparing the 
response elicited from injecting PLCζ in the same concentration of the 3 different 
conditions, it seems that the higher activation capacity was that of the third group. 
Traces in figure 4.7 are representative of the 3 groups. The mean number of Ca2+ 
spikes was significantly different between the 2 groups that were freeze dried, with 
the second group having the highest rate.  In group 2 there were about 33% (4/12) 
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of mouse eggs that did not show any response to PLCζ while the rest of the eggs 
started oscillating after a gap of at least 1 hour. Eggs in group 1, 3 started oscillating 
immediately with no gap. This data might suggest that freeze-drying might have 
promoted aggregation of the protein that requires time to fully reconfigure after 
reconstitution. However, it has to be noted that we found that once the protein is 
diluted to the required working concentration it loses its ability to induce any Ca2+ 
oscillations after 24hrs. 
 
 
State of PLCζ 
Response in mouse eggs 
Mean spike number /4hours 
+/-Std 
(a) PLCζ injected on Day 0 
(on purification day) 
6.14 (n=14) +/-6.2 
(b)  PLCζ injected on Day 1 
post freeze-drying (1 hr 
post reconstitution) 
1.83 (n=12) +/- 4.8 
(c) PLCζ injected on Day 2 
post freeze-drying (day 1 
post reconstitution) 
8 (n=10) +/- 2.9  
 
Table 5.3 Effect of freeze drying hPLCζ protein and its ability to trigger Ca2+ 
oscillations following different thawing conditions. 
The above table provides details of micro-injecting hPLCζ (a) on the day of 
purification and (b) post freeze drying and reconstitution and dilution at Day 1. (c) 
Injecting mouse eggs on Day 2 post reconstitution after dilution. A significant 
difference was detected between groups that were freeze dried (P= 0.007). 
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Figure 4.8 Ca2+ oscillations established in mouse eggs following injection of 
hPLCζ subject to different storage methods. 
A, A Ca2+ trace resulting from injection of the protein into a mouse egg on the same day of 
purification. B, Following freeze drying the protein was reconstituted to its original 
concentration then diluted to the working concentration required. C, Following reconstitution 
to the original stock concentration the protein was left at 4oC and diluted to the working 
concentration and micro-injected into mouse eggs the following day. All eggs were micro-
injected with 0.01mg/ml of hPLCζ protein. 
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Next to assessing the stability of the protein after being freeze-dried and 
reconstituted, it was necessary to ensure that storage would not compromise the 
activation capacity of the protein.  It has been reported that freeze-dried proteins are 
liable to denaturation in certain conditions by moisture and other mechanisms (Roy 
and Gupta, 2004).  For this purpose the second batch was used to identify if protein 
storage would have any effect on its activity. The second purified protein batch was 
30µl with an initial concentration of 1.25mg/ml. The stock was divided in three 
groups the first 10µl was divided into 2 of 5 µl aliquots and stored at -80oC after snap 
freezing using liquid nitrogen. The second group was divided into 2 of 5 µl and 
freeze-dried on the same day, post freeze drying the protein was kept in laboratory 
condition with a temperature ranging between 21oC - 23oC inside a drawer. The third 
group was also divided into 2 of 5 µl aliquots and freeze-dried on the same day and 
kept at about 4oC. All groups were stored for 4 weeks after which the protein was 
tested by injecting different concentrations (0.15mg/ml - 0.08mg/ml - 0.02mg/ml) into 
mouse eggs to identify if any differences would exist in the response elicited.  
There was no significant difference in the mean spike number per 2 hours detected 
between the 3 groups when a concentration of 0.15mg/ml was injected into mouse 
eggs (Table 4.4) (Fig.4. 10). When 0.08mg/ml was injected into eggs the highest 
oscillation frequency detected was seen in the group that was stored at 4oC and that 
was significantly different from the other 2 groups (P= 0.000) as illustrated in figure 
4.9 and figure 4.11. When the concentration of injection was further reduced to 
0.02mg/ml the only group that showed a response to the injection was the group 
that was injected with the protein that was stored at -80oC (Fig.4.12). The other two 
groups representing the frozen-dried protein did not trigger any response in mouse 
eggs injected. 
The results show that at high concentrations of the protein no difference exists 
between different modes of storage. However, when the concentration was lowered 
it seemed that the form of protein storage could possibly affect the activation 
capacity in that freeze-drying stored at 4oC was significantly superior in retaining the 
protein activity. With the lowest concentration of protein injected (0.02mg/ml) the 
form of storage that elicited a response was the one kept at -80oC indicating that 
long term storage could affect the protein activity.  
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Protein 
concentration 
injected 
Mean spike number/2hrs 
FD kept at 
room temp 
FD kept at 4oC Kept at -80oC 
0.15mg.ml 89  (n=8) 78.5  (n=8) 74 (n=8) 
0.08mg.ml 6.5 (n=6) 46.4 (n=8) 8.5 (n=8) 
0.02mg/ml 0   (n=6) 0.13  (n=8) 3.2 (n=9) 
Table 5.4 Ca2+ spike number following injection of various concentration of 
hPLCz that have been stored via different methods.  
The presented table shows the mean number of Ca2+ spikes imaged for the first 2 hours for 
the 3 different concentrations injected of the 3 different methods of protein storage. (FD, 
Freeze dried). 
Protein concentration injected
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Figure 4.9 Bar chart representing the mean number of Ca2+ spikes difference 
between various storage methods for the 3 different concentration of hPLCζ 
micro-injected.  
There was a significant difference detected for the means of spike numbers in the 0.08mg/ml 
concentration for the 3 different storage methods (P= 0.000) 
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Figure 4.10  Sample traces for Ca2+ oscillations in mouse eggs in a response 
to a microinjection of hPLCζ (0.15mg/ml). 
A hPLCζ concentration of 0.15mg/ml was microinjected into mouse eggs from the 3 
different storage methods used for the protein. 
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Figure 4.11 Representative traces for the Ca2+ oscillatory pattern detected in 
mouse eggs following a hPLCζ dose of 0.08mg/ml. 
The three traces are representative Ca2+ oscillation traces detected for the different 
storage methods of the protein for the given concentration. 
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Figure 4.12 0.02mg/ml of hPLCζ microinjected into mouse eggs following 
various methods of storage. 
Protein stored at -80oC was the only reliable source of Ca2+ oscillations at this particular 
concentration and it was significantly different from the other two methods of storage (P= 
0.001). Difference detected was between the mean spike number/2hrs.  
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4.3.5 Exploring methods for injecting PLCζ protein in IVF settings.  
A number of approaches have been developed to micro-manipulate gametes during 
various IVF techniques. The latest most commonly used technique is ICSI which 
involves introducing a single sperm into the egg cytoplasm via the use of a sharp 
injection pipette. The downside of this technique is that it involves puncturing the 
cytoplasmic membrane which has the risk of irreversibly damaging the egg by lyses 
or shrinkage (Palermo et al., 2009).  However, the learning curve of most 
embryologists led to optimal injections that had high survival rates. Loss of eggs 
when induced ovulation cycles yield a high number of eggs wouldn’t be an issue, 
however, in cycles where the egg harvest is low in poor responders a suboptimal 
injection technique could be of clinical relevance (Ebner et al., 2001). Current 
artificial activators such as ionomycin are used in way that does not involve 
mechanical intervention with the eggs, therefore reducing the risk of immediate 
damage to eggs. In light of the potential use of Nus-A hPLCζ protein as an artificial 
activator in clinical settings, it is important to find a method that would allow its 
introduction into egg cytoplasm without the risk of egg damage. To use PLCζ protein 
as an activator it be would require a suitable injection technique to be established. In 
this section we explored a number of techniques to identify a reliable method that 
would have the lowest risk in irreversibly damaging the eggs.  
4.3.6 The effect of pipette type on hPLCζ protein injection. 
In our laboratory settings we utilise a high pressure (>10 psi) injection system for 
injecting hPLCζ protein which uses an electrically driven sharp tip (~1µm) pipette 
after and ICSI injection in mouse eggs. In order for us to achieve this, two types of 
injection pipettes are needed, an ICSI pipette and the sharp tip pipettes. Both 
pipettes are different from that used in IVF clinics  
It was initially thought that hPLCζ protein could be injected as a second step in a 
process involving two subsequent measures. For that purpose a specific pipette was 
fabricated using a pipette puller, and a beveller to obtain the desired tip geometry. 
The idea here is that a second pipette could be used that mimics our procedure but 
which is wide enough to be used with low pressure injection apparatus typical of IVF 
clinics.  The bevelled tip was expected to facilitate the penetration through the zona 
pellucida while the tip diameter would be sufficient to release protein once inside the 
egg cytoplasm. The protein was placed in a separate drop to that containing the 
eggs placed adjacent to one another so that movement between drops would not be 
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problematic. There was no contact between both drops as they were bridged by the 
covering mineral oil. To examine the ability to carry a specific amount of protein and 
to inject it into eggs without diffusion from the end of the pipette, a fluorescent-
dextran was used as a tracer for this technique. The injection was carried out 
without the use of the high pressure as the system was unfamiliar to IVF clinics. The 
bevelled pipette was connected to the ICSI system and the protein was injected 
manually. By measuring the mean level of fluorescence of the indicator post 
injection we can see that using such a technique could be reliable in injecting 
comparable amounts of material across the eggs. The injection using a bevelled 
pipette was compared to that of utilising a standard high pressure mouse injection 
pipette (Fig.4.13) 
 No statistical difference was identified between eggs in each group (P= 0.275) and 
when the mean fluorescence level was measured between both groups no 
difference was statistical significant difference was detected either (P= 0.096). 
However, this was technically quite demanding as the control of the uptake of the 
fluorescent material was difficult to keep in the bevelled pipette once carried over to 
the injection media. It seemed as there was a constant diffusion from the pipette tip 
into the injection media drop. Initially the drop that had the fluorescent dextran was 
mixed with KCL Hepes.  When the drop was supplied with 10% polyvinylprolidine 
(PVP), it was hardly possible to take it up into the injection bevelled pipette. PVP is 
commonly utilised in the sperm suspension drop to reduce sperm movement in IVF 
clinics by increasing the viscosity of the drop (Van Steirteghem et al., 1993).  From 
this experience, I can conclude that the control of the amount of material injected 
under these experimental conditions into egg cytoplasm could be equally achieved 
via the use of both pipettes but with a notable degree of technical difficulty.  
The use of a single ICSI pipette would be favoured over the use of the second 
bevelled pipette, but this means it will be necessary to develop a co-injection 
method for sperm and protein. The concept of a co-injection would be ideal, as it 
would avoid exposing the eggs to a second round of mechanical manipulation that 
would be required by the use of the extra bevelled pipette. The ICSI technique 
basically involves including a sperm in the injection solution, therefore including 
sperm in a suspension was tested next. The setting remained the same as in the 
previous ICSI work, but with the addition of sonicated sperm to the drop containing 
fluorescein dextran as a fluorescent indicator. The comparison of amounts injected 
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was made between using a pipette with our usual high pressure injection method 
and the mouse ICSI pipette method. Once again, the experiment revealed that 
sperm could be co-injected into eggs with an amount of the indicator that showed no 
significant difference across the mean of fluorescence levels detected in both 
groups of eggs injected  (P= 0.083) (Fig.4. 14).  
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 Figure 4.13 Fluorescence images for mouse eggs following injection of 
fluorescein dextran using different pipettes.  
A, Eggs microinjected using a pipette for the high pressure injection system. B, 
Mouse eggs injected using a bevelled pipette. 
 
 
 
Figure 4.14 Fluorescence images of mouse eggs post injection with 
fluorescein dextran.  
A, Microinjection using a pipette that is used with high pressure injection. B, Mouse 
eggs injected using a mouse ICSI pipette. 
 
 
 
A B 
A B 
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4.3.7 Exploring media that would be suitable for a co-injection method. 
The ICSI protocol involves a setup where one drop of media will contain the eggs 
and other drops containing the sperm that will be manipulated prior to pick-up into 
the pipette. Following the holding of a sperm, the ICSI pipette will be moved towards 
the drop where eggs are placed and the injection of sperm will there take place. This 
coming set of experiments was to find the best place to add PLCζ protein and which 
media would provide the best survival rates post injection. The initial consideration 
was to have PLCζ protein at the concentration required (0.015mg/ml) within the 
media that contains the eggs. As most of our injection procedures are conducted in 
M2 media, it was the first media to test. Having PLCζ protein in the injection media 
proved to have deleterious effects on egg survival when a sham ICSI procedure was 
done (with no sperm). Only 4 out of 18 eggs survived the procedure and those that 
survived had a very high frequency of oscillations when imaged. Next, eggs were 
kept on their own in M2 medium drop. PLCζ protein was diluted to the required 
concentration in a separate KCL-Hepes drop. Both drops were next to each other 
separated via a bridge created by the covering mineral oil. The same results 
occurred, in that only 3 out of 12 eggs survived the injection and those that did 
survive had very high frequency oscillations. These data suggest that simply 
combining PLCζ protein with the normal media surrounding the egg is not an 
effective means of introducing it into eggs.  
The Ca2+ in M2 was suspected to be the main culprit behind the over-stimulated 
response of eggs and their lysis. PLCζ is notably very sensitive to Ca2+ and could be 
hyper-stimulated by the Ca2+ in media. . Because M2 is a ready bought media from 
Sigma we switched to KCL-Hepes, which was necessary to be able to manipulate 
the contents of the injection media and to test the effects of certain molecules. To 
this media 1mg/ml of PVP was supplemented to prevent the sticking of the eggs to 
the bottom of the injection dish.  Eggs and PLCζ protein were then placed in the 
drop at a concentration of (0.015mg/ml) and ICSI was performed. Ca2+ was omitted 
from the media at first but that caused lyses of all eggs after injection (survival 0/16). 
Next Ca2+ was added to reach a concentration of 10µM and there was a significant 
improvement in survival from the previous result (P= 0.002) with 15 out of 27 eggs 
surviving the injection. However, the frequency of oscillations was still high (7.5 
times the physiological rate). The concentration of Ca2+ was further increased to 
100µM. The survival rate was improved when compared to the first attempt, but 
significantly less than the group injected with 10µM of Ca2+ media (P= 0.0032), with 
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just 6 out of 21 eggs surviving  the injection. These data suggest that extracellular 
Ca2+ is needed for survival after ICSI, but even a small amount of extracellular Ca2+ 
causes problems when co-injected with PLCζ protein.   
HKSOM is a culture media that has components suitable for development and is 
made in our laboratory so adjustments can be applied. As a control for this group 
regular HKSOM media with 1.7mM Ca2+ was used for a regular ICSI experiment 
where sperm was placed in the drop with eggs. The survival rate was 22 out of 26 
injected eggs (84.6%) with 19 eggs (86.3%) having a physiological pattern of Ca2+ 
oscillation when imaged. Subsequently, HKSOM that had no Ca2+ addition was used 
for an ICSI run, but all 14 eggs of the first attempt stuck to the bottom of the dish. 
For that reason it was necessary to add bovine serum protein (BSA) which is a 
common blocking agent to prevent adhesions. So 4mg/ml of BSA was added to 
HKSOM, with no Ca2+ and a sham ICSI was performed where no sperm or PLCζ 
protein. The run was repeated 3 times where a total of 37 eggs were injected but 0% 
of eggs survived the injection. Ca2+ was reintroduced to the media gradually starting 
from 10µM, and a sham ICSI was performed to test the survival and 18 out of 22 
(81.8%) survived and looked healthy post injection. Sperm was added to the 
injection media and 25 eggs from a total of 28 eggs injected survived the procedure 
(89.3%). Sperm and PLCζ protein were added to the media with a final 
concentration of (0.015mg/ml) but no egg survival occurred at all after 3 separate 
attempts ICSI (Table 4.5, 6, 7 a,b,c). These data using HKSOM resemble those 
using KCl Hepes and again suggests that Ca2+ is important for egg survival and that 
eggs are stressed by the combination of Ca2+ and PLCζ protein injection.   
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A  
ICSI conditions  Survival rate  
Oscillation 
pattern  
Media  Additions  
M2  
Control set  
ICSI with sperm  
11/13  
84.6%  
Physiological  
M2  
Sham ICSI & 
PLCζ 
0.015mg/ml  
4/18  
22.2%  
Very high 
frequency  
PLCζ 
protein in 
a separate 
drop (KCL-
Hepes) 
ICSI with sperm 
& PLCζ 
0.015mg/ml 
3/12  
25%  
High frequency  
 
Table 5.5  Assessment of M2 as a medium for a protocol of co-injecting sperm 
and hPLCζ protein. 
A, Variations in the co-injection protocol using M2 medium, including survival rates 
and pattern of Ca2+ oscillations detected. 
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B           ICSI conditions  
Survival rate  Oscillation pattern  Media  Additions  
KCL-Hepes  
No Ca2+  
1mg/ml PVP  
0.015mg/ml 
PLCζ 
0/16  ---------------  
10µM Ca2+  
1mg/ml PVP 
0.015mg/ml 
PLCζ 
15/27  
55.6%  
High frequency  
100µM Ca2+  
1mg/ml PVP 
0.015mg/ml 
PLCζ 
6/21  
28.6%  
Very high 
frequency  
 
Table 5.6 Search for a media that would allow maximum survival rates for 
mouse eggs post ICSI-hPLCζ co-injection. 
B, Mouse eggs were placed in a drop of KCL-Hepes with various additions the table 
shows results of egg survival and Ca2+ oscillation patterns detected post injection. 
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 C             ICSI conditions
Survival rate
Oscillation 
pattern
Media Additions
HKSOM
1.7mM Ca2+
ICSI with sperm
22/26
(84.6%)
19/22 responded 
with physiological 
frequency
No Ca2+
ICSI with 
0.015mg/ml PLCζ
All eggs stuck to 
bottom of the dish
----------------
No Ca2+
4mg/ml BSA
Sham ICSI 
No egg survival -----------------
10µM Ca2+
4mg/ml BSA
Sham ICSI
18/22
81.8%
-----------------
10µM Ca2+
4mg/ml BSA
ICSI with sperm
25/28
89.3%
Physiological 
frequency
10µM Ca2+
4mg/ml BSA
ICSI with 
0.015mg/ml PLCζ
No egg survival ----------------
 
Table 5.7  HKSOM as a medium for a co-injection protocol for ICSI and hPLCζ 
protein. 
C, The table represents results from experimenting with different changes to the 
regular HKSOM, no physiological Ca2+ oscillations were detected apart from the 
control listed as the first test in the table and when no hPLCζ was included in the 
media. 
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4.3.8 The relationship between egg survival during ICSI-PLCζ co-
injection and medium osmolarity. 
Osmolarity can affect the size of the vitelline space by either shrinkage or swelling in 
a reaction to the surrounding medium osmolarity (Kaufman and Surani, 1974). Frog 
eggs are often injected in Ca2+ free media (to prevent egg activation) and it has 
been reported that survival of frog eggs after injection is improved by increasing the 
osmolarity of the media (Edwards et al., 2004). The normal range of osmolarity that 
experimental or culture media are expected to be is around 280-300mOsm/Kg, 
which simulates mammalian serum osmolarity (Waymouth, 1970). To investigate the 
effect of osmolarity, more specifically a high osmolarity on the survival rate of eggs 
during an ICSI- PLCζ co-injection. I deliberately made the osmolarity of the injection 
media so it will be higher than normal. The change to an increased level of 
osmolarity was induced by subtracting NaCl from the injection media (HKSOM) and 
replacing it with choline to achieve the desired osmolarity. Therefore all sodium salts 
were replaced by choline, measurements of the end-point osmolarity was checked 
using a calibrated freezing point osmometer. The new osmolarity ranged between 
350-400mOsm/kg. Choline unlike sodium does not cross the cytoplasmic membrane 
by the use of channels and it has a membrane protection capability as shown by 
previous work on eggs (Stachecki et al., 1998).   
When eggs were placed in the injection medium, a morphological change appeared 
in the size of the egg probably due to a change in the peri-vitelline volume.  The 
result of placing the eggs into a higher osmolarity medium was felt in addition to 
being visualised. It seemed that the cytoplasmic membrane was toughened and was 
more resistant to needle advancement. However, despite the effect of increasing the 
osmolarity on the eggs particularly on the membrane, there were no beneficial 
effects detected in terms of egg survival.  Part of the experiments conducted in 
HKSOM regular media were repeated with the high osmolarity version. The last two 
ICSI conditions in table 4.5 C were repeated and mixed results were found. The 
conditions were that where 10μM Ca2+, 4mg/ml of BSA and either sperm or 
0.015mg/ml of hPLCζ was present. In terms of survival there was a significant 
improvement when the experiments were repeated in different medium osmolarity. 
Egg survival of 14/20 (70%) (P= 0.016) for co-injection in HKSOM, 10μM Ca2+, 
4mg/ml of BSA and sperm was detected. Moreover, egg survival of 11/19 (57.9%) 
(P= 0.021) for co-injection in HKSOM, 10μM Ca2+, 4mg/ml of BSA and 0.015mg/ml 
of hPLCζ was detected. This was significantly better in comparison with regular 
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media osmolarity. However, the improvement seen in survival rate was not seen in 
the normalization of Ca2+ oscillation frequencies. The rate of Ca2+ oscillations 
detected for the ICSI with sperm had a reduction of about 67% of the spike 
number/2hrs.  While the group which had an ICSI- PLCζ protein co-injection only 
3/28 eggs oscillated and that was in an unusual pattern as seen in figure 4. 15.   
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Figure 4.15 Representative traces for cytosolic Ca2+ changes following 
injecting hPLCζ protein in media with various osmolarity levels. 
A, Represents an abnormal Ca2+ oscillatory pattern detected following hPLCζ 
injection. B, No Ca2+ oscillations detected in mouse eggs after injection. 
146 
 
4.3.9 Could a conventional method of ICSI injection be the solution? 
 
Since development of the ICSI technique, it has not seen a dramatic alteration in the 
way it is has been performed. The basic protocol has almost remained unchanged 
throughout the years (Palermo et al., 2009). The technique, as described in details 
elsewhere, includes a dish with multiple media drops usually each containing a 
single egg to be injected. A separate drop for the sperm preparation is either located 
on the side or at the centre of the dish.  Sperm preparation is usually supplemented 
with PVP, although controversy surrounds its use, it is still a common practice to 
reduce sperm mobility. In my previous experiments exploring media suitable for a 
co-injection technique, there was a diffusion issue of the material from the end of the 
injection pipette. This was noticed first when M2 medium was used with an adjacent 
KCL-Hepes drop containing hPLCζ. However, when 10% PVP was added to KCL-
Hepes this phenomenon was reduced. For that reason, it was thought that going 
back to the original configuration of the technique could provide a solution to the 
diffusion issue. Therefore the initial setup was to test if the diffusion would be 
reduced if a PVP concentration used in IVF settings (5-10%PVP) was used in the 
separate drop.  
A dish with a M2 drop containing eggs and another being KCL-Hepes supplemented 
with 10%PVP and a fluorescent heavy molecule (Fluorescein isothiocyanate–
dextran ,FITC-dextran, sigma) were covered by mineral oil and placed on the 
injection stage. The vibrant yellow colour of the indicator allowed an instant 
assessment of any diffusion occurring after loading the injection pipette and moving 
it across to the injection media. It seemed that the viscosity difference between the 
two media brought by the use of PVP prevented the diffusion. Eggs were injected 
either by multiple loads or with a single load which is a common practice during ICSI 
with experienced embryologists. All eggs injected (n=34) showed a fluorescent 
signal when imaged, indicating that the carried over solution remained in the 
injection pipette after crossing to the injection drop (Fig.4. 16). Figure 4. 17 
represents various experiments conducted for developing a protocol for the co-
injection technique.  
147 
 
  
 
Figure 4.16 Fluorescent images following a protocol for co-injecting sperm 
and hPLCζ using the mouse ICSI pipette. 
The top image is for mouse eggs injected with the fluorescent indicator using a high pressure 
injection system and the pipette used for that system. The bottom image is for eggs post co-
injection of sperm and hPLCζ after carry over from a drop containing 10%PVP using a 
mouse ICSI pipette. Both injection materials contained the same fluorescent indicator. 
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To examine if the results would be consistent when PLCζ protein is added to the 
PVP solution, a stock that had an initial concentration of 0.06mg/ml was used in the 
next set of experiments. The protein was diluted down to 0.01mg/ml in KCL-Hepes 
with 10%PVP and the mix was co-incubated for 30minutes on an ice block. The dish 
was setup as mentioned previously, when the protein drop was examined under 20X 
it appeared that there was aggregate formation (Fig.4.18). A brief spin in the bench 
top centrifuge to assess if the aggregates would re-dissolve in the solution proved to 
be of no benefit. On the contrary, it promoted an increase in the apparent size of the 
aggregates. I carried on with the experiment to assess if the aggregate formation 
has caused any effect on protein function. ICSI was performed with the use of the 
mouse ICSI pipette, the protein mix that had the smaller aggregate size was used.   
In the first run for this experiment, due to the difficult control over the advance of the 
injection material within the injection pipette, each pipette load was used to inject up 
to 3 eggs. A total of 12 eggs were injected, 9 survived (75%), 6 eggs showed Ca2+ 
oscillations. However, the frequency amongst the six eggs was variable, ranging 
from a very high frequency to a single initial spike. All eggs released a second polar 
body, in the high frequency pattern cell fragmentation was noticed.  The variability of 
the oscillation frequency was very likely to be caused by the unequal amounts being 
injected into the eggs. Therefore, to have control over the amount of media injected 
into each egg, a separate load was taken for every single egg. A total of 25 eggs 
were injected in this second run, first, 12 eggs were injected, 9 survived (75%) and 8 
eggs oscillated when imaged. The next group of this second run included 13 eggs, 
10 survived (76.9%) and 9 oscillated. With this method of injection the variability 
previously seen in the oscillation frequency was reduced (Fig.4. 19).  Results were 
indicating that the method of co-injecting the protein and sperm is a valid technique. 
It had the advantage that it would not need any extra training sessions for 
embryologists as it is the current protocol in use. However, the aggregates that were 
seen in the media needs to be further analysed in terms of components and if any 
protein activity was lost due to this effect. Could PVP be replaced by any other 
molecule that would be fit for purpose, slowing the sperm and being inert to PLCζ 
protein? This enquiry has been picked up as a separate project in our laboratory.   
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Figure 4.17 Schematic diagrams for the various protocols tested for the co-
injection technique.  
1, A single drop of M2 containing mouse eggs and sperm with hPLCζ at the required 
concentration. 2, A trial for using KCL-Hepes as an injection medium for the co-injection 
protocol. 3, Using a separate drop for the co-injection technique (KCL-Hepes with hPLCζ 
and sperm), to be carried over to the injection drop using the mouse ICSI pipette. 4, 
Supplementation of the KCL-Hepes drop with 10%PVP on top of hPLCζ and sperm.  
a, Egg holding pipette. b, Injection medium (M2, KCL-Hepes in 2). c, Mouse ICSI pipette. d 
Sperm suspension drop with 10%PVP and hPLCζ. 
 
150 
 
AB
 
Figure 4.18 DIC images for aggregates formed when hPLCζ was mixed with 
10%PVP. 
Images of the KCL-Hepes drop with 10%PVP and a final 0.01mg/ml of hPLCζ 
protein. The dashed arrow points to the egg holding pipette held on the edge of the 
drop, while the block arrow shows the injection pipette with the some injection media 
taken inside. The surrounding medium has specs dispersed within the whole drop. 
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Figure 4.19 Representative traces for Ca2+ oscillations detected following a co-
injection protocol for sperm and hPLCζ. 
A, One egg had only one spike after a latent period. B, Ca2+ oscillations started regularly but 
had a premature stop. C, A response detected that resembles the physiological Ca2+ 
oscillation frequency pattern. D, A trace representing traces form eggs that had a heavy 
frequency of oscillations.  
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4.4 Discussion 
Gamete micromanipulation was introduced into the IVF field to overcome failures 
seen in conventional IVF treatments, with ICSI procedure having the highest degree 
of invasiveness (Ebner et al., 2001). Even with all the advances in protocol 
development, cases of fertilisation failure are still documented post-ICSI. The failure 
rates following ICSI were mainly caused to activation failure (Tesarik and Sousa, 
1994, Nasr-Esfahani et al., 2010). A growing interest within IVF clinics for the use of 
artificial activation protocols has occurred to try and solve cases with fertilisation 
failure.  With the sperm factor currently widely agreed to be the PLCζ protein, its use 
during ICSI cycles to rescue activation failure has received increasing attention.  
This section of my study was to focus on developing a reproducible methodology to 
co-inject PLCζ protein during ICSI and to further asses the response of human eggs 
to a PLCζ protein injection. I had the advantage that our lab has made the active 
recombinant human protein (hPLCζ); the protein made had a NusA tagged to its C 
terminus (Nomikos et al., 2013). NusA as a fusion protein has a dual function of 
maintaining stability and solubility of recombinant proteins (De Marco et al., 2004). 
In unpublished data the PLCζ protein was injected into mouse eggs without the 
NusA tag, there would be a dramatic loss of the protein’s activity seen as diminished 
Ca2+ oscillation frequency. That indicates the importance of the fusion tag for protein 
function. Previous studies published by our group have shown that a microinjection 
of hPLCζ protein could support blastocyct development in mouse eggs (Yu et al., 
2012). Moreover, it has been shown that microinjecting NusA fusion tag on its own 
along with a live sperm did not have any detrimental effects on the blastocyst 
development rate in mouse eggs (Sanusi et al., 2015). In my results I have injected 
hPLCζ protein into human eggs that have failed an IVF procedure. The same 
concentration was injected in mouse eggs as well as human eggs (0.015µg/ml), the 
main difference detected between the eggs that have oscillated in both groups was 
in the frequency of Ca2+ oscillation. A general perception from the results is that the 
mouse eggs had a higher frequency of oscillations. The data presented is supported 
by original data with regard to the Ca2+ releasing ability of mPLCζ in comparison to 
hPLCζ in mouse eggs, when hPLCζ had a higher potency in mouse eggs (Cox et 
al., 2002). The difference seen in response to PLCζ of different species could be 
explained by a number of possibilities. First, is that the human egg is about five 
times bigger in volume than the mouse eggs. The human egg has a diameter of 
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around 120µm without the zona pellucida, while the mouse egg’s diameter is 
approximately 70µm. Therefore, a dilution factor effect due to size difference could 
explain a weaker response in human eggs when compared to mouse eggs. The 
extra volume in the cytoplasm of human egg over the mouse egg would require an 
extra amount of protein to trigger a similar response to that of the mouse egg.  
Differences between species with human and mouse eggs could also be due to 
different sensitivities to PLCζ protein. In the case of hamster eggs for an instance, it 
was found that, compared to mouse eggs, their response to sperm extract showed a 
lower sensitivity despite the egg being the same size (Parrington et al., 1996).  
The other main difference that exists between both groups of eggs injected is that 
mouse eggs were freshly ovulated when used, while human eggs were Day 1 (over 
24hrs post collection). Post ICSI/IVF procedure human eggs are checked for 
pronuclei formation at about 17hrs later, and then for my experiments the eggs had 
were transported in a temperature controlled flask with a drive of about 2hrs. So the 
transportation could have affected the eggs as well. The age factor could have 
possibly caused the inefficient response to hPLCζ microinjection. To test for a real 
difference in sensitivity, that would require freshly ovulated eggs from both species. 
The limited availability of donated human eggs for research would make that quite 
problematic. However, it would be interesting to determine the effectiveness of 
hPLCζ in supporting development up to blastocyst stage in freshly ovulated eggs 
and compare that to conventional ICSI/IVF alone.  
The degree of oocyte maturation has a fundamental role in the egg’s ability to 
release Ca2+ , the Ca2+ release mechanism go through a series of changes 
throughout this process (Mehlmann and Kline, 1994, Carroll et al., 1994). Moreover, 
the given ability to any egg to respond by the series of long lasting Ca2+ oscillations 
is entirely dependent on a successful journey through maturation (Jones et al., 
1995). The response that I have seen in immature oocytes (MI, GV) could therefore 
be explained by the poor cytoplasmic maturation. Further support to this is that it 
has been shown that in immature mouse eggs, the response from sperm fusion 
results in either a single Ca2+ transient or maximally three transients (Jones et al., 
1995). The only GV that had a Ca2+ oscillation response similar to that of fertilisation 
was the one that matured into an MII oocyte. Whether it was a cause or a response I 
cannot comment on, as I have no evidence for any of those explanations. The 
experiments carried out on human eggs that have failed to fertilise were subject to a 
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number of limitations. Previous handling/transportation as well as the number of 
eggs included, that made the conclusions from results in need of further support 
from further studies.  
In the remaining part of this section of results I went on into testing whether the 
activation capacity of hPLCζ protein would be preserved via freeze-drying, as it is a 
common method used to preserve function of biologically active material after 
transformation into a solid form.  After injecting mouse eggs with the same 
concentration of hPLCζ protein (0.01mg/ml) that has been freeze-dried, a significant 
difference was seen between groups indicating that the protein that was 
reconstituted and kept overnight at 4C0 had the highest activity preservation. This 
result is supportive of the idea that hPLCζ protein matures over a period of time to 
gain its maximum ability to hydrolyse PIP2. However, when protein storage was 
examined, I injected a range of protein concentrations into mouse eggs again for 3 
different storage spots.  It was apparent that the concentration of protein used has 
an effects on the response elicited for the storage method. The freeze-dried batch 
kept at 40C seems to have an overall persistence of activity as compared to the 
other 2 storing conditions (-80oC, at room temperature). Basically there are two 
types of protein stability which are important, the first is during freeze-drying process 
which proved to be maintained for hPLCζ protein. The second is stability 
preservation during storage. Constantino et al showed how some proteins can be 
denatured by forming aggregate during storage after freeze-drying due to the 
prescence of moisture (Roy and Gupta, 2004). Another explanation could be 
aggregate formation due to formation of covalent non-disulphide bonds, as shown in 
tetanus toxoid after freeze-drying. A proposed preventive strategy to see if the 
relative deterioration in hPLCζ protein function is due to these proposed 
mechanisms is to add a preservative, or lower the pH during freeze-drying process. 
Due to time limitation further work on this issue was put on hold and to be resumed 
later within the laboratory.  
The hPLCζ protein currently is microinjected into mouse eggs and human eggs, as a 
second injection subsequent to ICSI, using a high pressure injection device which is 
not available in IVF clinics. To design a practical method that could easily be 
reproduced by embryologists, I first tested a strategy that includes a second 
injection that would not require a high pressure injection. This consisted of a 
bevelled pipette that was made in the laboratory and that could be used with low 
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pressure equipment found in IVF clinics. However, the issue with this method was 
the diffusion of material after carrying the pipette across to the injection medium. 
This problem is also seen with conventional ICSI pipettes, so it seem reasonable to 
juts use a standard (mouse) ICSI pipette since this could, at least, be used for a 
single ICSI and PLCζ injection protocol.  
With the change back to the ICSI pipette, the first hurdle was the low survival rate 
post injection. This was due to the initial Ca2+ transient that was too big for the egg 
to handle. The injection itself creates a Ca2+ increase within the cytoplasm and with 
hPLCζ protein being in the injected material as well, it leads to a potentiated Ca2+ 
rise that caused a significant egg loss post injection. Egg damage and loss was also 
the result with a   co-injection protocol with the injection media either with Ca2+ or 
with no Ca2+ or with a low level of Ca2+. The idea that Ca2+ absence from the 
injection media leads to cell lysis is supported by an early report by Steinhardt RA et 
al. They showed that in unfertilised sea urchins a micropipette induced membrane 
puncture requires a minimum level of 300µM extracellular Ca2+ in order for resealing 
to occur.  These studies indicated that a Ca2+ dependant mechanism for resealing  
might include vesicle delivery, docking and fusion, in a similar fashion to what 
occurs during exocytosis of neurotransmitters (Steinhardt et al., 1994). Hence, 
failures may occur by excluding Ca2+ within the injection media to improve the 
survival rate for eggs post ICSI.   
I tested the effect of increasing the osmolarity of the injection medium and there was 
a perceptible increase in membrane rigidity that could be explained by the reduction 
of membrane fluidity due to hyper-osmotic stress (Kaufman and Surani, 1974).  The 
increase in osmolarity did not have any beneficial effect on the egg survival rate post 
ICSI. The return to the original configuration of conventional ICSI had a more 
successful result. The protocol included supplementing the sperm drop that 
originally had 5-10% PVP with the required dose of hPLCζ protein. Carrying over 
protein to the injection media was controllable given the viscosity of PVP and so the 
triggering of Ca2+ oscillations could be recorded. The survival rate of eggs post 
injection was almost restored to usual levels post ICSI for my personal experience 
(80-90%) However, there were noticeable aggregates seen within the PVP drop 
which could explain the variability in the frequency of oscillations detected. It is 
possible that aggregation occurs on smaller scale when hPLCζ is diluted in KCl 
Hepes medium and that this explains some variability in the response of human 
156 
 
eggs to hPLCζ seen in the above section.  A further exploration of the composition 
of the aggregates formed would be informative. The possibility of a substitute for 
PVP, which may be the main cause behind aggregate formation, might also be 
considered. Furthermore, a trail run for assessing mouse embryo developmental 
capability post ICSI using the co-injection technique post, resolving the aggregation 
issue, could bring the use of hPLCζ protein in IVF clinics a step closer.  
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5 HyPer Probe, A Novel Application in Mouse Eggs 
 
5.1 Introduction 
Mitochondria are unique intracellular organelles in that they have their own DNA 
which allows them to replicate independently of the hosting cell (Ernster and Schatz, 
1981). They are the major providers of the energy demand of the cell in the form of 
ATP, they are the main site for the citric acid cycle, fatty acid oxidation and oxidative 
phosphorylation (Ernster and Schatz, 1981).In offspring all genetic material come 
from maternal and paternal DNA, each side providing and equal contribution. One 
exception is that of the mitochondria, all mitochondria come are derived from the 
maternal side (Shoubridge, 2000). More than the supply of ATP to the cell, in eggs 
they play a critical role in regulating the Ca2+ changes that occur during fertilization 
in ascidians (Dumollard et al., 2003) and mouse eggs (Dumollard et al., 2004). It 
seems that there is a bidirectional interaction between Ca2+ signaling during 
fertilization and the mitochondria. It has been found that the Ca2+ increases 
occurring in an oscillatory pattern are necessary to trigger the turnover of ATP from 
mitochondria (Campbell and Swann, 2006). This dynamic interaction between the 
Ca2+ signaling during fertilization and the mitochondria opened a research area to 
study mechanisms of interactions and how that subsequently affects the outcome of 
the fertilization process. 3 main areas of interest have been identified, first is the 
buffering capacity of mitochondria for the changing cytosolic Ca2+, ATP turnover and 
the production of reactive oxygen species (ROS). Mitochondria is one of the major 
sources of ROS, Ca2+ is thought to be able to stimulate the oxidative 
phosphorylation process (García-Pérez et al., 2002). Available data suggests that 
during fertilization there is an increasing demand on the antioxidant defense system, 
as the level of glutathione (an antioxidant defense enzyme) was down by about 45% 
by the end of the Ca2+ oscillations triggered at fertilization (Luberda, 2005). 
However, there is no direct evidence of an increase of ROS available. Perturbation 
of the antioxidant defense mechanism or an increase of the levels of ROS can 
negatively impact embryo development (Johnson and Nasr-Esfahani, 1994, Harvey 
et al., 2002, Guérin et al., 2001). Moreover, within every cell hydrogen peroxide a 
short living molecule and a member of the ROS, has a wide impact on a spectrum of 
biological processes. Hydrogen peroxide (H2O2) is considered an important second 
messenger within the cell and the germ cell line is of no exception. ROS are known 
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to have a detrimental effect on the cell viability if levels rise beyond the ability of the 
cell to scavenge the excess. However, other than having the negative impact, they 
are vital for certain essential enzymatic activities within the cell and have a role as 
cofactors for a number of transcriptional factors (Dröge, 2002). Reports available on 
the estimation of ROS production in vitro are mostly dependant on indicators that 
are controversial in their use. The dicholorfluorescein (DCF) indicators are crticised 
for their non-specific reaction with ROS as they interact with nitrogen species as well 
(Crow, 1997). Moreover, available data suggest that the indicator itself during 
exposure to light produces ROS (Belousov et al., 2006). Making results from the use 
of the DCF questionable, as to how much of the signal detected is a genuine 
production of the cell and not an indicator contribution?   
 
Studying H2O2 (ROS) has proven to be challenging, however, a modern genetically 
encoded fluorescent biosensor, HyPer has recently been reported to be a selective 
H2O2 indicator in living somatic cells. The indicator has promising results in regard to 
its selectivity and specificity to H2O2 (Belousov et al., 2006). The basis behind the 
probe is the OxyR regulatory domain of Escherichia coli, the domain is specifically 
sensitive to H2O2. To develop a fluorescent probe, the group inserted a circular 
permuted yellow fluorescent protein (cpYFP) into the regulatory domain. The signal 
is a result of a confirmatory change due to a transformation from the reduced to the 
oxidised form by the exposure to H2O2. The oxidisation allows formation of a 
disulfide bond between two cysteine residues (Belousov et al., 2006). Moreover the 
probe is a ratio-metric indicator, giving an advantage of the signal being 
independent of the amount of probe available.  
5.2 Aim 
With all data available around the new probe for H2O2 I wanted to find out if this 
sensor could be used to assess the intracellular in vitro redox state represented by 
H2O2 in mouse eggs. The ultimate aim was to identify an explanation to the long 
term effect of patterns of Ca2+ oscillation during fertilisation on later events of 
embryo development. As to how an early phenomenon influences embryo 
development days after it has ceased. The main hypothesis is that different patterns 
of Ca2+ oscillation during fertilisation cause variability in the levels of ROS produced 
which eventually influence embryo development. 
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5.3 Results 
5.3.1 Characterisation of the HyPer probe signal after injection into 
mouse eggs.   
HyPer, is a genetically developed biosensor that is claimed to enable to follow the 
dynamic changes of H2O2 in living cells. There is no report for the use of the HyPer 
probe in the context of any eggs and the effect of fertilisation or parthenogenetic 
activation on the oxidative system. In this section we aimed to investigate the use of 
this probe in mouse eggs, as oxidative stress is a possible explanation for an 
abnormal course of development in embryos. However, quantifying the levels of 
H2O2 as a measure of ROS has proven to be a challenge. This part of work reports 
the use of the HyPer probe in mouse eggs which is a novel application. To enable 
this, signal detection and its separation from other signals that could be used in 
conjunction was essential. The experiments in this Chapter are designed to examine 
if detection of fluorescence signal from HyPer probe is possible after it is micro-
injected into mouse eggs.  
 
The HyPer protein was initially microinjected into mature mouse eggs and a 
fluorescence ratio signal recorded. Figure 5.1 A, B shows that the fluorescence 
signal ratio was measurable and remained constant for the duration of imaging, the 
imaging was done with two different exposure duration (100ms, 500ms) and both 
showed similar difference in results.  With the use of this probe the intention was to 
be able to use it for prolonged durations extending to hours, in parallel to 
measurements of Ca2+ oscillations. The next experiment was to determine whether 
the HyPer signal can last throughout that length of an experiment without 
compartmentalisation or bleaching of the probe. For this purpose MII mouse eggs 
were micro-injected with the HyPer probe and incubated for 4 hours in a drop of M2 
covered by mineral oil. Then fluorescence ratio from the eggs was later recorded 
and continued for 2 hours. Although there was sometimes a drift in the signal, no 
substantial reduction in the signal was detected and a comparable ratio level and 
noise level was seen to that of freshly injected eggs (Fig. 5. 1C). Figure 5. 2 reveals 
the photo-bleaching effect for various exposure duration (A, B) and a prolonged 
exposure for 4hours after microinjection (C) for the single wavelengths of the probe.  
161 
 
5.3.2 Does HyPer probe respond to changes of H2O2 in mouse eggs? 
The HyPer probe is proposed to rely on a conformational change in triggering a 
fluorescent signal change. A disulfide bond forms between two Cys residues due to 
the oxidisation of either one of them. This conformational change will cause the 
cYFP to shift its fluorescent spectrum in relation to the amount of H2O2 available 
(Belousov et al., 2006). To find out if HyPer could be utilised in mouse eggs, MII 
mouse eggs were microinjected with the H2O2 sensor and placed on a preheated 
dish on the fluorescence imaging system. Measurement of the fluorescence before 
and after the addition of H2O2 was done. A range of H2O2 concentration was used to 
measure the response (100µM 1mM and 10mM). The minimal response of the 
probe was seen with a concentration of 100µM H2O2 (Fig.5. 3A, B, C). An increase of 
fluorescence excitation ratio was seen when the concentration of H2O2 was 
increased. The signal increase indicated an oxidation event of the probe. However, 
with an increase in the duration of imaging to beyond a full hour the signal did not 
recover to the pre H2O2 baseline. It has been reported that the probe oxidisation 
outlasts the peroxide removal by the antioxidant system within the cell which means 
reversal of the probe oxidation status is rate limiting (Bilan et al., 2013, Lim et al., 
2014). Another explanation is that the probe relies on cellular disulfide reductase 
activity to bring the probe back to its reduced state. Any perturbation in this 
scavenging mechanism will make the probe no longer available for another cycle of 
oxidation in vitro. All eggs post imaging were looking healthy except for those 
exposed to the highest concentration of H2O2 used which seemed to be swollen. 
Once the eggs were swollen, they did not recover and eventually died. Despite 
these effects at high concentration, these data do show that the HyPer probe can at 
least respond to a large change in H2O2 concentration.    
 
5.3.2.1 Does DTT affect the HyPer probe signal? 
The signals from the HyPer probe are caused by a disulphide bond forming and 
breaking between two active SH groups. Dithiothreitol (DTT) is widely known to be a 
preventive agent for formation of intra-molecular and inter-molecular disulfide bonds. 
It was prepared as 1M stock solution in water and kept in -20oC until further use. 
DTT was mixed with the probe in order to maximise its potential to be oxidised and 
to aid in the reduction post oxidisation during the addition of the peroxide (H2O2). 
Additionally, to see the effect of prior reduction of the HyPer probe, it was co-
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microinjected into mouse eggs with DTT. A final concentration of 1mM was made 
when added to the HyPer probe and incubated for about 10 minutes before further 
use. The recording shown in (Fig.5. 4) shows that the fluorescence ratio, and the 
response to H2O2, was similar to an egg injected with HyPer probe without DTT. 
These data suggest that prior reduction of the HyPer probe does not substantially 
effects its behavior in eggs.  
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Figure 5.1 HyPer fluorescent signal ratio detection in mouse eggs. 
The traces are representative of various excitation protocols to HyPer probe after micro-
injection into mouse eggs. A, HyPer probe signal during an exposure with 100ms exposure 
(n= 16). B, An exposure of 500ms has no negative effect on the signal detected (n= 12). C, A 
prolonged exposure at 100ms exposure shows no substantial photo bleaching effect on the 
probe (n= 17). 
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Figure 5.2 Fluorescent signals from the single wavelengths of the HyPer probe 
under various conditions. 
Traces representing the effect of photo bleaching on the single emission wavelengths for the 
HyPer probe. A, Effect of 100ms exposure on 490, 430 signals. B, 490, 430 signal Exposure 
to 500ms. C, The effect of 100ms exposure after 4hrs from the injection procedure. 
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Figure 5.3  Hyper probe response after micro-injection into mouse eggs with 
the addition of various H2O2 concentrations 
A, HyPer probe signal ratio pre and post addition of 100µM of H2O2 (n= 23). B 
representative trace for the effect of 1mM H2O2 on the HyPer probe fluorescent signal (n= 
20). C, A tenfold increase in the concentration of H2O2 effect on HyPer signal detected in 18 
mouse eggs. Arrows indicate to the time point where H2O2 was added. 
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Figure 5.4 Hyper probe signal with DTT. 
Traces representing the effect of the co-injection of DTT with the HyPer probe in mouse 
eggs. Top trace, the signal detected for HyPer probe shows no change in comparison to 
traces representing HyPer alone (n= 24). Bottom trace, HyPer signal and DTT response to 
the addition of 100µM of H2O2, arrow indicates the point of addition (n= 22). 
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5.3.3 The relationship between signals detected due to cytosolic Ca2+ 
change and the HyPer probe signal. 
The main aim of this chapter was to investigate a potential existence of a change in 
the H2O2 levels in parallel to the cytosolic increase of Ca2+ during parthenogenetic 
activation or at fertilisation. A change in H2O2 levels could be generated by 
mitochondria and could override the ability of the regulatory system to scavenge the 
excess production. The production of H2O2 could be considered as a signal for a 
number of intracellular biological functions, be it could also have a detrimental effect. 
In the latter case embryo developmental arrest could be due to the early events in 
mouse eggs associated with Ca2+ signals.  
5.3.3.1 No interference between HyPer probe signal and Ca2+ fluorescent 
indicators. 
Another factor in determining the possible use of HyPer probe for the study was the 
need for its signal to be distinguishable from that of Ca2+ indicators. Here, a direct 
comparison of both indicators is made.  Under my loading and illumination 
conditions, I have found that both indicators have permitted a long term 
measurement. Rhod-dextran as a Ca2+ indicator can be used at an excitation and 
emission wavelengths (ex. 556nm- em. 677nm) that would not conflict with the two 
peak excitations of 500nm and 420nm of the HyPer probe and its one peak 
emission at 516nm. Figure 5.5 demonstrates that both indicators have been 
recorded for an extended duration of about 9 hrs, a steady and reliable fluorescence 
signal was verified for both indicators. 
5.3.3.2  Hyper probe does respond to cytosolic Ca2+ changes induced by Ca2+ 
Ionophore Ionomycin.   
Cytosolic Ca2+ levels in mouse eggs could be manipulated either in a physiological 
manner or by inducing a parthenogenetic activation. The form of alteration in terms 
of level and frequency can differ between methods used.  Here we made a 
comparison between the effects of Ca2+ transients induced by Ca2+ ionophore (5µM 
Ionomycin) along with other agents, PLCζ and IVF (Fig.5. 5, Fig.5. 6 and Fig.5. 7). 
The MII mouse eggs were injected with the HyPer probe and Rhod-dextran and 
after a period of recovery of about 10 minutes the eggs were placed on the 
fluorescence imaging system. In all activation protocols a signal was obtained 
before adding the stimulus. Figure 5. 5(A, B, C) shows the first experiment in this 
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series where a final concentration of 5µM ionomycin in the dish induced a predicted 
rise in the Rhod-dex signal. Alongside this there was a rise in the fluorescence ratio 
of the signal of HyPer probe suggesting a possible parallel rise in the level of H2O2. 
Whereas a Ca2+ rise induced by IVF or PLCζ injection fails to induce a change in the 
HyPer probe signal similar to that induced by ionomycin. We observed that there 
was a sharp rise in the fluorescence signal of the probe concomitant with the 
addition of the ionophore. In figure 5.6 A, B, C it can be seen that the fluorescent 
signal of HyPer showed some signs of an increase with the addition of 0.5µM 
ionmycin but not during the initial addition of thapsigargin (endoplasmic reticulum 
Ca2+ ATPase inhibitor).   
Since there was an indication that Ca2+ possibly influences the level of ROS as 
represented by H2O2 within the egg cytoplasm, examining the effect of other Ca2+ 
modulating protocols was necessary. IVF and micro-injection of PLCζ protein were 
the two protocols examined. The IVF protocol as described elsewhere was tested 
first. For all experiments in this instance, a trace for the signal of both probes was 
obtained as a reference for any upcoming change after adding sperm to the media. 
In the case of PLCζ protein micro-injection, it was not always the case that a long 
trace was captured prior to the start of the Ca2+ oscillations. The action of the PLCζ 
protein is more rapid (within minutes), however, in some traces it was manageable. 
A similar response to the ionophore addition was not detected when IVF or PLCζ 
were used as a method of inducing cytosolic Ca2+ changes and egg activation. The 
Ca2+ oscillation associated fluorescence signal of rhod-dextran were associated with 
a gradual increase in the HyPer probe signal (Fig.5. 7 a, b).  However, this signal 
was not related to the Ca2+ changes in eggs because the gradual signal increase 
started before the onset of Ca2+ oscillations. In addition when the signal from eggs 
that were not fertilized by sperm were analysed, the same gradual rise in HyPer 
probe ratio was also observed. The gradual increase of the signal was that of 
equilibration as time was needed for the probe to reach plateau for the response. 
The same observation was documented for the PLCζ protein micro-injection group. 
Hence the only HyPer probe response detected seemed to be with ionomycin. In 
one experiment the Ca2+ oscillations were set off by PLCζ where no HyPer probe 
response was detected. After a while, an addition of 5µM ionomycin was made to 
the oscillating eggs, and then a HyPer probe response was detected (Fig.5 7 C).The 
results were consistent throughout 3 separate runs for each group. 
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Figure 5.5 HyPer probe and Ca2+ indicator signal interaction. 
A, A sample trace for Rhod-dex (Ca2+ indicator) in response to the addition of 5µM 
ionomycin (arrow). B, Hyper probe signal in response to the addition of the ionophore, HyPer 
and Ca2+ signals were obtained from the same egg (n= 25). C, Signal overlay for both 
probes (Hyper and Ca2+). 
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Figure 5.6 The effect of thapsigargin and two different concentrations of 
ionomycin on the HyPer probe signal. 
After a co-injection of Hyper probe and Ca2+ indicator into mouse eggs signal of both were 
detected. A, The response of the Ca2+ indicator to the addition of 20µM thapsigargin followed 
by a 0.5µM ionomycin then 5µM ionomycin (n= 18). B, HyPer response to the 3 different 
stimuli. C, An Overlay of both signals, HyPer and the Ca2+ indicator. Arrows indicate time 
point of additions. 
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Figure 5.7 Ca2+ oscillations triggered by fertilisation and PLCζ and their effect 
on HyPer probe signal. 
Changes detected in fluorescence signal and ratio for the Hyper probe and the Ca2+ indicator 
following, signal for both probes overlaid. A, In vitro fertilistaion (n= 22). B, failed fertilization 
(n= 12). C, Ca2+ oscillations induced via a micro-injection of 0.01mg/ml of hPLCζ followed by 
an addition of 5µM ionomycin (n= 27). 
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5.3.4 Germinal vesicle breakdown and egg maturation, does it cause 
any change in the ROS levels? 
The role of the ROS in the course of in-vitro maturation of mouse eggs is still a 
matter of controversy (Morado et al., 2009). It was found that H2O2 can trigger GVBD 
in immature eggs, however, later it inhibited the ability of the egg to release the first 
polar body and initiated degeneration (Chaube et al., 2005). Here I decided to 
investigate if there were any fluctuations in H2O2 production during the course of 
mouse egg maturation. We were interested in examining oocytes undergoing 
germinal vesicle breakdown (GVBD) for their potential association with a possible 
transient increase in H2O2.  Eggs at the germinal vesicle stage were obtained by 
dissecting ovaries in a media containing 100µM of IBMX then picking up the oocytes 
that have a well-defined GV. To assay for this possible natural ROS transient, 
oocytes at this particular developmental stage were subject to a high pressure 
injection system to inject the HyPer probe. The injection step was done in media 
containing IBMX to prevent premature GVBD. Subsequently, they were placed on 
the imaging system where IBMX was omitted from the imaging media. The 
temperature was maintained at around 37oC +/- 0.5oC via a heated chamber.  
The fluorescence signal generated from Hyper was recorded by the system 
described elsewhere, the developmental progress was assayed by differential 
interference contrast (DIC) microscopy. The system allows for switch between the 
two modes of imaging and with the use of an approximate timeline, it can correlate 
changes in the fluorescence signal to developmental progress. A positive control 
was used for this experiment where the media for imaging had IBMX to prevent 
GVBD. The signal of both experiments with and without IBMX is shown in (Fig.5.8 A, 
B). There was a slight increase in the Hyper probe signal in oocyte in these 
experiments but this increase was not consistent and occurred regardless of 
whether oocytes underwent GVBD or not. The data suggests that there was no 
change in the level of ROS during the process of GVBD (maturation). We further 
examined this process by the use of the HyPer probe pre-incubated with DTT, and 
again the results were the same suggesting that no alteration of the ROS was 
evident (Fig.5. 8c).  
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Figure 5.8 Germinal vesicle breakdown and prevention, effects on Hyper 
probe signal. 
GVs were micro-injected with the HyPer probe. A, allowed to undergo GVBD (n= 20) and the 
signal compared to that of (B) GVBD prevention (n= 23). C, Fluorescence ratio of HyPer 
probe with added DTT detected in GVs during maturation (n= 19).  
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5.3.5 The contribution of mitochondria to the change of HyPer probe 
signal. 
Mitochondrial un-couplers such as carbonilcyanide p-
triflouromethoxyphenylhydrazone (FCCP),   have long been used as a tool for 
investigating the role of mitochondria in cellular functions. As mitochondria plays a 
significant role in Ca2+ buffering capacity of the cell, mitochondrial inhibitors can be 
used in research of the cytosolic Ca2+ homeostasis. Mitochondria can either promote 
uptake or release of Ca2+ depending on their energy level. Mitochondria could also 
be a significant source of H2O2 (Murphy, 2009) and the production of ROS depends 
upon mitochondrial potential. Hence, reducing the mitochondrial potential with FCCP 
could reduce the production of H2O2.  
This experiment was set up to investigate the source of H2O2 when external 
additions were omitted. HyPer probe was then introduced by high pressure injection. 
Eggs loaded with both indicators were placed on a preheated glass bottom dish 
after stripping the zona’s off for egg stabilisation. A baseline for both signals was 
established for some time, in the presence of 1.7mM external Ca2+, then 1µM of 
FCCP was added to the surrounding media. This addition caused a transient rise of 
the cytosolic levels of Ca2+ (Fig.5. 9), which was presumably was due to the 
depolarisation effect of FCCP on mitochondria and release of Ca2+. The addition of 
FCCP was done in two steps, the first addition then followed by another after 
allowing for a recovery of the signal close to the baseline. In conjunction with the 
increase in cytosolic Ca2+ shown by the rise of the designated trace, we can identify 
a similar increase in the HyPer probe signal in terms of timing of the change. 
Indicating that the parallel change in HyPer probe signal is probably caused by a 
factor related to Ca2+ change which may be H2O2.  However, this signal is not what is 
expected if mitochondria were producing significant resting H2O2.  
We have used 10µM dipheneylene-iodonium (DPI) as an inhibitor of NADPH-
oxidase inhibitor, which is another potential significant ROS producer in cells.  DPI is 
non-specific in inhibiting NADPH oxidase-mediated ROS formation, as it inhibits 
other flavo-enzymes such as xanthine oxidase (XOD). Despite the unspecific mode 
of action, it was not effective in our experiments because it was unable to abolish 
the intracellular production of ROS.  Following a parthenogenetic activation by 5µM 
ionomycin the same effect on the HyPer signal was detected in the presence of DPI. 
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Figure 5.9  Mitochondrial contribution to changes detected in the HyPer probe 
signal. 
Signal tracking for HyPer probe and Ca2+ during two consecutive additions of 1µM of FCCP. 
The second addition was done after the return of the Ca2+ signal indicator to baseline(A) 
arrows indicate to time of addition. B, Hyper fluorescence signal change after the two 
addition of FCCP. C, The overlay of both signals (n= 28).   
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5.3.6 Investigating the influence of the antioxidant system on HyPer 
signal. 
5.3.6.1 Catalase inhibitor effect on the signal generated by HyPer 
When compared to other ROS, H2O2 is considered to be the most stable and most 
significant in terms of concentrations.  Characteristically it is uncharged and can 
freely diffuse between and within cells. Catalase is an essential enzyme that is 
found in all mammalian cells exposed to O2. The enzyme catalyses the 
decomposition of H2O2 into water and oxygen. As an enzyme it has one of the 
highest turnover rates (Chelikani et al., 2004). 
3AMT (aminotriazole) is a catalase inhibitor that has the ability to significantly 
abolish catalase’s activity. In other studies it has been found that the highest level of 
the enzyme inhibition was obtained when a concentration of 50mM AMT was used. 
Therefore, when eggs were incubated with 50mM AMT this should only indirectly 
affect the levels of H2O2 by suppressing the activity of catalase. MII eggs were 
stripped from their zona’s and placed in a preheated dish at (36.5-37.5oC) 
containing 50mM AMT and incubated for about 1hr. After establishing a steady 
baseline, an addition of H2O2 was done.  From (Fig.5.10 A, B) it can be seen that the 
after the addition of two different concentration of H2O2 (100µM H2O2, 1mM H2O2) 
the signal detected is almost identical to previous fluorescence signals when no 
AMT was used. This result has at least two interpretations. One is that catalase 
plays little role in the recovery of mouse eggs from a pulse of H2O2. The other is that 
the fluorescent signal change of HyPer is effected by other factor than the 
concentration of H2O2. 
5.3.6.2 Inhibiting Glutathione peroxidise, does it have any influence on the 
HyPer signal generated? 
We further examined the relationship between ROS eliminating machinery and the 
signal originating from HyPer probe. It was aimed to investigate the contribution of 
the antioxidant enzyme glutathione peroxidase (GPx) to the signal change produced 
(Shiba and Shimamoto, 1999). MII eggs were stripped from their zona pellucida 
using acid tyrode’s and placed in a preheated dish containing HKSOM with a final 
concentration of 100µM of mercaptosuccinate which is a recognized inhibitor of 
GPx.  After a designated time (1 hour) which is to allow for the uptake of the drug, 
an addition of H2O2 was made to the dish. Two concentrations of H2O2 were 
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separately tested (100 µM and 1M) figure 5.10(C, D). In each case there was a 
large rise in the HyPer ratio signal followed by a steady decline and he fluorescence 
imaging was terminated before the signal came back to baseline. The observed 
fluorescent signal resulting from the HyPer probe was again undistinguishable from 
mouse eggs that were untreated. These data and the above are surprising since 
both inhibitors of GPx and catalase failed to affect the HyPer signal changes 
induced by H2O2, It is possible that the signal change was not entirely due to an 
increase and decrease in H2O2 alone. 
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Figure 5.10 The influence of the antioxidant system on the HyPer probe signal. 
Traces representing the use of 50mM AMT attempting to block the pH change detected by 
the HyPer probe (A, n= 19, B, n= 19). 100µM mercatosuccinate was used to investigate the 
cause of the pH detected by the HyPer probe (C, n= 17) (D, n= 21). Both experiments tested 
the effect of 100µM and 1mM of H2O2. 
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5.3.7  Intracellular pH during egg activation, does it influence the 
resulting HyPer signal? 
A number of reports indicate that Ca2+ changes have the ability to cause an increase 
in the intracellular pH in certain cell types including mouse eggs (Kline and Zagray, 
1995). In the light of reports indicating a possible pH sensitivity of the HyPer probe, I 
decided to examine the possibility of a contribution of cytosolic pH to the signal 
change of the HyPer probe in some of the types of experiments reported above.  
Eggs were micro-injected in M2 media with 5µM of the dye SNARF that was 
covalently bonded to 10.000MW dextran. This pH indicator was shown to remain 
within the cytoplasm of unfertilized mouse eggs by House 1994 (House, 1994). 
Following the high pressure injection, eggs were allowed to recover for a short 
period of time. Each experiment was conducted by a random pick of about 9-12 
eggs at a time. Zona’s were stripped and eggs placed in a temperature controlled 
glass bottom dish approximately at 37oC. Using the fluorescence measuring system 
described elsewhere, one excitation wavelength of 580nm and emission 
wavelengths of >620nm and at 580nm were recorded for SNARF. The ratio of the 
emission intensity was calculated by dividing both images subsequent to a 
background subtraction. The change in the emission intensity was mainly pH 
dependant.  
5.3.7.1 Does the presence of a pH indicator affect the performance of the 
HyPer probe? 
In order to determine whether both indicators would have any interaction or affect 
the performance of one another, both have been micro-injected separately. First the 
pH indicator was micro-injected and after a brief period of recovery the eggs were 
micro-injected with the HyPer probe. Eggs were washed through several drops of 
M2 then allowed for a second round of recovery. Once micro-injected and 
recovered, eggs were transferred to the preheated dish and a baseline was 
observed. Once the baseline for both indicators was established an addition of 
10mM NH4CL was done and once the signal response had peaked it was washed 
out (Figure 5.11). Additions of NH4Cl are commonly used to raise intracellular pH in 
cells. The system in use allows for multichannel switch, as both indicators are ratio-
metric necessitating a four channel wavelength emission measurement. Figure 5. 12 
(A,) shows the response of both indicators to the induced alkalosis as they respond 
by a sharp increase in the signal generated. When both are signals overlaid they 
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demonstrate a synchronized response to NH4CL, suggesting that the HyPer probe 
is influenced by the change in the intracellular cytosolic pH.  
5.3.8 Parthenogentic activation, does it cause a shift in the egg pH? 
Now that it has been established that a rapid pH change in mouse eggs can 
possibly influence the HyPer probe signal, it was important to find out if the increase 
in cytosolic Ca2+ influences the pH. To measure the changes in egg pH during 
parthenogenetic activation using 5µM ionomycin, eggs were micro-injected with both 
indicators as previously described. Once a baseline signal was established for both 
indicators (SNARF-dextran & HyPer) an addition of ionomycin was done so that the 
final concentration to the surrounding media would be of 5µM. It can be seen from 
Figure 5.12 (B) that there was a rapid change response triggered by the ionmycin 
addition and a synchronized signal response was seen with both signals (SNARF-
dextran & HyPer) recorded as demonstrated. The signal change in both probes was 
of a quick increase that once it reached a peak it declined rapidly. However, the 
signal remained above the baseline that was detected before the ionophore 
addition. From this result it is evident that ionomycin causes a pH change and that 
the HyPer probe is highly influenced by such induced pH changes. 
 
 
 
 
 
 
 
 
 
Figure 5.11  SNARF dye response to addition of NH4Cl in mouse eggs. 
The response of SNARF following micro-injection into mouse eggs and the addition of 
10mMNH4Cl, bar indicates the addition and the washout NH4Cl (n=23). 
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Figure 5.12 SNARF and HyPer signal detection in mouse eggs. 
A, An overlay of fluorescent signals for HyPer& SNARF in response to addition and washout 
of 10mMNH4Cl (n= 17). B, HyPer (black trace) and SNARF (blue trace) fluorescent signal 
ratios in response to the addition of 5mMionomycin (n= 26). 
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5.3.9 Investigating the pH change during Ca2+ influx throughout 
parthenogenetic activation of mouse eggs. 
Mouse eggs (MII oocytes) gain their ability to regulate their intracellular pH right 
towards the end of their growth (Erdogan et al., 2005). Two exchangers are 
accountable mainly for this control, the HCO-3/CL- exchanger which by its action can 
increase or decrease the intracellular pH, and the Na+/H+ exchanger which works to 
increase the intracellular pH. The upcoming sets of experiments were set to 
determine the basis of the pH change detected by SNARF, which has influenced the 
probe under investigation (HyPer).  
5.3.9.1 Activation of mouse eggs in a media containing 2.5mM Amiloride. 
In order to search for the cause of the pH shift I investigated the most common 
reasons behind a cellular pH change. The sodium-dependant channels or to be 
more specific a Na+/H+ antiporter was the first studied. This antiporter has a high 
affinity for the diuretic amiloride. Amiloride has the ability to irreversibly prevent the 
movement of Na+ through Na+/H+ exchange. Eggs were treated with 5µM ionomycin 
after a baseline acquisition, with the media containing 2.5mM amiloride. Both 
fluorescent signals had an increase in their intensity. With the SNARF signal 
increase outlasting that of HyPer probe. However, both signals declined and met at 
a point above the initial baseline for both probes. The shift in the signal after the 
ionophore addition indicated that there was a shift in the pH which affected the 
HyPer probe signal in parallel as seen in figure 5, 13A.  This result indicates that this 
exchanger was not the cause of the change in pH detected in our experiments. 
5.3.9.2 Activation of mouse eggs in a media containing 50µM DIDS 
The next set of experiments was designed to examine whether the pH change 
observed during the parthenogenetic activation protocol using 5µM ionomycin was 
bicarbonate dependant. More specifically, is the change caused by a sodium-
dependant or independent HCO3−/Cl− exchanger. To do this we used the drug DIDS 
which is a recognized inhibitor of this exchanger and is effective in mouse eggs 
(Baltz et al., 1991).   
After obtaining a baseline signal for a brief period of time in a medium containing 
50µM of DIDS, a treatment with 5µM Ionomycin was done. Again here there was a 
rise in both fluorescent signals, but the change for the SNARF signal was bigger 
than that detected for the HyPer probe. Both signals did not return to the pre-
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ionomycin baseline signal. The treatment resulted in an increase of the intracellular 
pH (Fig.5.13B). As the pH change was not prevented by the use of DIDS, it 
excludes HCO3−/Cl− exchanger as the cause behind the change. 
5.3.9.3 Activation of mouse eggs during the inhibition of H+ ATPases. 
Until this point examining the common pH regulation mechanisms could not explain 
the shift in the pH detected and measured by the SNARF probe during the treatment 
with 5µM ionomycin. So next, my attention was turned to the vacuolar-type 
ATPases. They are considered the main candidate for generating acidity in the 
central vacuolar system.  Bafilomycin, a macrolide antibiotic (Werner and 
Hagenmaier, 1984) is used specifically to inhibit H+ ATPases in a nanomolar 
concentration. After establishing a baseline for the signal in a media containing 
500nM Bafilomycin a final 5µM ionomycin was attained. Figure 5.13(C) 
demonstrates the response recorded and shows that both probes responded by a 
sharp increase in their fluorescence signal that started to decline slowly after it 
reached a peak. The fluorescent signal increase in this case was almost the same 
for both probes. These data suggest that bafilomycin could not block the changes in 
both signals, for the pH probe and ROS probe once again.   
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Figure 5.13 Traces representing the investigation into the cause of pH 
changes in mouse eggs detected during artificial activation by ionomycin. 
Mouse eggs are micro-injected with both indicators HyPer & SNARF. A, B, C are fluorescent 
signal ratios overlaid for both probes in response to the addition of 5µM ionomycin in the 
presence of 2.5mM amiloride, 50mM DIDS and 500nM bafilomycin respectively. Arrow 
indicates addition of 5µM ionomycn (n= 22, 27, 19) for A, B, and C respectively. 
184 
 
5.4 Discussion  
Oxygen, an essential molecule for aerobic life, is essential in many ways. It serves 
as a terminal acceptor of electrons in the very vital process of respiratory chain 
reaction, as well as a regulator to many intracellular and extracellular signalling 
pathways. Reactive oxygen species (ROS) are produced in a tightly controlled 
manner. However, in circumstances where the balance between production and 
elimination leads to an excess of ROS, it gives rise to pathological conditions. 
Oxidative stress is a term used to identify the non-specific damage that occurs to 
proteins, lipids and DNA due to excess ROS. In field of reproductive cell biology, it is 
well documented that Ca2+ oscillations during fertilisation induce an increased 
mitochondrial activity in terms of an increase in ATP production (Campbell and 
Swann, 2006). A key source for ROS in the cell is the mitochondria (Turrens, 2003) 
and the mouse egg is of no exception. H2O2, a member of the ROS has been shown 
to mediate programmed cell death (PCD) in the blastocyst stage of embryos (Pierce 
et al., 1991). Likewise, human embryos that had high levels of H2O2 displayed sign 
of PCD (Jurisicova et al., 1996).  The aforementioned was the reason behind the 
interest in studying the effect of Ca2+ oscillations, and transients induced by different 
means, upon the production of H2O2 and thereafter upon embryo development. 
There are studies suggesting an increase in levels of H2O2 as embryos progress to 
the 8-cell stage after fertilisation or after parthenogenetic activation (Nasr-Esfahani 
et al., 1990a). However, most of these studies used the fluorescent probe 2’, 7’-
dichlorodihydrofluorescein (DCHF), which fluoresces after oxidation by H2O2 which 
yields 2’, 7’-dichlorofluorescein (DCF). It is thought that the level of DCF is produced 
in linearity with the level of H2O2 present within the eggs (Nasr-Esfahani et al., 
1990b). On the other hand, these reported compounds have two major drawbacks 
that make any claims resulting from their use questionable. The first drawback is 
that the dihydro-compounds in themselves are highly photosensitive to variable 
degrees. Therefore in the presence of excitation light they tend to autooxidise to 
produce significant background fluorescence in the absence of any detectable ROS 
(Afzal et al., 2003). For that reason when these compounds are used for ROS 
detection, the increase in fluorescence intensity detected is a sum of auto-oxidation 
of the probe along with the presence of ROS. Another credible argumentative point 
against the use of this compound is the lack of specificity for ROS; generally they 
are thought as to be indicative of the overall state of the oxidative species (Hempel 
et al., 1999). These probes originating from DCFH compounds are widely used as a 
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ROS probe despite the concerns about what fact it is really measuring. Therefore, 
the demand for novel probes that have the ability for detecting individual ROS with 
high levels of specificity and sensitivity is increasing.  
Belousov et al in 2006 reported the use of a novel H2O2 fluorescent probe that has 
the ability to detect intracellular levels of H2O2. The basis of the probe was built 
around the regulatory domain of Echerishia coli OxyR which is specific for H2O2. 
This genetically encoded biosensor consists of circularly permuted yellow 
fluorescent protein (cpYFR) inserted into the OxyR domain. The conformational 
changes that occur to the probe during exposure to H2O2 are the origin behind the 
fluorescent signal change (Belousov et al., 2006). The HyPer probe has been 
reported to be sensitive to sub-micromolar levels of H2O2 with the advantage of 
being a ratio-metric sensor, so the signal change would be independent of the level 
of probe injected.  
I have investigated the first use of this new H2O2 specific sensor in any species of 
egg. My experiments initially demonstrated that the probe is able to record changes 
in its fluorescence in a response to a range of H2O2 concentrations (100µM, 1mM 
and 10mM). The authors of the original paper claim that the probe was able to 
sense a level of 25nM for the isolated probe while the sensitivity was reduced to 5-
25µM in E.coli. Next, we went on to test if the probe would be able to sense any 
changes in H2O2 levels in the eggs during parthenogenetic activation. That was done 
via the use of 5µM Ionomycin which induces relatively a large single cytosolic Ca2+ 
transient. To correlate cytosolic Ca2+ changes to H2O2 levels, injection of two probes 
into the eggs was done. Measuring the changes in the fluorescence level of both 
probes revealed that at the point where the Ca2+ indicator starts to show an 
increase, the HyPer probe also demonstrates an increase in its fluorescence. 
However, when we followed this pattern of change to see if it extends to other 
causes of Ca2+ changes in mouse eggs the picture was not so clear. In-vivo 
fertilisation could not induce any changes in HyPer probe signal despite the 
fertilisation induced Ca2+ oscillations being observed quite distinctly with the rhod-
dextran probe. Notably the fluorescence of the HyPer probe in eggs that were 
fertilised and those that did not fertilise showed no marked differences.  
An immature oocyte is also thought to be significantly affected by during In-vitro 
maturation (IVM) by oxidative stress. Four transcripts encoding the main enzymatic 
antioxidants (GPx, Cu/Zn-SOD, Mn-SOD and G-glutamylcysteine synthetase) have 
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been detected not only in mature mouse eggs but in immature eggs as well 
(Mouatassim et al., 1999).  This implies that this defence system is important for the 
IVM process. For these reasons I examined the IVM process, from germinal vesicle 
stage to an MII egg. The eggs were imaged via DIC during the breakdown of the GV 
while recording the HyPer probe fluorescence signal. Again the results failed to 
show any significant change that could indicate a detectable increase in the 
production of H2O2 during IVM. The controls that these were measured against were 
immature oocytes with intact GVs that were imaged in IBMX to halt the maturation 
process.  To my knowledge there are no reports on changing ROS levels during GV 
breakdown 
Next we investigated the role of mitochondrial contribution to the change in the 
signal of HyPer probe. It was earlier thought that following fertilisation induced Ca2+ 
transients there would be an increase in the pH. This phenomenon was considered 
to be a universal act across species (Steinhardt et al., 1974).  It has been reported 
that in bovine, porcine and murine eggs during their activation using ionophores 
namely A23187 and 7% ethanol they all showed a change in their cytosolic pH. The 
exact mechanism of the pH change was further investigated but the cause is yet to 
be identified (Ruddock et al., 2000). However, Kline and Zagray in 1994 reported 
contradictory results in mouse eggs (Kline and Zagray, 1995). Furthermore, it has 
been established that after GV breakdown, unfertilised eggs and in-vitro fertilised 
eggs had no difference in their baseline pH levels (Phillips and Baltz, 1996).  
The results presented failed to demonstrate a persistent response to the increase in 
H2O2, while Ca2+ transients triggered by ionomycin led to an increase in HyPer 
probe fluorescence, in vitro fertilisation failed to do so. We went on to investigate the 
effect of inhibiting the catalase activity by 3AMT. 3AMT has the ability to 
immediately inhibit the enzyme at a rather high concentration which can be 
reversible (Yoshioka et al., 2006). After a suitable dilution, it was found that the 
signal generated by HyPer probe after the addition of H2O2 was similar to the 
change seen when no catalase inhibitor was used. The lack of any detectable 
difference in the signal indicated that the change was possibly not due to changing 
levels of H2O2. Furthermore, no detectable difference in the signal was seen when a 
glutathione peroxidase inhibitor was used. We investigated the role of mitochondria 
on this signal via the application of a mitochondrial un-coupler (To et al., 2010). 
FCCP application led to a Ca2+ increase due to the depolarisation effect on 
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mitochondria. This signal generated from the HyPer probe matched that of the Ca2+ 
transient effect on the Hyper signal using Ca2+ ionophores.  
It has been reported the Hyper probe is pH sensitive (Belousov et al., 2006). This 
sensitivity is related to the cpYFP integrated into the probe, since cpYFP is a 
fluorescent protein that is pH sensitive (Wang et al., 2008, Bilan et al., 2013). 
Therefore, given the probe’s pH sensitivity it is plausible that at least part of the 
signal generated in eggs is due to a change in the pH. To validate this hypothesis, 
further experiments were carried out. Observing the signal generated with the HyPer 
probe along with a pH sensitive probe were thought to be informative. HyPer and 
SNARF-dextran are both ratio-metric probes with molecular weights of 52 and 
70.000 kDa respectively. The concomitant use of both probes in mouse eggs was 
done to enable the measurement of the HyPer probe signal versus any change in 
the pH probe. To my knowledge, the results reported here are the first with the use 
of these probes together in any egg. The data generated suggests that they are 
detecting the same event which is a change in the pH level rather than a change in 
the level of ROS. This is in agreement with the critical evaluation of a similar 
mitochondria HyPer probe (mt-cpYFP). Schwarzlander et al in 2011 showed that the 
superoxide flashes detected by this probe were altered by manipulating the 
mitochondria pH. With our set of experiments the questions remain: are both probes 
reporting the same event? More specifically are they reporting changes in pH levels 
or in H2O2 levels? Having said that, it has been documented previously that there is 
no pH change during in-vitro fertilisation (Kline and Zagray, 1995). Similarliy, no pH 
change was detected during parthenogenetic activation by 7% ethanol (Phillips and 
Baltz, 1996).  On the contrary, studies in pig have revealed an increase in 
intracellular pH during parthenogenetic activation using 7% ethanol and ionophore 
A23187 (Ruddock et al., 2000). Our results have revealed that there is a 
measurable pH change during parthenogenetic activation using 5micromolar 
ionomycin, which comes in disagreement with both previous reports on mouse eggs. 
Before proceeding to any conclusions, a short series of experiments were performed 
in an attempt to explain the pH change detected. Firstly, the common pH regulatory 
mechanisms were examined. Inhibiting both the amiloride-sensitive Na/H antiport 
and the HCO3/Cl exchanger demonstrated no change in the signal recoded. 
Previous reports suggested that Ca2+ ionophores have the ability activate vacuolar-
type H+ ATPases (Ruddock et al 2000). For that, we extended the experiments to 
examine a less common regulatory mechanism. If Ca2+ release or influx induced by 
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ionomycin turns on the activity of H+ ATPases in our mouse eggs, by using 
Bafilomycin A1 it should be possible to block the pH change detected without 
affecting the Ca2+ influx. In contrast to this prediction, upon the addition of 5µM 
ionomycin, bafilomycin prevented the return of both signals to baseline and did not 
prevent the change. Further experiments could have been conducted to examine 
the possibility of whether it is Ca2+ increase within the cell, or was it the activity of H+ 
ATPases behind the last result. However, we felt that pursuing this matter further 
would lead to a deviation from our primary interests.  
In conclusion, our results have indicated that during parthenogenetic activation of 
mouse eggs via ionomycin there is an increase in intracellular pH. It is clear that we 
have not managed to find the cause of this change nor we could prevent it.  Ca2+ 
ionophore activation leads to a pH change that was independent of external sodium 
or bicarbonate but otherwise due to an initial rise in of cytosolic Ca2+ levels. It would 
be interesting to further study which mechanisms are behind the pH change that I 
detected. Unfortunately, our primary point of interest was studying the effect of Ca2+ 
changes during fertilisation and parthenogentic activation upon the levels of ROS 
and specifically H2O2. The data in this chapter suggest that Hyper is not usable for 
this purpose.  Regrettably, until other probes are made available this project could 
not be taken any further.  
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6 General Discussion 
6.1 Overview 
The thesis that I have presented, is a continuation into the research being carried 
out on sperm PLCζ. Several findings have resulted from my work. I have shown the 
efficiency of hPLCζ protein in causing Ca2+ oscillations in mouse eggs that have 
failed to activate following an ICSI procedure. Currently there is no method to 
identify a sperm’s level of the activation factor prior to injection. So, I have also 
presented results suggesting that the protein can be used in all cases of ICSI, 
without any deleterious effects on subsequent embryo development. However, 
these results were from experiments conducted on mouse eggs, further evidence 
will be needed from examining the response of human eggs.  The effect of the vital 
tag (Nus-A) for the protein was looked at as well, no detrimental effects on pre-
implantation development of mouse embryos was found.  
In this chapter I will be discussing current parthenogenetic protocols used to cause 
Ca2+ oscillations in mammalian eggs, including mouse and human eggs. Similarly, I 
will include a comparison of various activation protocols against hPLCζ protein. I 
will include as well a discussion for the challenges that could face the introduction 
of hPLCζ protein into clinical practice. A separate section had an aim of developing 
a reproducible method for injecting the hPLCζ protein during ICSI. In this section I 
have showed preliminary results indicating that a single co-injection technique is 
likely to be successful. However, a substitute for the current PVP molecule used to 
increase the medium viscosity is required. An increase in medium viscosity is 
required to reduce sperm motility without the formation of aggregates that could 
affect the functionality of the protein. A number of experiments were also included 
in this thesis attempting to explain how Ca2+ oscillations would have an extended 
effect on embryo development subsequent to their cessation. The experiments 
were focusing on the possibility of the effect being delivered through changes of 
ROS levels. However, the probe (HyPer) used to investigate such a cause and 
effect has proved to be unreliable because as it proved to be very sensitive to pH 
changes. Therefore, no conclusions could be made until further probes are 
available.  
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6.2 Modern IVF and Egg Activation Problems 
The success of fertilised mammalian eggs to further develop is mainly dependant 
on orchestrated operation of genetic and developmental programmes. Whether an 
embryo would be able to advance to the pre-implantation stage or arrest at early 
stages, is highly dependent on factors present at or before the 1-cell stage (Hardy 
et al., 2001). However, prior to fertilisation other factors could affect success rates 
such as the  presence of chromosomal abnormalities (Munne et al., 1995),  egg 
quality in what is known as oocyte maturity  (Moor et al., 1998),  as well as other 
factors that  could negatively impact the ability of an egg to fertilise.  Since the 
early 1990’s it has been shown that the sperm was not a prerequisite for egg 
activation (Swann, 1994). The challenges for developing artificial activation 
protocols were caused by an incomplete understanding of egg activation as a 
process. However, with time it has become clear that the common factor for all 
approaches was to induce a cytosolic Ca2+ increase/increases in the egg 
(Whitaker, 2006). Ca2+ was found to be influencing not only the immediate release 
of eggs from arrest, but extended to affecting the development potential of 
embryos in mouse and rabbit (Ozil, 1990, Ozil and Huneau, 2001, Bos-Mikich et 
al., 1997). If Ca2+ transients were manipulated during their application in terms of 
frequency and duration, an increase to a certain limit will cause an enhancement of 
pre-implantation embryos undergoing compaction (Ozil, 1990). Not only the 
number of embryos undergoing compaction would increase, but the quality of 
rabbit post-implantation embryos in terms of somite and heart formation could also 
improve (Ozil and Huneau, 2001).   
Internal release and external influx of Ca2+ was successful in releasing the egg 
from its meiotic arrest. Ca2+ ionophores such as ionomycin, or 7% ethanol were 
amongst the agents that promoted a cytosolic Ca2+ increase (Cuthbertson and 
Cobbold, 1985). A divalent cation (Sr2+), also showed to cause credible egg 
activation in mouse eggs  (Kline and Kline, 1992). Moreover, this cation triggers the 
closest response to that of sperm during fertilisation. In fact, Sr2+ is the only known 
egg activator that triggers a series of Ca2+ oscillations during its application (Kono 
et al., 1996), while other agents can only induce a montonic single Ca2+ rise. The 
efficiency of the montonic Ca2+ rises in causing egg activation have been 
questioned, although they have been reported to cause egg activation in 
mammalian eggs including human eggs (Borges Jr et al., 2009b, Nasr-Esfahani et 
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al., 2010). In a direct comparison of various activating agents on mouse eggs, the 
results showed that Sr2+ has the highest efficiency in activating eggs and 
supporting further embryonic development when compared to other agents such 
ionomycin (Vanden Meerschaut et al., 2013b). My results have supported these 
previous studies since Sr2+ was superior to other artificial activators apart from 
PLCζ, in terms of that blastocysts development. The results emphasise the 
importance of the repetitive nature of the Ca2+ increase. However, Sr2+ treatment 
needed a supplementary action such as sperm introduction into eggs or 
cytochalsin treatment, otherwise it could not support early embryonic development 
(Bos-Mikich et al., 1997). That is explained by the need to have a diploid embryo. 
Not much success has been seen in the case of Sr2+ use in human eggs. A number 
of reports have shown that IVF and ICSI success rates can be enhanced with the 
use of Sr2+ (Yanagida et al., 2006, Kyono et al., 2008). However, studies using Sr2+ 
as an artificial activator failed to show Ca2+ transients as a result of its use in 
human eggs (Rogers et al., 2004, Heindryckx et al., 2008). In fact, whilst Sr2+ 
remains an effective activator and trigger of embryo development in rodent eggs, 
its effects have not been reproduced in eggs of any other non-rodent species 
including human. The cause of this species specific effect remains unknown.  
The monotonic Ca2+ rise triggered by the use of Ca2+ ionophores can lead to 
successful early embryo development in sheep, pig, cattle and mouse. However, 
success rates are of moderate efficiency to say the least. It is unusual for an 
ionophore to be used as a sole egg activator as it is usually combined with a 
protein synthesis inhibitor such as puromycin. The aim is to ensure an egg release 
form the meiotic arrest which is maintained by the high levels of MPF. MPF in turn 
is kept at high levels by the turnover of cyclin B and that is where the action of 
protein synthesis inhibitors. Preventing the turnover of cyclin B reduces the level of 
MPF and therefore releasing the egg from its meiotic arrest. Freshly ovulated 
human eggs were activated via a single Ca2+ transient and went on to develop up 
to the blastocyst stage (Lin et al., 2003). However, this success reported, was only 
seen in one egg out of a total of six, and eggs were subject to an extended period 
of 15minutes to ionomycin. The ionophore treatment came subsequent to a sham 
ICSI procedure which would have caused an additional rise in Ca2+ (Lin et al., 
2003). I have shown that in mouse eggs, embryos had the least ability to further 
develop when activated using ionomycin albeit the initial high activation rates to the 
pronuclear stage. The use of other parthenogenetic protocols in human eggs, such 
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as the use of protein synthesis inhibitors (Puromycin/cycloheximide) in conjunction 
to a monotonic rise of Ca2+ promoted early cleavage(De Sutter et al., 1992). Others 
reported that blastocysts were never obtained using this method of activation (Lin 
et al., 2003).  
One of the embryo quality markers is the degree of fragmentation detected in the 
blastocysts. A level of <10% is considered as minor and can still result in embryos 
that have the ability to implant and continue into a term pregnancy. A fragmentation 
below 10% has results of implantation and continuation to term in rates similar to 
that of embryos that had no signs of fragmentation. However, any level beyond 
10% would have a negative influence on implantation and documented clinical 
pregnancy rates (Giorgetti et al., 1995, Ziebe et al., 1997). Fragmentation is not the 
only predictive indicator for embryo quality, maternal age (Giorgetti et al., 1995) 
and the blastocyst’s inner cell mass number (ICM) are other important 
factors(Richter et al., 2001). Moreover, the ICM number was an effective method in 
deciding on the most competent embryos that would improve pregnancy rates in 
IVF (Liu et al., 2014). Studies have shown that the method of parthenogenetic 
activation influences the degree of apoptosis in mouse embryos. In a comparison 
between Sr2+ (Ca2+ oscillatory change) and a protein synthesis inhibitor 
(cycloheximide, no Ca2+ change) there was a significant difference in their 
apoptosis degree in favour of Sr2+ (Rogers et al., 2004). This indicates again the 
importance of the oscillatory nature of the Ca2+ changes. When different levels of 
Ca2+ oscillatory activity were examined in their ability to support embryo 
development to the blastocyst stage, it was found that the number of Ca2+ spikes 
influenced the ability of embryos to reach the pre-implantation stage and not the 
activation rates (Yu et al., 2008).  It has to be noted that other down-stream effects 
of the Ca2+ oscillatory pattern could not be excluded from influencing the capability 
of embryo development. In this regard my results are consistent with previous 
results. I have shown that the number of Ca2+ spikes had a significant difference 
between the embryos that arrested at the two cell stage and the eggs that further 
developed to the morula stage. Generally, it can be concluded that the oscillatory 
activity of Ca2+ during egg activation could be at least in part responsible for some 
of the later effects on development such as the level of fragmentation and ICM cell 
number detected in blastocysts defining embryo quality. 
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Since the introduction of IVF procedures (IVF, ICSI) there has been  an ever 
increase in studies evaluating differences between both procedures in terms of 
Ca2+ oscillations, activation rates, gene expression pattern  and clinical 
pregnancy rates (Pregl Breznik et al., 2013, Sato et al., 1999a). The search of 
difference was based on the sperm incorporation mechanism since the initial 
location of sperm is substantially different in IVF and ICSI (Sutovsky et al., 
1996). In terms of gene expression there was no significant difference between 
both procedures (Bridges et al., 2011). Again both techniques displayed a first 
Ca2+ spike that was higher and lasted longer than the subsequent spikes, 
however, in ICSI the first spike outlasted the first spike generated in IVF. The 
difference in the duration of the first spike had no significant difference on the 
down-stream effects of Ca2+ changes (Ozil et al., 2005). The ICSI procedure 
unlike IVF includes a mechanical reversible damage to the egg membrane, 
which causes by itself a Ca2+ rise (Sato et al., 1999b, Tesarik and Sousa, 1994, 
Nakano et al., 1997), therefore the initial spike in ICSI could be a sum of two 
Ca2+ rises.  In mice, it was found that the overall duration of Ca2+ oscillations was 
less in ICSI than those in IVF (Kurokawa et al., 2004). However, in a study by 
Sato MS et al on the effect of ICSI procedure on subsequent Ca2+ oscillations it 
was found that the main effect was on the first Ca2+ spike induced by the sperm. 
The relation was an inverse one, the larger the first Ca2+ rise due to the injection 
the smaller the first spike resulting from the release of the sperm factor. The rest 
of the Ca2+ pattern was unaffected by the procedure (Sato et al., 1999a). ICSI as 
a procedure had inconsistent results across mammalian species. It is 
established that equine embryos display a low frequency of Ca2+ oscillations for a 
short duration after ICSI, hence the very few embryos progress to the blastocyst 
stage (Bedford et al., 2004). Bovine eggs are another example of failure of the 
ICSI technique to produce embryos that are capable to develop to blastocysts. 
The reason behind such failure being the insufficient Ca2+ oscillations triggered 
after injecting the sperm (Malcuit et al., 2006). The failure is mostly thought to lie 
in the ‘compromised’ activation of the sperm factor within the egg after ICSI, 
leading to a defective pattern of Ca2+ oscillations and a premature termination of 
embryo development (Bedford et al., 2004, Malcuit et al., 2006). These data all 
suggest that there is still more to learn and more to improve on with the ICSI 
procedure.  
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6.3 PLCζ, a common trigger for egg activation across 
mammalian species. 
The long lasting Ca2+ oscillatory activity during egg fertilisation is a mandatory 
and sufficient condition to release the egg from its meiotic arrest and support 
further embryo development. Differences were detected in terms of frequency of 
occurrence, ranging from one Ca2+ spike every few minutes to every hour. These 
observed Ca2+ oscillations in mice last until around the formation of pronuceli, an 
indication that a plausible termination mechanism is by sequestration into the 
formed pronuclei. There is undisputed evidence that sperm releases a soluble 
protein into the egg cytoplasm which triggers the initiation of the Ca2+ oscillations. 
A novel phospholipase (PLCζ) was revealed as the sperm factor after a search 
into mouse and human testis Expressed Sequence Tag (EST) database. As a 
confirmation of this theory, injecting sperm extract into mouse eggs resulted in a 
series of Ca2+ oscillations similar to that occurring during fertilisation. When PLCζ 
cRNA was microinjected into mouse eggs, an indistinguishable Ca2+ oscillatory 
pattern from fertilisation was the result (Saunders et al., 2002). Data from the 
previous study provided direct and reliable evidence that PLCζ was the long 
sought after physiological sperm factor. PLCζ gene was found to be existent in a 
number of mammalian species, moreover, it has been reported that 
microinjecting chicken PLCζ cRNA into mouse eggs could trigger a series of 
Ca2+ oscillations (Coward et al., 2005). In light of the previous results, a plausible 
conclusion that a common function for PLCζ across vertebrates may be factual. 
More recently a new proposition for the sperm factor title has been put forward. 
Aarabi et al has put forward data claiming that PAWP could be the long sought 
after sperm factor (Aarabi et al., 2014b).  Significantly, they reported that PAWP 
could cause Ca2+ oscillations in mouse and human eggs. However, their case 
has been challenged by a number of reports. Firstly, a study identifying the 
SOAF from the perinuclear theca (Perry et al., 1999). The perinuclear theca 
extracts contained a number of proteins including PLCζ, but not PAWP. 
Furthermore, no independent research group was able to reproduce Ca2+ 
oscillations after injecting the PAWP protein or the cRNA (Nomikos et al., 2015). 
The injection of PAWP cRNA showed protein expression levels which exceeded 
that present in sperm, yet, no Ca2+ transients were observed. The final verdict on 
the PAWP case came when sperm from male mice that were genetically 
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modified to abolish PAWP. The sperm from those mice successfully triggered 
Ca2+ oscillations and supported development after ICSI in mouse eggs (Satouh 
et al., 2015). Previous data provides evidence that PAWP cannot be the sperm 
factor.  Therefore, PLCζ remains the only candidate that fulfils the requirements 
to stand as sperm factor. 
Variability in egg sensitivity to PLCζ between species was reported. Hamster 
eggs were reported to be less sensitive to sperm extracts when compared to 
mouse eggs (Parrington et al., 1996). The PLCζ protein is thought to be present 
in an inactive state whilst in the sperm (Swann et al., 2004), upon its release into 
egg cytoplasm it regains activity suggesting an intrinsic egg mechanism that 
would allow for the protein switch on. Having that said, differences in the amount 
of PLCζ, its solubility and activity could subsequently affect the pattern of Ca2+ 
oscillation triggered. Therefore response variability could be a species related 
difference. Sperm PLCζ is present in variable quantities across species, which 
could cause a variable response when injected into an egg of another species. It 
has been shown that pig sperm has higher quantity of PLCζ than mouse sperm 
(Kurokawa et al., 2005). My results are supported by previous findings, in that 
mouse eggs demonstrated a significant higher frequency of Ca2+ oscillations 
when microinjected in comparison to those seen in human eggs. Another factor 
that could explain such a variable response is egg size, cytoplasm volume differs 
due to size difference between human and mouse eggs. Nevertheless, , I have 
shown in my results that when the dose of hPLCζ microinjected into mouse eggs 
is adjusted it can effectively trigger a physiological series of Ca2+ oscillations, 
even though it’s an enzyme from another species. Since it has been identified 
that egg activation occurs within a window of PLCζ concentration (Yu et al., 
2008), anything below or beyond that level would have detrimental effects on 
further embryo development. Therefore, identifying an appropriate amount of 
hPLCζ to be injected into human eggs would be a cornerstone in making its use 
in IVF clinics. Unfortunately, my attempts at identifying a dose range for hPLCζ 
that would induce a Ca2+ response similar to that seen during fertilisation in 
human eggs, have not been successful. My effort was hindered by a number of 
obstacles. First was the shortfall in the supply of human eggs that were made 
available for the project. Secondly, was the age of the human eggs that I was 
microinjecting, all eggs were day 1 post-IVF/ICSI procedure. I would like to bring 
to attention that the recombinant protein that was used in all of my experiments 
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was made in our laboratory, the human recombinant protein is tagged to a fusion 
protein NusA (Nomikos et al., 2013). The choice of the fusion protein was based 
on its ability to enhance stability, solubility and aid in protein purification (Li et al., 
2013). Previous studies from our group revealed that the protein injection devoid 
from the fusion tag was unable to trigger efficient Ca2+ oscillations in mouse 
eggs. This indicates the importance of the fusion tag in preserving hPLCζ protein 
function. To test if the tag would have any implications on egg activation and 
subsequent embryo development, I injected the pure fusion tag into mouse eggs 
following an ICSI procedure with fresh sperm. Our results indicate that within the 
range that the protein is injected into mouse eggs it does not hinder the egg’s 
activation or developmental capacity up to the blastocyct stage in mouse 
embryos.  Finally, it is possible that there may be some solubility issues with 
hPLCζ protein since the mixing with compounds such as PVP lead to a clear 
precipitation reaction and this is likely to cause protein denaturation.   
 
6.4 Clinical implications of mutational amino acids in PLCζ 
gene. 
Whenever an original amino acid is substituted by another at the germ-line level, it 
can cause a number of various effects. The effects can range from benign 
(polymorphism) to a genetic disease with subsequent implications on an individual’s 
health. However, great number of amino acids can be altered without any 
detrimental effect on the resultant protein functionality (Frillingos et al., 1998). At the 
other end of the spectrum mutations for certain positions can have a negative 
impact on protein structure and function. The effect of genetic mal-positioned amino 
acids will usually be a structural defect within the protein (Yue et al., 2005).   In a 
clinical case following multiple attempts of ICSI with failure to achieve egg activation, 
a genomic search into the patients PLCζ sequence found evidence for the protein 
being essential in egg activation.  A single point mutation (PLCζH398P), made the 
protein inactive. The amino acid substitution had a helix-destabilising effect on the 
protein, which led to a disruption of the catalytic Y domain rendering the protein 
enzymatically inactive in eggs (Heytens et al., 2009).  Further confirmation was 
obtained when the same point mutation was made in mouse PLCζ (PLCζH435P). The 
equivalent PLCζ cRNA with the specific point mutation was microinjected into 
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mouse eggs and protein expression was monitored. It was reported that Ca2+ 
oscillations were totally abolished despite the fact that protein expression was 
optimum levels (Nomikos et al., 2011a).  Further analysis into the same genome led 
to a discovery of a second novel point mutation (PLCζH233L), replacing a hydrophilic 
amino acid (Histidine) by a hydrophobic one (Leucine) which had detrimental 
consequences on protein folding. By microinjecting cRNA encoding the new point 
mutation into mouse eggs, it triggered an abnormal Ca2+ profile. It further reinforced 
that abnormal PLCζ forms can lead to activation failure in eggs    (Kashir et al., 
2012).  
From that point onwards there has now been increasing evidence that PLCζ can be 
present as a dysfunctional form in sperm (Kashir et al., 2011, Kashir et al., 2012). 
The abnormal forms of the protein can contribute to causes of male factor infertility 
and this supports the rationale behind the use of PLCζ protein as a therapeutic 
agent for these cases (Yoon et al., 2008, Heytens et al., 2009). For a comparative 
study, we have developed subtypes of male infertility via heat treatment of mouse 
sperm to various durations. This resulted in Ca2+ profiles that were suboptimal or 
absent and therefore deficient in causing egg activation and embryo development. 
After ICSI with sperm that had different time exposure to heat, a second injection 
with a dose of PLCζ protein was carried out in the eggs. The results presented in 
this thesis shows that microinjection of PLCζ protein following ICSI has the potential 
to rescue the eggs from expected activation failure and developmental arrest.  
It is not clear how prevalent is PLCζ lack may be in male factor infertility. When the 
exact pattern of PLCζ in human sperm was investigated no single definite pattern 
was found, however, different functions were assigned for different localisations 
(Grasa et al., 2008, Young et al., 2009). A detailed study into the levels and pattern 
of PLCζ protein in human sperm using immunofluorescent analysis, did not identify 
any significant difference between patterns from controls that had no history of male 
factor infertility and sperm from men who had oocyte activation deficiency following 
IVF (Kashir et al., 2013). They concluded that sperm from normal controls could 
have a variable level of PLCζ. In reference to that mouse eggs are activated with a 
range of protein concentration (20-50fg) (Saunders et al., 2002, Yu et al., 2008), it is 
possible that human eggs have a window range as well for successful egg 
activation. Yu et al in a previous study showed that successful egg activation per se 
is not a predictor of successful embryo development, only the eggs that had PLCζ 
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protein within a specific range managed to further develop post activation (Yu et al., 
2008). In an interesting study by Vanden Meerschaut F et al, they used 
heterologous ICSI to assess the capability of human sperm to trigger Ca2+ 
oscillations in mouse eggs.  The results demonstrated that only just over 50% of 
sperm from controls (normal) had the ability to trigger a response in mouse eggs 
that could be described as normal if injected into human eggs (Vanden Meerschaut 
et al., 2013b). Data presented from the previous studies indicate that variable 
quantities of the protein exist even in “normal” human sperm. To add to the 
complexity of the situation, currently there is no method to identify the level of 
protein in sperm prior to its use in IVF. The question for us was, if the recombinant 
protein was to be used in IVF clinics would it be a matter of patient selection? 
Should the protein treatment be applied for all patients undergoing IVF treatments?  
If PLCζ were to be used for all patients that would potentially mean that some eggs 
would have an extra dose of the protein on top of a normal sperm. Could that 
possibly have any consequences on egg activation and subsequent embryo 
development? To determine whether an extra dose of PLCζ protein to eggs during 
fertilisation have any toxic effects or block embryo development, a specific 
experiment was set up. I have injected mouse eggs with a dose of PLCζ protein that 
is sufficient to support egg activation and embryo development, the microinjection 
was done post ICSI with fresh sperm. By following the embryos through their 
development, it was found that the extra protein did not have any negative influence 
on mouse embryo development up the blastocyst stage. There was no significant 
difference detected in all stages of embryo development up to the blastocyst stage 
between eggs activated by one sperm and eggs activated by one sperm plus a dose 
of PLCζ protein.  Furthermore, in a parallel set of experiments I examined the 
frequency of Ca2+ oscillations triggered in both groups: ICSI versus ICSI plus PLCζ. 
There was no significant difference in the number of Ca2+ oscillations detected. My 
results argued against a previous study that demonstrated a significant difference 
between Ca2+ oscillations triggered in monospermic and dispermic mouse eggs 
(Faure et al., 1999).  However, the differences detected between monospermic and 
dispermic induced Ca2+ oscillations was quite small (5.2+/- 0.3, 6.6+/- 0.3 
respectively). Figures are representing the mean number of Ca2+ oscillations in each 
case and their SEM (Faure et al., 1999). The difference between results could be 
explained by the difference in methodology used in both studies.  The study was 
assessing Ca2+ oscillations following an IVF procedure not ICSI.  Evidence for the 
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number of sperm involved in the fertilisation process was assumed based on the 
number of pronuclei formed (Faure et al., 1999).  Moreover, the duration for 
observing Ca2+ oscillations in the previous study was done for two periods of 
45minutes with an interruption of 45 minutes in-between while in our study we 
observed Ca2+ oscillations for uninterrupted 2 hour duration. The gap in the imaging 
process has the potential in missing some of the spikes that could have affected the 
results. It is imperative to examine the relevance of variability in PLCζ protein 
detected in human sperm by a direct assessment of its Ca2+ release profile in 
human eggs.  
6.5 Response variability to PLCζ microinjection.  
Turning away from the sperm as being the main culprit behind the variability seen in 
the egg’s response after fertilisation, the next potential cause could be a factor 
within the egg. With the advances seen in the fine art of ART, it is obvious that it is a 
solution for sperm penetration failure. For a successful fertilisation process a wide 
range of cascades need to take place. The egg quality has an undeniable role in 
responding to the release of PLCζ from sperm into its cytoplasm. The importance of 
the level of intracellular Ca2+ storage becomes evident once the egg is fertilised. 
Ca2+ brings forward the process of meiosis resumption. Meiosis resumption is an 
important step in fertilisation, it starts from metaphase to anaphase transition and 
continues until the formation of the pronuclei (Sen and Caiazza, 2013). The egg is 
held in a meiotic arrest via the activity of Maturation Promoting Factor (MPF) and 
MAP kinase (Gonzalez-Garcia et al., 2014). The key event during fertilisation that 
allows this transition is the periodic Ca2+ oscillations, calmodulin dependent protein 
kinase II (CamKII) is the link between the two events. All the evidence from Ozil’s 
studies suggests that a certain pattern and the size of the Ca2+changes during 
fertilisation are required for this process to be completed. If the MPF decline has not 
been suppressed adequately it can regain activity and cause another metaphase 
arrest. This is supported by the inability of the egg to release the second polar body 
and form pronuclei if Ca2+ oscillation are stopped prematurely (Ozil et al., 2006). 
That is also what happens in some cases of parthenogenetic activation of eggs with 
ionophores. As ionophores induce a single Ca2+ transient, it is particularly prone to 
the possibility of not causing a full activation process.  
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At GVBD the release of nuclear content into the cytoplasm has an associated 
positive influence on the degree of egg maturation. Yet, some aspects of the 
maturation process are independent of the nuclear release consequences (Swain 
and Pool, 2008). Eppig et al 1994 demonstrated that the developmental ability to the 
blastocyst stage of embryos significantly differed between eggs obtained from mice 
aged 26 and 18 days. Both groups of eggs morphologically appeared normal as 
they had released the first polar body. It seemed the younger group were lacking 
some sort of maternal factors causing a reduced ability to support development 
(Eppig et al., 1994, Eppig and O'Brien, 1996).  Moreover, data from a study 
investigating the effect of maternal age on eggs and their maturation status, 
suggests that in-vitro maturation is not the cause behind reduced blastocyst 
developmental rates. Eggs that have matured in-vitro taken from 24 day old mice 
produced Ca2+ oscillations in response to fertilisation similar to those matured in-
vivo. It was suggested that the ability of an egg to generate Ca2+ response was 
developed during the final stages of their development (Cheung et al., 2000). The 
previous observations give an impression that a simple evaluation by inspecting the 
appearance of the eggs could be misleading in regard to maturation. Oocyte 
maturation plays an important role in the redistribution of the ER and the sensitivity 
of IP3 receptors (Mehlmann et al., 1995, Mehlmann et al., 1996). The maturation 
process was suggested to cause a build-up in the Ca2+ store levels as suggested by 
Tombes and co-workers (Tombes et al., 1992). However, later it was shown that 
oocyte maturation enhances IP3 receptor sensitivity and number, while in terms of 
Ca2+ stores it was suggested a reorganisation process takes place rather than 
enlarging the reserve levels (Mehlmann and Kline, 1994). The other important 
aspect of ART, is that it utilises eggs that were forcefully recruited by various ovarian 
stimulation protocols. Therefore, eggs that were not likely to ovulate naturally 
become included in IVF treatments and this has the possibly contributing to the 
causes of fertilisation failure  
The presence of Ca2+ is an absolute requirement for activation of the Ca2+ release 
mechanism through phosphoinositide specific phospholipase’s C. It is well 
established that Ca2+ release during fertilisation is mediated via the hydrolysis of 
phosphatidylinositol (4,5) bisphosphonate (PI(4,5)P2) and the production of IP3. 
Although the main mechanism is the same for all PLC’s, the PLCζ has a unique 
variation.  PLCζ does not require any activation upon its entrance into the egg, nor is 
it in need of G-protein binding to become activated unlike other forms of PLC’s. One 
202 
 
possible explanation is its high degree of sensitivity to Ca2+, which is such that once 
it is inside the egg it is able to hydrolyse PI(4,5)P2  at the basal resting Ca2+level. 
However, the possibility of other players that mediate PLCζ and PI(4,5)P2 coupling 
cannot be excluded and are yet to identified. The phosphatidylinositol’s (PI) initial 
production is the endoplasmic reticulum. However, special phospatidyl transfer 
proteins (PITPs) allow the translocation of the PI into the plasma membrane where it 
is made into PI(4,5)P2. This translocation process allows for the hydrolysis by PLC’s. 
After hydrolysis, one of the two messengers which is IP3 diffuses into the cytoplasm 
and binds to its receptor on the ER triggering Ca2+ release (Cox et al., 2002, Swann 
et al., 2004). The initial release of Ca2+ creates a positive feedback loop for further 
Ca2+ release, and the subsequent Ca2+ oscillations usually last for several hours (4-
6hrs). A series of IP3 production cycles is the only explanation for the sustainability 
of the Ca2+ oscillations. PI(4,5)P2 is not an egg specific substrate, it is present in 
most somatic cells. So it could be assumed that PLCζ when injected into somatic 
cells would trigger a reasonable Ca2+ response, but that turned out not to be true. 
Interesting results were reported when PLCζ was injected into somatic cells (CHO 
cells) (Phillips et al., 2011). These cells did not show any Ca2+ oscillations despite 
the high expression levels of the PLCζ protein. However, when these cells were 
microinjected into mouse eggs, Ca2+ oscillations were observed (Phillips et al., 
2011). Another observation is that PLCζ protein is originally present within the 
sperm where there is no shortage of PI(4,5)P2 , still, the protein remains in its 
inactive form. That can only lead to one conclusion, which is that the egg has 
specific factors that can allow the presence of PLCζ to bind to PI(4,5)P2. The 
intriguing question then would be, by which means can PLCζ distinguish between 
PI(4,5)P2 present in eggs and that present in other cells? A question, which still has 
no definitive answer. 
It is well known that once PLCζ is released into egg cytoplasm, its main action is to 
hydrolyse PIP2. Initially, it was suggested that PLCζ targets plasma membrane PIP2 
(Nomikos et al., 2007).  However, a recent study challenged the localisation of PIP2 
on the cell membrane. The data presented revealed that the PIP2 target for PLCζ is 
located on intracellular vesicles (Yu et al., 2012). By the use of PLCζ antibodies and 
immunocytochemistry, PLCζ after microinjection was found localised within the 
cytoplasm with small vesicles (Yu et al., 2012). The exact nature of the vesicles is 
unknown. Moreover, the main intrinsic mechanism for this localisation and binding 
still remains unclear. Nomikos et al in 2007 suggested that the main driving force 
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behind PLCζ and PIP2 interaction is through an electrostatic interaction. PLCζ is a 
positively charged, while PIP2 is a negatively charged residue (Nomikos et al., 
2007).  On further investigation it was found that the XY Iinker region has a 
preference over the C2 domain in interaction with membrane PIP2 (Nomikos et al., 
2011b).  The EF hand was suggested to have the main function of binding to the XY 
linker (Nomikos et al., 2011b). In a recent study (Escoffier et al., 2016) on a mutation 
detected in the gene for PLCζ, the homozygous mutation was localised in C2 
domain. The C2 domain is known to be a lipid binding protein with little or no affinity 
for Ca2+. In the case of PLCζ, however, the C2 domain is not necessary for the 
enzymatic activity of the protein (Kuroda et al., 2006). This suggests the C2 domain 
may also play some role in targeting. The Escoffier et al study attempted to localize 
the wild type of C2 mutant PLCz. A significant overlap was identified with the 
endoplasmic reticulum of the egg in the case of the WT protein, while the protein 
expressed from the cRNA with the mutation localised around the nucleus. So it is 
possible that PLCζ also localizes to the endoplamic reticulum.  
Of the PLC family, PLCδ1 has the closest homology to PLCζ, the major difference in 
structure between both PLC’s is the absence of the PH domain from PLCζ (Nomikos 
et al., 2012a) (Nomikos et al., 2012b). The PH domain is responsible for the 
tethering of PLCδ1 to PIP2 in the cytoplasmic membrane, interestingly a chimera for 
PLCζ with the PH domain did not show any greater affinity for the PIP2  
(Theodoridou et al., 2013). Despite the lack of clarity about the exact vesicles that 
PLCζ  protein binds to,  and the means by which it binds, it remains clear that  PIP2 
hydrolysis is key for generating the Ca2+ release profile that supports egg activation 
and embryo development. 
6.6 Ethical and practical considerations in the clinical use of 
PLCζ recombinant protein.  
At the heart of the ethical debate around the IVF domain is whether infertility should 
be considered as a “disease” and should treatment be regarded as a “cure”. Clearly, 
infertility does not have a direct threat to health in physical terms. Non treatment 
would not have any immediate impact on public health nor would it cause any rise in 
the population morbidity/mortality index.  However, it has been argued that 
childlessness has an indirect effect on the well-being of the men and women 
involved, as well as the social suffering caused in some traditional cultures. There is 
no doubt that ART carries a significant risk to health as issued in the World Health 
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Organisation Report in 2001. A staggering 20-fold surge of multiple pregnancy risk 
has been documented when compared with general population. As a consequence, 
it is more likely that more preterm infants are born, which is followed by the 
increased costs of intensive care required for these births. Medical risks for mothers 
are also a matter of concern.  IVF entails invasive procedures which could be life 
threatening. Multiple pregnancies are not only physically demanding but impose an 
extra burden financially and emotion on families in the short and long term. Ovarian 
hyperstimulation syndrome in some of its forms is a life threatening condition (Rizk 
et al., 1990, Lamazou et al., 2011), and the condition can appear in up to 10% of 
patients treated with ART (Rizk and Aboulghar, 1991, Joint Society of et al., 2011). 
Mortality rates of 3 for 100,000 have been reported (O'Donovan et al., 2015, Joint 
Society of et al., 2011), and the condition can add to the emotional stress if the 
treatment cycle has to be cancelled (Abuzeid et al., 2003). Despite the wide 
discussion and debate, currently there is a wide acceptance of treatment modalities 
in IVF. However, ethically defensive variants have risen due need to solve problems 
in the field. Sperm, egg and embryo donation generated a great deal of controversy. 
The freezing process for sperm and embryo, not to mention genetic testing of 
embryos were all grounds for ethical consideration. Nevertheless, it has been found 
that medical technology and techniques could be effectively developed when carried 
out in ethically sound scientific research environment.   
Introducing recombinant PLCζ protein, under the existing realm of egg activation for 
cases of egg activation failure should not need to lead to any reasons in creating 
controversies over its use. Moreover, the sound evidence of its positive influence in 
the IVF field will alleviate most of the concerns that will appear. The main aim of this 
research project was to contribute to the IVF field in an acceptable and ethical way, 
to enhance the results of fertilisation rates where male factor related failures are 
reported.  In that sense, some of the data presented in this thesis has provided 
evidence that recombinant PLCζ has the potential to be used as a therapeutic agent 
to overcome some causes of fertilisation failure.  
In the early days of PLCζ discovery, Yoon et al 2008 showed the potential of PLCζ 
in treating causes of egg activation failure following ICSI. The ICSI procedure was 
done on mouse eggs, globozoospermic sperm was used and followed by an 
injection of PLCζ cRNA. The cRNA injection managed to rescue the eggs from 
activation failure. Ethically this method would not be applicable on human eggs 
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because the RNA is a genetic material and its injection into human eggs could lead 
to a genetic modification of the embryo genome after its incorporation (Kashir et al., 
2010). Our research team in its early attempts in making the human recombinant 
PLCζ used a hexa-histidine tag. Results demonstrated a protein expression level 
that was unsatisfying, however, the protein expressed was functional nut not very 
active. In a study using the hexa-histidine tag, the level of protein required for 
inducing Ca2+ oscillations was in the range of 5,000fg-10,000fg (Yoon et al., 2012). 
Furthermore, the expressed protein could not support embryo development to the 
blastocyst stage (Yoon et al., 2012). In view of the Ca2+ release profile of the 
expressed previous protein along with stability issues, our group turned to a NusA-
hexa-histidine fusion preparation that was purified (Nomikos et al., 2013). In contrast 
to previous tags, a significant level of soluble protein (Nus-A PLCζ) was obtained 
and it had a molecular mass of about 130KDa as predicted. The 130 molecular 
mass was a sum of the 70 KDa PLCζ protein and the 60 KDa Nus-A tag (Nomikos 
et al., 2013). It was established that about 80fg of the protein was able to elicit a 
series of Ca2+ oscillations undistinguishable from those induced by physiological 
fertilisation in mouse eggs. This level of protein gives an overall increase of protein 
activity of about 100 times from that of the previous report (Yoon et al., 2012). 
Furthermore, this protein supported mouse embryo development up to the 
blastocyst stage (Yu et al., 2008). Our group’s research included a closer look into 
the effects of the Nus-A tag, it was concluded that the tag was both necessary and 
with no detrimental effects for egg activation and embryo development (Nomikos et 
al., 2013, Sanusi et al., 2015). Additional confirmation that the protein is a valid 
treatment for some male factor infertility cases was when PLCζ protein mutations 
were discovered.  When microinjection of the mutant PLCζ into mouse eggs was 
followed by a rescue injection of the wild type of PLCζ it elicited a series of Ca2+ 
oscillation and supported early embryo development up to the blastocyst stage.  
 
6.7 Practical considerations in introducing PLCζ into clinical 
settings. 
ICSI as a procedure is often taken for granted. However, great care in identifying 
suitable cases is essential, as there is no significant effect on pregnancy rates for 
ICSI over IVF. The technique involves a great degree of invasiveness. The sperm 
deposition into the cytoplasm is not of great concern, but an effect on the disruption 
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of the cytoplasmic organelles may occur. The multiple step process including egg 
denudation and plasma membrane piercing using a sharp needle, could hinder 
developmental success rates. My data is encouraging for the possible use of the 
protein as a method for rescue of activation failure, or as a general measure during 
all ICSI procedures. There was no evidence of a harmful effect on embryos 
developing when normal sperm was used for ICSI with an additional dose of PLCζ. 
However, with the current method that I was using for the injection protocol it would 
mean that IVF clinics would need to invest in further equipment to use the protein. 
To avoid this we carried out a number of experiments testing a suitable method with 
low pressure injections that could be applicable in IVF clinics in the future. At first we 
used a specially designed pipette in the laboratory with a bevelled tip mimicking the 
ICSI pipette but with a narrower opening. I managed after some trial and error to 
control the amount of material carried over to be injected into the mouse eggs, but 
the technique would be regarded as a second mechanical injury to the precious 
human egg and could be avoided if necessary.  
The most obvious way to introduce PLCζ into the egg is to do at the same time as 
the sperm.  I initially started by incorporating PLCζ into the injection medium, but 
due to the influx of Ca2+ from the surrounding media (Tesarik and Sousa, 1994) into 
the eggs alongside PLCζ it produced a significant Ca2+ increase in the cytoplasm. 
The challenging part for me in this experiment was egg survival since it seemed that 
the eggs were very vulnerable to lysis once injected. This could be explained by the 
previous reports suggesting that PLCζ is highly sensitive to the level of Ca2+ present 
in solutions (Kouchi et al., 2004). Another possible source of the Ca2+ rise during the 
ICSI procedure is the disruption of the endoplasmic reticulum by the injection pipette 
(Tesarik et al., 2002) adding to the overall level of Ca2+ which can be detrimental to 
the egg. In an attempt to overcome the low egg survival rate from the previous 
method, the addition of PLCζ to the sperm drop was tested. The sperm drop is 
supplemented with PVP which allows the slowdown of sperm to facilitate its pickup. 
Moreover, PVP allows greater control over the amount of medium injected into the 
egg during ICSI (Joris et al., 1998). Hence, PVP was supplemented into the sperm 
drop which aided in the control of the amount of PLCζ being injected while 
performing ICSI. The method seemed to be reliable in its technique, however, there 
were aggregates forming in the sperm drop. My initial results regarding the co-
injection technique suggest a substantial aggregate formation. The possibility that 
the aggregates could compromise protein activity or even cause impairment in the 
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cellular function after being injected needs more evaluation. Additional experiments 
will be needed to assess any pathogenic effects of the aggregates on egg activation 
and embryo development.  Other sperm slowing agents could be tested in a co-
injection technique as a further alternative.  
 
6.8 Safety considerations for the clinical use of PLCζ 
In the past few decades there has been a surge in the use of ART, namely IVF and 
ICSI.  Mother and offspring health risks have been noted from the use of such 
technology. When Bonduelle’s group followed a cohort of children born as a result of 
ART it was deducted that there was an increased likelihood of congenital 
abnormalities when compared to the cohort conceived normally (Belva et al., 2007). 
In the previous retrospective analysis the outcome of ICSI procedures was 
compared to a singleton spontaneous pregnancy.  15/150 of the children in the ICSI 
group had a major congenital malformation compared to 5/147 in the spontaneous 
pregnancy group (P< 0.05) (Belva et al., 2007). In terms of child development delay, 
there was no indication that the IVF or ICSI children had any incompetence when 
compared to naturally conceived children (Bonduelle et al., 2003). On the contrary, 
the cohort of children born after an IVF/ICSI procedure had a trend that was 
statistically significant for having a higher IQ and verbal performance (Leunens et 
al., 2006). However, that could have been a reflection of maternal and paternal 
educational levels as opposed to that of the spontaneous conception group. 
Challenges do exist when it comes to reporting risks and adverse outcomes of ART. 
The main challenge however, is the inconsistency seen in the definition of 
anomalies identified. What seems to be a set of diagnostic criteria for a paediatrician 
might not fit into the criteria set by a geneticist. Another aspect is that children born 
to these procedures might be examined with more vigilance as opposed to children 
of natural conception and it is true the closer you look- the greater possibility of 
finding an abnormality.  Researchers believe that at least 75% of all infertility has a 
contributory genetic basis to it and at present limitations exist in identifying all 
causes. As far as infertility is concerned, the condition itself would limit the spread of 
any genetic traits to offspring as there will be no offspring.  But due to many couples 
taking on infertility treatment without a complete understanding of the underlying 
causes, these genetic traits are given the opportunity to resurface.  
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Existing data suggests, from retrospective studies, that IVF/ICSI is considered to be 
safe technology (Alukal and Lamb, 2008), but it remains evident that certain birth 
defects are more common in children born after ART (Hansen and Bower, 2014). 
Fertilisation to be successful needs to have a specific Ca2+ signature (Jones, 1998, 
Stricker, 1999), physiologically the trigger would be the sperm factor (Saunders et 
al., 2002, Swann et al., 2004).  The effect of this Ca2+ signature extends beyond the 
time frame of their occurrence, and they can have long term effects on late embryo 
development (Ducibella et al., 2002, Ozil et al., 2005).  IVF clinics have been using a 
number of activation protocols to cover a shortage in the Ca2+ signalling system, 
which is probably due to either a quantitative or qualitative deficiency in the sperm 
factor.  Activation protocols in current practice rely on Ca2+ ionophores (Kashir et al., 
2010), and these protocols trigger a single Ca2+ rise within the egg. It is suggested 
that both ionomycin and A23187 cause a Ca2+ increase by increasing plasma 
membrane permeability to Ca2+ influx. It was suggested as well that they might have 
an effect on internal Ca2+ stores through a similar mechanism as IP3 induced Ca2+ 
release (Yoshida and Plant, 1992).  In a study by Heindrycks’s group, it was shown 
that ionomycin was superior in triggering a larger Ca2+ transient than A23187 in 
mouse eggs and in vitro matured human eggs (Nikiforaki et al., 2016). However, it 
could be argued that the difference seen in activation rates was due to protocol 
differences, as eggs were exposed to a double exposure to ionomycin while the 
A23187 group had only a single exposure. Again the total duration that the eggs 
were exposed to both ionophores was different giving another explanation for the 
differences detected in the total Ca2+ release profile for both ionophores. From the 
early use of parthenogenetic activation there were reports indicating that they could 
have effects on developing embryos. It was reported that mouse eggs activated 
parthenogenetically had an embryo size that was significantly smaller than that of 
normal fertilisation (Hardy and Handyside, 1996). It was suggested that the effect 
could extend to the early post-implantation period were mouse embryos had a 
diminished developmental capability possibly due to a defective gene expression 
(Surani and Barton, 1983).   Having said that, other research groups have reported 
results that disagree with the notion that parthenogenetic activation has deleterious 
effects on future embryo development (Loi et al., 1998). With all the controversy in 
regard with safety concerns with the use of chemicals to induce artificial oocyte 
activation, there are many reports describing their use and valuable outcome on 
human eggs (Mansour et al., 2009, Nasr-Esfahani et al., 2010, Borges Jr et al., 
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2009b, Borges Jr et al., 2009a). It has to be said that up to date there has been no 
reports  for any mental or physical side effects for children born after assisted 
activation protocols were applied (Kyono et al., 2008, Nasr-Esfahani et al., 2008). It 
is also an issue that all of the activation protocols reported had no parallel control 
groups to compare to.  
J.P Ozil and co-workers conducted a study to determine if interfering with the Ca2+ 
release profile during fertilisation would have any compromising effect on embryo 
development. The experiments were conducted on mouse eggs that have fertilised 
in vivo, and the interference with the physiological Ca2+ profile was either by 
premature termination of the Ca2+ oscillations or overriding the endogenous 
response by triggering a series of 20 Ca2+ oscillations. Embryos resulting from both 
protocols were returned to recipients to minimise detrimental effects of in vitro 
culture on gene expression and development. Results have shown that although 
blastocyst developmental rates were not compromised for both groups, it was 
evident that interfering with the physiological Ca2+ signal had detrimental effects on   
further developmental potential of the blastocysts. The consequence of having few 
Ca2+ oscillations was seen as having less offspring born, indicating that the 
implantation process was compromised. Whereas in the case of triggering a higher 
Ca2+ oscillation frequency pattern it was found that there was a greater variability in 
the weight of offspring (Ozil et al., 2006). My results tend to disagree slightly with 
these previous finding as I have shown that by reducing the number of Ca2+ spikes 
during early fertilisation  it does significantly affect the rate of blastocyst developing 
in mouse embryos. However, the differences could be due to the strain of mice 
used, since previous studies by Ozil used F1 hybrid mice which are genetically 
selected to develop to blastocyst at high rates, whereas I used an inbred strain of 
mice with ~50% development rate to blastocysts stages. Still, both results highlight 
the influence of perturbing the physiological Ca2+ profile. The influence of a 
diminished Ca2+ profile was seen as reduced capability for blastocysts to implant, 
while blastocysts developing from the overstimulated Ca2+ response were failing to 
continue development post implantation (Ozil et al., 2006). In light of previous 
findings, it is of a concern that performing ICSI to treat male infertility would allow 
introduction of a sperm into the egg that cannot trigger the required set of Ca2+ 
oscillations. That will ultimately lead to failure of implantation or failure to develop to 
term as in the case of early miscarriages. These pre-implantation and post-
implantation failures should not necessarily be seen as a poor outcome because 
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they could be seen as an alternative to yielding an offspring with certain diseases. A 
kind of natural selection process may occur where only the most viable embryo can 
continue to develop.  
In previous studies our group has shown that PLCζ protein can activate and support 
development up the blastocyst stage in human and mouse eggs (Cox et al., 2002, 
Rogers et al., 2004). However, the amount of protein that would support early 
embryo development was not clarified. It was until Yu et al demonstrated a 
relationship between the amount of protein injected and the developmental ability of 
mouse embryos (Yu et al., 2008). The study revealed that the egg activation 
process is sensitive to the level/frequency of Ca2+ oscillations. However, the ability to 
proceed to the blastocyst stage had a “window” requirement for both the amount of 
protein and ultimately the frequency of Ca2+ oscillations. The ‘window’ covers about 
a fourfold range of PLCζ concentrations. The results in the previous study support 
my findings, where I found that there was a significant difference between the 
number of Ca2+ spikes occurring in embryos that have progressed to the morula 
stage and the ones arresting at the 2-cell stage. In Yu’s et al study it was found that 
low expression levels of protein led to a poor Ca2+ pattern, whereas a high protein 
level had a corresponding high Ca2+ oscillation frequency and both had poor 
blastocyst development rates. From our previous studies, we can assume that 
whenever PLCζ protein is microinjected into mouse eggs if not within the “window 
requirement” the embryos will not be developing. It can be generally concluded that 
far too much or too little of the protein would translate into failure of embryo 
development. Furthermore, if to extrapolate the findings from studies on mouse 
eggs to human eggs then our results may suggest a self-limiting safety mechanism 
for PLCζ protein since embryos receiving too much will not develop further than the 
cleavage stages. This makes PLCζ protein a very strong prospect for treating its 
deficiency that can be held accountable for some of the failed fertilisation failure 
after ICSI (Battaglia et al., 1997, Heindryckx et al., 2005). Safety concerns over any 
new treatment protocol are a justifiable matter and it should be in the hands of 
patients to make informed choices. Making an informed decision can only happen 
when proper counselling about all options is done. All couples seeking treatment for 
infertility should receive information for their treatment options before they start the 
long stressful and emotional journey. Patients should always be reminded that there 
is no guarantee for perfect outcomes although the scientific evidence of harm is 
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negligible. However, they should also be reminded that even in the case of couples 
with normal fertility, no such guarantee exists.  
6.9 HyPer probe and limitations in eggs.  
It is established that abnormal patterns of Ca2+ oscillations during early events of 
fertilisation can influence embryo development capacity (Ozil et al., 2006, Yu et al., 
2008). More specifically the high frequency of Ca2+ oscillations causes failure of 
post-implantation development. However, the mechanism and the signalling 
pathway for a detrimental outcome are yet to be known. The more interesting 
question is by which means can an early phenomenon during fertilisation influence 
such a late event in embryo development? What mediates the developmental 
arrest? It is tempting to speculate that a link between the frequency of Ca2+ 
oscillations during fertilisation and the ROS production level has a cause and effect 
relationship. A speculation that a defective embryo development is caused by an 
increasing ROS level due to a high Ca2+ oscillation frequency during fertilisation. In 
aged mouse eggs it is known that the Ca2+ release profile will switch from a 
fertilisation signal into an apoptotic triggering signal (Gordo et al., 2000). The 
suggested mechanism behind this is the loss of the anti-apoptotic gene balance 
which determines whether a cell lives or dies (Elmore, 2007). However, in freshly 
ovulated eggs the signalling system for developmental arrest remains unclear.  A 
cellular reaction to an overdose of any signalling stimulus would be shown as cell 
toxicity or cell death. Ca2+ is an example of such a stimulus, that whenever rises 
beyond physiological levels can cause cell death (Trump and Berezesky, 1996).  
It is well established that the mitochondria population within the egg is the only 
source of future mitochondria in all cells for the developing embryo (Jansen, 2000). 
The multifunctional organelle is responsible for energy production (ATP) and aids in 
the balance of cytosolic Ca2+ levels by acting as a store for excess levels. Another 
aspect of its many functions is that it acts as a store for proapoptotic factors and a 
source of ROS production in the embryo (Minamikawa et al., 1999). Some of the 
developmental compromise could be attributed to the sensitivity of this particular 
organelle to insults during in vitro manipulation/fertilisation (Thouas et al., 2004).  
Such insults can result in ROS production from the mitochondria which damages 
organelles where after they leak into the cytoplasm triggering a degenerative 
cascade (Jansen, 2000).  
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Mitochondria produce both ROS and ATP. It has been known for some time that the 
morphological appearance of some mammalian species such as bovine eggs is 
directly correlated with the level of ATP within. Moreover, the developmental 
capacity to the blastocyst stage is dependent on ATP (Stojkovic et al., 2001). 
Furthermore, in other reports it has been suggested that for successful human and 
mouse embryos development there is a mandatory requirement for a certain level of 
ATP (Ginsberg and Hillman, 1973, Van Blerkom et al., 1995, Van Blerkom, 2011). It 
is known that mouse pre-implantation embryos rely on pyruvate as an energy 
source due to the block in the glycolysis pathway (Ray et al., 1995). In a more 
recent study it was observed that during mouse embryo fertilisation, in particular 
during the Ca2+ oscillatory phase, there was evidence for an increase in the 
production of ATP.  The ATP increase was from mitochondria and was both 
necessary and sufficient for embryo development (Campbell and Swann, 2006).  
The previous study demonstrates that the Ca2+ oscillations influences the influx of 
Ca2+ into mitochondria and subsequently modulating ATP production levels to meet 
the embryo requirement during fertilisation. However, it has to be shown whether the 
temporary increased levels of ATP has any clear effect on embryo development 
(Quinn and Wales, 1973). Moreover, an ATP dependant protease (proteasome) in 
cells has been found to respond to low and high levels of ATP. The bidirectional 
effect of the ATP levels on this enzyme has detrimental effects on cell viability 
(Huang et al., 2010). 
A key molecule for intracellular signalling is without doubt ROS, and H2O2 is one of 
the most important species.  The mitochondria are a major source for the ROS, 
within the cell they have a wide spectrum of influence, from cell proliferation to cell 
death. They are as well involved in the activation process of a number of genes and 
contribute to signalling pathways (Turpaev, 2002). The source of ROS in an egg 
during fertilisation can be either from the mitochondria during the oxidative 
phosphorylation process or from the cytoplasm via cytoplasmic oxidases (Nohl, 
1994). The ability of the mitochondria to uptake Ca2+ during fertilisation into its 
matrix, raises a question of what impact would that have on the egg activation 
process. The developmental capacity of the mammalian embryo is affected at 
various levels by any imbalance in the antioxidant system (Guérin et al., 2001, 
Morado et al., 2009).  A number of reports have linked the detrimental influence of 
increase levels of in vitro ROS production on pre-implantation embryo development 
(Guérin et al., 2001, Yang et al., 1998, Bain et al., 2011). In human embryos there 
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was a direct link found between the internal levels of H2O2 and apoptosis (Yang et 
al., 1998). Thompson JG’s group reported an observation of an increase in the 
production of ROS during early embryo development in bovine eggs (Lopes et al., 
2010).The observation was based on the first cell division in bovine embryos, it was 
found that the first cleavage was preceded by an increase in mitochondrial activity. 
This rise in mitochondrial activity is required to meet the energy demand necessary 
for the cleavage to complete. In addition to the mitochondrial activity, there was an 
increase in the oxygen consumption levels. Furthermore, an oxygen consumption 
peak was detected on two separate incidents post fertilisation within the first 24hrs 
in bovine and sea urchin eggs (Heinecke and Shapiro, 1992, Lopes et al., 2010), 
these peaks had parallel rises in the production of ROS level. These data all indicate 
a possible link between mitochondrial activity and the overall ROS levels. During the 
early stages of mouse embryo development it was shown that during pronuclei 
formation there was an increase in glucose oxidation through the pentose 
phosphate pathway (Pantaleon et al., 2001). Moreover, reports support the 
observation that around the time of fertilisation in mouse eggs there is a respiratory 
burst that directly causes a measurable increase in the intracellular levels of H2O2 
(Nasr-Esfahani and Johnson, 1991).  
All of all, the literature suggests that mitochondrial activity could be one of the 
causes behind a rise in the ROS level during fertilisation. The level of ROS if beyond 
the egg’s ability to handle, could possibly explain some of embryo developmental 
failure. In the third chapter of my results, I have attempted to unravel the mechanism 
of developmental failure observed in certain patterns of Ca2+ oscillations, especially 
the high frequency pattern. In light of previous reports, the hypothesis was that an 
early event during fertilisation could negatively influence embryo development. The 
hypothesis was that high Ca2+ oscillation patterns trigger an excess production of 
ROS via its effect on mitochondria. I attempted this study with the aid of a new 
probe used for detection of H2O2.The claim was that the probe was superior to other 
previous probes in monitoring H2O2 changes in vitro (Belousov et al., 2006). The 
author of the previous paper, pointed to the various pitfalls of the widely used ROS 
indicator utilised in the majority of studies investigating ROS and its effect during 
fertilisation. It was argued that the dichlorofluorescein (DCF) derived indicator had 
an unspecific reaction to H2O2, as it could react to the oxidisation of other species. 
The more significant drawback was that the indicator itself could contribute to the 
amplification of the fluorescent signal. The DCF indicator, upon exposure to light, 
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can cause artificial generation of ROS and cause a signal exaggeration. The new 
HyPer probe constructed was claimed to have high specificity towards H2O2 and not 
other oxidants. Initially in our experiments it was found that the probe introduced into 
mouse eggs indeed responded to an increase in H2O2 levels in the surrounding 
media. However, doubts casted by the changes detected in the fluorescent signal 
seen during fertilisation, indicated that there could be other contributors to the signal 
change. Upon further examination, it was found that the fluorescent changes 
detected were coinciding with intracellular pH changes within the egg. The change 
in the egg intracellular pH was investigated, but unfortunately the source was 
unidentified and its prevention was unsuccessful.  The probe has been criticized for 
its sensitivity to pH changes (Muller, 2009, Quatresous et al., 2012), and since then 
other enhanced versions of the probe have been developed named HyPer2 and 
HyPer3 (Markvicheva et al., 2011, Bilan et al., 2013). The group is claiming that the 
new probes have a reduced pH sensitivity, however, further improvements were 
recommended (Ermakova et al., 2014, Lukyanov and Belousov, 2014). It would be 
interesting to examine the new probes in mouse eggs and identify if any 
improvements will be seen in its pH sensitivity. Unfortunately, due to time 
constraints of my study, further enquiry would need to be set up as a future project.  
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